Western Michigan University

ScholarWorks at WMU
Dissertations

Graduate College

12-2014

Probing the Unfolding and the Stability of the Last Four Metal
Binding Domains of Wilson Disease Protein Using Circular
Dichroism and Novel Spectroscopic Techniques
Ibtesam Yaseen Alja’afreh
Western Michigan University, jaafreh.ebtesam@gmail.com

Follow this and additional works at: https://scholarworks.wmich.edu/dissertations
Part of the Analytical Chemistry Commons, Medicinal-Pharmaceutical Chemistry Commons, and the
Organic Chemistry Commons

Recommended Citation
Alja’afreh, Ibtesam Yaseen, "Probing the Unfolding and the Stability of the Last Four Metal Binding
Domains of Wilson Disease Protein Using Circular Dichroism and Novel Spectroscopic Techniques"
(2014). Dissertations. 366.
https://scholarworks.wmich.edu/dissertations/366

This Dissertation-Open Access is brought to you for free
and open access by the Graduate College at
ScholarWorks at WMU. It has been accepted for inclusion
in Dissertations by an authorized administrator of
ScholarWorks at WMU. For more information, please
contact wmu-scholarworks@wmich.edu.

PROBING THE UNFOLDING AND THE STABILITY OF THE LAST FOUR METAL
BINDING DOMAINS OF WILSON DISEASE PROTEIN USING CIRCULAR
DICHROISM AND NOVEL SPECTROSCOPIC TECHNIQUES

by
Ibtesam Yaseen Alja’afreh

A dissertation submitted to the Graduate College
in partial fulfillment of the requirements
for the degree of Doctor of Philosophy
Chemistry
Western Michigan University
December 2014

Doctoral Committee:
David Huffman, Ph.D., Chair
Ramakrishna Guda, Ph.D.
Sherine Obare, Ph.D.
Charles Ide, Ph.D.

PROBING THE UNFOLDING AND THE STABILITY OF THE LAST FOUR METAL
BINDING DOMAINS OF WILSON DISEASE PROTEIN USING CIRCULAR
DICHROISM AND NOVEL SPECTROSCOPIC TECHNIQUES
Ibtesam Yaseen Alja’afreh, Ph.D.
Western Michigan University, 2014

Wilson disease protein is a copper-transporting P1B type ATPase. It has large Nterminal copper binding domain which is composed of six homologous sub-domains.
Each of these six domains is ~72 residues and connected to one another by linking
regions of various lengths. They all possess similar ferrodoxin fold, and metal-binding
motif, MXCXXC.
The need of having six metal binding domains and the manner in which they are
communicating with each other is not well understood. To better understand how the last
four metal binding domains function, I pursued a detailed biophysical characterization of
these domains. Using molecular biology I have produced domains 3 through 6 (WLN36), domains 4 through 6 (WLN4-6) and domains 5 through 6 (WLN5-6). Unfolding of
these constructs was performed chemically using guanidine hydrochloride (GuHCl) and
monitored by circular dichroism (CD). WLN5-6 unfolds in two-state model where half of
its structure is retained at 3.2 M GuHCl. However, denaturation of WLN3-6 and WLN4-6
produced a double sigmoidal curve in which the first sigmoidal transition almost matches
the unfolding of WLN5-6 while the second transition matches the unfolding of WLN4.
The thermal unfolding illustrated high stability for all constructs.

The unfolding of a mutant of WLN5-6 where tyrosine 48 mutated to histidine,
Y532H in the whole Wilson protein, was studied by CD and femtosecond time-resolved
fluorescence spectroscopy. CD showed no significant differences in the thermal and
chemical unfolding but the tyrosine fluorescence was reduced because the mutation
disturbs the hydrophobic core of the protein.
To study the unfolding of the protein efficiently, I introduced two-photon
absorption (2PA) cross-sections as novel fluorescence technique to monitor the unfolding
of proteins and imaging the change in its local electric field. Green Fluorescent Protein
(GFP) was used to test our hypothesis and the method was applied in WLN5-6 after
binding it to an extrinsic CPM dye. Two constructs were produced, with CPM at
positions 51 and 6, WLN5-6C51_CPM and WLN5-6C6_CPM. In both constructs the
anisotropy and the 2PA cross-sections increased with protein unfolding and matches the
CD results, this result suggests the validity of this method to monitor protein unfolding.
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Ibtesam Yaseen Alja’afreh
2014

ACKNOWLEDGMENTS

Foremost, I would like to express my sincere gratitude to my advisor Dr. David
Huffman for his endless support, guidance, patience, and advice in the course of this
project. I admire and would love to acquire his intrinsic qualities of patience, objective
judgment and decision making.
In addition, I would like to express my deepest gratitude to Dr. Ramakrishna
Guda, committee member and collaborator in most of my projects. Without his constant
guidance, motivation, enthusiasm, and immense knowledge this work would not have
been possible.
I would also like to thank the other members of my dissertation committee, Dr.
Sherine Obare and Dr. Charles Ide, for their availability in my committee meetings and
also for their encouragements, and insightful comments.
I also convey my gratitude to the dedicated faculty and staff at Western Michigan
University. Dr. Michael Barcelona, Dr. Donald Screiber, Dr. Andre Venter, Dr. Ekkhard
Sinn, Dr. Steve Bertman, Dr. Gary Blackmer, and Dr. Blair Szymczyna. Staff members:
Pam McCartney, Robin Lenkart, and Sean Bashaw.
In my daily work I have been blessed with a friendly and cheerful group of fellow
students. I am grateful for the past and present members of both Dr. Huffman’s and Dr.
Guda’s research group who have been invaluable for practical help, discussions, and
constructive criticism. Past members include: Dr. Joshua Muia, Dr. Alia Hinz, and Ms.

ii

Acknowledgments—Continued

Nastaran Marzijarani. Present members include: Dr. Jameel Hasan, Dr. Edwin Mghanga,
Mr. Saad Alotaibi, Mr. Abu Bakar Abu Hagar, Mr. Javan Kisaka and Mr. Mohammad
Hatshan.
Last, but not least, I would like to dedicate this dissertation to my parents for all
their love and encouragement, to my brothers and sister who have loved me and
supported me in all the endeavors.
In conclusion, I recognize that my study would not have been possible without the
financial support from Tafila Technical University, which provided me with a scholarship
for four years of my study, the Graduate College at Western Michigan University for
research and travel grants, and the Department of Chemistry for teaching assistantships
and recognition awards.
Ibtesam Yaseen Alja’afreh

iii

TABLE OF CONTENTS
ACKNOWLEDGMENTS .................................................................................................. ii
LIST OF TABLES ............................................................................................................. xi
LIST OF FIGURES ......................................................................................................... xiii
LIST OF ABBREVIATIONS ........................................................................................... xx
CHAPTER
1. COPPER CHAPERONES AND TRANSPORTERS ..................................................... 1
1.1

Introduction .......................................................................................................... 1

1.2

Function and transporting of copper .................................................................... 3

1.3

High affinity copper uptake proteins .................................................................... 5

1.4

Copper transporter protein 1 (CTR1) ................................................................... 7

1.5

Copper metallochaperones ................................................................................. 10

1.5.1

COX17 ........................................................................................................ 11

1.5.2

CCS ............................................................................................................. 13

1.5.3

ATX1-type copper chaperones ................................................................... 16

1.5.4

Putative chaperones .................................................................................... 18

1.6

ATOX1 (HAH1) ................................................................................................ 19

1.7

Copper transporting ATPases ............................................................................ 20

1.7.1

Menkes disease protein ............................................................................... 21

1.7.2

Wilson disease protein ................................................................................ 22

1.8

Copper transfer from HAH1 chaperone to Cu-ATPase ..................................... 25

1.9

References .......................................................................................................... 29

iv

Table of Contents-Continued

CHAPTER
2. MATERIALS AND EXPERIMENTAL METHODS .................................................. 40
2.1

Introduction ........................................................................................................ 40

2.2

Kits, chemicals and reagents .............................................................................. 40

2.2.1

Protein notations and primers ..................................................................... 42

2.3

Instrumentation................................................................................................... 45

2.4

Procedures .......................................................................................................... 48

2.4.1

Construction of WLN3-6 plasmid .............................................................. 48

2.4.2

Transformation, expression and purification of WLN3-6 .......................... 51

2.4.3

DNA plasmid, Cloning and Purification of WLN4-6 ................................. 53

2.4.4

DNA plasmid, Cloning and Purification of WLN5-6 ................................. 56

2.4.5

Transformation, expression and purification of WLN5-6 .......................... 57

2.4.6

Tobacco etch virus (TEV) protease expression and purification ................ 59

2.4.7

1

2.5

H,15N NMR HSQC for WLN3-6, WLN5-6 .............................................. 60

Biophysical properties of proteins...................................................................... 63

2.5.1

Dynamic light scattering ............................................................................. 63

2.5.2

Fluorescence ............................................................................................... 67

2.5.3

Fluorescence anisotropy.............................................................................. 71

2.5.4

Measurements of fluorescence anisotropies ............................................... 74

2.5.5

Two-photon absorption. .............................................................................. 76

2.5.6

Ultrafast fluorescence spectroscopy via upconversion ............................... 77

v

Table of Contents-Continued

CHAPTER
2.5.7

Circular dichroism ...................................................................................... 81

2.5.8

Circular dichroism for biological molecules............................................... 83

2.6

References .......................................................................................................... 85

3. BIOPHYSICAL PROPERTIES OF WLN3-6, WLN4-6 AND WLN5-6 .................... 89
3.1

Introduction ........................................................................................................ 89

3.2

Biophysical characterization and analysis of WLN5-6 ...................................... 92

3.3

Circular dichroism .............................................................................................. 93

3.4

Biophysical characterization and analysis of WLN4-6 ...................................... 98

3.4.1

Chemical and thermal denaturation of WLN4-6 ...................................... 100

3.4.2

Isoelectric point (pI) of WLN4-6 .............................................................. 104

3.4.3

Dynamic light scattering ........................................................................... 105

3.5

Biophysical characterization and analysis of WLN3-6 .................................... 106

3.5.1

Mass spectroscopy (MS) ........................................................................... 106

3.5.2

Dynamic light scattering ........................................................................... 109

3.5.3

Circular dichroism .................................................................................... 112

3.5.4

Isoelectric point ......................................................................................... 116

3.6

High resolution gel filtration ............................................................................ 117

3.7

Secondary structure of WLN5-6, WLN4-6 and WLN3-6................................ 120

3.8

Summary and conclusion ................................................................................. 122

3.9

References ........................................................................................................ 125

vi

Table of Contents-Continued

CHAPTER
4. WILSON DISEASE CAUSING MUTANT Y532H .................................................. 128
4.1

Introduction ...................................................................................................... 128

4.2

Experimental methods ...................................................................................... 131

4.2.1

Expression of Y532H ................................................................................ 131

4.2.2

Circular dichroism .................................................................................... 132

4.2.3

Fluorescence spectroscopy........................................................................ 133

4.2.4

Quantum yield ........................................................................................... 133

4.3

Results and discussion...................................................................................... 134

4.3.1

Circular dichroism .................................................................................... 134

4.3.2

Fluorescence measurements...................................................................... 139

4.3.3

Quantum yield ........................................................................................... 142

4.3.4

Ultrafast time-resolved fluorescence spectroscopy .................................. 144

4.4
4.4.1

Comparison of Y532H to other mutants V536A, and L492S .......................... 145
Mechanism of ultrafast fluorescence quenching in disease causing
mutations…..…………..…………………………………………………150

4.5

Summary and conclusion ................................................................................. 151

4.6

References ........................................................................................................ 152

5. GREEN FLUORESCENT PROTEIN UNFOLDING ................................................ 154
5.1

Introduction ...................................................................................................... 154

5.2

Experimental methods ...................................................................................... 158

5.2.1

Plasmid generation .................................................................................... 158

vii

Table of Contents-Continued
CHAPTER
5.2.2

Expression and protein purification .......................................................... 160

5.2.3

Unfolding of GFP ..................................................................................... 164

5.2.4

Fluorescence spectroscopy........................................................................ 164

5.3

Results and discussion...................................................................................... 165

5.3.1

Mass spectrometry .................................................................................... 165

5.3.2

Steady state optical properties .................................................................. 168

5.3.3

Circular dichroism .................................................................................... 171

5.3.4

Fluorescence lifetime ................................................................................ 172

5.3.5

Fluorescence upconversion ....................................................................... 174

5.3.6

Two-photon absorption ............................................................................. 177

5.3.7

Two-photon absorption cross-section ....................................................... 179

5.4

Summary .......................................................................................................... 181

5.5

References ........................................................................................................ 182

6. MONITORING THE UNFOLDING OF THE N-TERMINAL DOMAINS 5-6 OF
WILSON DISEASE PROTEIN USING EXTRINSIC FLUOROPHORE ................ 185
6.1

Introduction ...................................................................................................... 185

6.2

Experimental methods ...................................................................................... 189

6.2.1

Construction of plasmid pET24dWLN5-6C51 ......................................... 189

6.2.2

Expression and purification of WLN5-6C51 protein................................ 193

6.2.3

Binding WLN5-6C51 to CPM dye ........................................................... 194

6.2.4

Cloning, expression and purification of WLN5-6Cys6 protein ................ 195

viii

Table of Contents-Continued
CHAPTER
6.2.5

Circular dichroism .................................................................................... 197

6.2.6

Fluorescence spectroscopy........................................................................ 198

6.2.7

Quantum yield ........................................................................................... 198

6.3

Results and discussion...................................................................................... 198

6.3.1

Measuring of quantum yield of WLN5-6C51_CPM ................................ 198

6.3.2

Mass spectrometry .................................................................................... 200

6.3.3

Circular dichroism .................................................................................... 203

6.3.4

Steady-state measurements ....................................................................... 209

6.3.5

Two-photon absorption cross-section ....................................................... 215

6.3.6

Time-correlated single photon counting ................................................... 217

6.3.7

Fluorescence upconversion ....................................................................... 218

6.4

Summary .......................................................................................................... 220

6.5

References ........................................................................................................ 224

7. SUMMARY AND FUTURE OUTLOOK ................................................................. 226
7.1

Summary of dissertation work ......................................................................... 226

7.2

Significance ...................................................................................................... 229

7.3

Future outlook .................................................................................................. 230

7.4

References ........................................................................................................ 230

APPENDICES
A. Amino acid sequences of WLN5-6, WLN4-6, and WLN3-6 ............................. 232
B. Fluorescence lifetime decays and residuals of GFP at various concentrations of
GuHCl ................................................................................................................. 234
ix

Table of Contents-Continued
APPENDICES
C. Lifetime components of GFP at various concentrations of GuHCl .................... 236
D. Project approval certification .............................................................................. 238

x

LIST OF TABLES
1.1: Copper-dependent proteins and their functions ............................................................3
2.1: Chemicals and reagents ..............................................................................................41
2.2: Enzymes, biological reagents and process kits. ..........................................................42
2.3: PCR primers................................................................................................................43
2.4: Notations of proteins ...................................................................................................44
2.5: Plasmids and their vectors properties .........................................................................44
2.6: Instrumentations and their manufacturer and applications .........................................45
2.7: Columns used with AKTA FPLC to purify proteins ..................................................46
2.8: Solutions and buffers ..................................................................................................47
2.9: KOD hot start DNA polymerase protocol ..................................................................48
2.10: T4 DNA polymerase protocol...................................................................................50
3.1: Free energies and m values of unfolding of WLN4-6 ..............................................101
3.2: Free energies and m values of denaturation of WLN3-6 by GuHCl ........................114
3.3: Elution volumes of the standards and the proteins ...................................................118
3.4: Molecular weight of proteins by high resolution gel filtration and the calculated
one by amino acid composition ................................................................................120
3.5: Percentage of helicity for WLN5-6, WLN4-6, and WLN3-6 ...................................121
3.6: Physical properties of WLN5-6, WLN4-6 and WLN3-6 .........................................124
4.1: Free energies of unfolding WLN5-6 and Y532H obtained from chemical and
thermal unfolding ....................................................................................................139
4.2: Quantum yields of WLN5-6 and Y532H ..................................................................142
4.3: Free energy, and percentage of helicity calculated from CD measurements at
222 nm .....................................................................................................................149
xi

List of Tables- Continued
4.4: Lifetimes of WLN5-6, mutants, and free tyrosine in 50 mM phosphate buffer pH
7.0, at room temperature. ..........................................................................................149
5.1: KOD hot start DNA polymerase reaction .................................................................159
5.2: PCR parameters for amplifying GFP gene ...............................................................159
5.3: T4 DNA polymerase reaction for GFP .....................................................................160
6.1: Sample preparation for mutations in WLN5-6C51 and WLN5-6C6. .......................192
6.2: Thermocycle parameters for mutagenesis. ...............................................................193
6.3: Quantum yield measurements of WLN5-6C51_CPM at 0, 0.5 and 4 M
Guanidine Hydrochloride. .......................................................................................199

xii

LIST OF FIGURES
1.1: Transport mechanism. The three subunits are shown , with residues of interest
depicted in astiric and the copper ion in yellow. .................................................................9
1.2: Copper transport pathway ....................................................................................................11
1.3: Model for membrane-dependent copper distribution to CCS and SOD1 ............................15
1.4 :The major functional domains of Wilson protein ................................................................25
1.5: The proposed mechanism of copper transfer between HAH1 (left, green) and a
domain of the Wilson or Menkes protein (right, blue). .....................................................27
2.1: 0.8 % Agarose gel showing PCR product of WLN3-6 amplification .................................49
2.2: Purification of PCR product of WLN3-6 gene amplification: (A) gel photo after
excised WLN3-6 gene. (B) gel after purification of the gene. ...........................................50
2.3: Digestion of WLN3-6 plasmid ............................................................................................51
2.4: 12.5% SDS-PAGE gel shows steps of WLN3-6 expression and purification ....................53
2.5: 0.8% Agarose gel shows purified PCR product of amplifying WLN4-6 gene....................54
2.6: Digestion of WLN4-6 plasmid ............................................................................................54
2.7: 12.5 % SDS-PAGE showing purification steps of WLN4-6. ..............................................55
2.8: SDS-PAGE gel shows pure WLN4-6 protein......................................................................55
2.9: TEV purification steps. A, cell extract. B, flowthrough. C, eluted protein. .......................60
2.10: 1H,15N-HSQC results for WLN5-6 and WLN3-6. .............................................................62
2.11: Schematic representation of speckle pattern. Applications of DLS to Proteins ................66
2.12: Fluorescence process .........................................................................................................68
2.13: Schematic diagram of TCSPC setup..................................................................................70

xiii

List of Figures-Continued
2.14: L and T format to measure fluorescence anisotropies. ......................................................74
2.15: Schematic diagram of upconversion ..................................................................................79
2.16: Scheme for fluorescence upconversion measurements. ....................................................80
2.17: CD for proteins of different secondary structure. ..............................................................84
3.1: Cartoon structure of WLN3-4, WLN5-6, and WLN2 .........................................................91
3.2: ESI-IT/MS data showing the molecular weight of WLN5-6 determined by MagTran
software ..............................................................................................................................92
3.3: Molar ellipticity for the unfolded WLN5-6 using GuHCl ...................................................93
3.4: Fraction denatured of WLN5-6 as GuHCl is added ............................................................95
3.5: ∆G of WLN5-6 at different [GuHCl], at 293 K ...................................................................96
3.6: Thermal unfolding of WLN5-6............................................................................................96
3.7: Analysis of thermal unfolding for WLN5-6. .......................................................................97
3.8: ESI-IT/MS data showing the molecular weight of WLN4-6 determined by MagTran
software ..............................................................................................................................99
3.9: Unfolding of WLN3-6 by GuHCl ......................................................................................100
3.10: Thermal unfolding of WLN4-6........................................................................................102
3.11: Analysis of thermal unfolding of WLN4-6......................................................................103
3.12: Phast gel 3-9 and isoelectric focusing of WLN4-6 ..........................................................105
3.13: Autocorrelation fit of the hydrodynamic radius of WLN4-6 ...........................................106
3.14: ESI-IT/MS data showing the molecular weight of WLN 3-6 determined by MagTran
software ............................................................................................................................108
3.15: Mass distribution of WLN3-6 protein versus volume. The solid lines (line)
indicate(s) the trace from refractometer while "dots" are weight average MW .............110
3.16: Hydrodynamic radius (Rh) determined from “on line” dynamic light scattering of
WLN3-6 ...........................................................................................................................111
xiv

List of Figures-Continued
3.17: Autocorrelation fit of hydrodynamic radius of WLN3-6.................................................111
3.18: Unfolding of WLN3-6 by [GuHCl] .................................................................................113
3.19: Thermal unfolding of WLN3-6........................................................................................115
3.20: Analysis of thermal unfolding of WLN3-6......................................................................115
3.21: Phast gel 3-9 and isoelectric focusing of WLN3-6 ..........................................................116
3.22: Standards calibration curve of high resolution gel filtration ...........................................118
3.23: Calibration curve of the standard proteins Stoke’s radius ...............................................119
3.24: CD scan of WLN5-6, WLN4-6, and WLN3-6 ................................................................121
3.25: Unfolding of WLN5-6, WLN4-6, and WLN3-6 by GuHCl ............................................122
3.26: Thermal unfolding of WLN5-6, WLN4-6, and WLN3-6 ................................................123
4.1: Cartoon structure of WLN5-6 (PDB:2EW9), and WLN5-6 Y532H (Tyr48 replaced by
His)...................................................................................................................................131
4.2: CD scan for Y532H ...........................................................................................................135
4.3: Thermal unfolding of Y532H monitored at 222 nm ..........................................................136
4.4: CD scan for folded and unfolded sample of Y532H .........................................................136
4.5: Unfolding of Y532H by GuHCl monitored at 222 nm ......................................................137
4.6: Analysis of chemical unfolding of Y532H to calculate free energy in water ....................138
4.7: Thermal unfolding analysis to obtain free energy .............................................................138
4.8: Emission scans of Tyrosine in Y532H at different [GuHCl].............................................139
4.9: Fluorescence counts at 310 nm for Y532H at different [GuHCl]......................................140
4.10: Emission scans for Tyrosine in WLN5-6 (wild type) ......................................................141
4.11: Fluorescence counts at 310 nm for WLN5-6 ...................................................................141

xv

List of Figures-Continued
4.12: Absorbance scan for quantum yield measurements of WLN5-6 and Y532H .................143
4.13: Fluorescence scans of WLN5-6 and Y532H for quantum yield measurements ..............143
4.14: Fluorescence decay of WLN5-6, Y532H, and Tyrosine .................................................145
4.15: Cartoon structure of WLN5-6 (PDB:2EW9) showing the position of V536 and L492 ..146
4.16: Unfolding of WLN5-6, Y532H, L492S, and V536A by GuHCl monitored at 222nm ...147
4.17: CD scan of WLN5-6, Y532H, V536A, and L492S. ........................................................148
4.18: Fluorescence decay of Tyrosine, WLN5-6, and the mutants (Y532H, L492S, and
V536A) ............................................................................................................................150
4.19: Cartoon structure of WLN5-6 showing the hydrogen bonding between Y48 (Y532),
Y75 (Y559) , and Y110 (Y594) .......................................................................................151
5.1: Formation of GFP chromophore. .......................................................................................155
5.2: Cartoon structure of GFP, (PDB: 1GFL) ...........................................................................156
5.3: 15 % SDS-PAGE showing GFP after purification ............................................................164
5.4: ESI-IT/MS data showing the molecular weight of GFP determined by MagTran
software. ...........................................................................................................................167
5.5: Absorbance scan and emission scan of GFP, Excitation wavelength is 470 nm. ..............168
5.6: Absorbance scan of GFP at different [GuHCl] and the inset represents the absorbance
for each sample at 480 nm and 380 nm. ..........................................................................169
5.7: Emission scan of GFP at different [GuHCl], the inset showing the fluorescence counts
for each sample at 507 nm ...............................................................................................170
5.8: Quantum efficiency of GFP ...............................................................................................171
5.9: CD scan for GFP ................................................................................................................171
5.10: CD scan of GFP at different [GuHCl], inset shows the molar ellipticity at 215 nm. ......172
5.11: Lifetime of GFP chromophore at various GuHCl concentrations ...................................174

xvi

List of Figures-Continued
5.12: Fluorescence decay traces as a function of increasing Guanidine hydrochloride.
Also, shown is the average lifetime with increasing GuHCl following the unfolding
transitions. ........................................................................................................................176
5.13: Anisotropy values of GFP at various [GuHCl] ................................................................176
5.14: Log-log graph for GFP showing a slope of 2. .................................................................178
5.15: Fluorescence emission spectra of GFP at 800 nm excitation, inset shows the
fluorescence counts at 507 nm at various [GuHCl]. ........................................................178
5.16: Two-photon absorption scan of GFP at different [GuHCl], inset shows the relative
2PA cross-section.............................................................................................................179
5.17: Change in local electric field in GFP as it unfolds ..........................................................180
6.1: CPM dye structure and covalent bond formation between maleimide group and thiol
group. ...............................................................................................................................187
6.2: Cysteine positions in both constructs of WLN5-6. ............................................................188
6.3: Constructions of WLN5-6C51 ...........................................................................................190
6.4: Scheme represents the mutations performed for WLN5-6C6 ...........................................196
6.5: ESI-IT/MS data showing the molecular weight of WLN5-6C51 determined by
MagTran software. ...........................................................................................................200
6.6: ESI-IT/MS data showing the molecular weight of WLN5-6C51_CPM determined by
MagTran software. ...........................................................................................................201
6.7: ESI-IT/MS data showing the molecular weight of WLN5-6C6 determined by
MagTran software. ...........................................................................................................202
6.8: ESI-IT/MS data showing the molecular weight of WLN5-6C6_CPM determined by
MagTran software. ...........................................................................................................203
6.9: CD signal for the unfolding of WLN5-6C51 by GuHCl. ..................................................204

xvii

List of Figures-Continued
6.10: Free energy of WLN5-6C51 by linear extrapolation method ..........................................205
6.11: CD signal of the unfolding of WLN5-6C51_CPM..........................................................205
6.12: Free energy of WLN5-6C51_CPM..................................................................................206
6.13: CD signal of the unfolding of WLN5-6C6 by GuHCl.....................................................207
6.14: Free energy of WLN5-6C6. .............................................................................................207
6.15: CD signal of the unfolding of WLN5-6C6_CPM by GuHCl. .........................................208
6.16: Free energy of WLN5-6C6_CPM....................................................................................208
6.17: Absorption scan of WLN5-651_CPM at various [GuHCl]. ............................................210
6.18: Emission scan of WLN5-6C51_CPM at various [GuHCl]..............................................210
6.19: log-log plot for two-photon absorption measurements. ...................................................211
6.20: Emission scan of two-photon absorption for WLN5-6C51_CPM at various [GuHCl]...212
6.22: Neutralized emission maximum counts for WLN5-6C51_CPM at 480 nm at
different [GuHCl].............................................................................................................212
6.22: Absorbtion scan for WLN5-6C6_CPM at various [GuHCl], inset shows λmax changes
while protein unfolds. ......................................................................................................213
6.23: Emission scan of WLN5-6C6_CPM at various [GuHCl], inset shows Fl. counts at
478 nm with respect to [GuHCl]......................................................................................214
6.24: Emission scan of two-photon absorption for WLN5-6C6_CPM at various [GuHCl].....214
6.25: Neutralized emission maximum counts for WLN5-6C6_CPM at 480 nm as a
function of [GuHCl].........................................................................................................215
6.26: Two-photon absorption cross-section for the control, WLN5-6C51_CPM and
WLN5-6C6_CPM. ...........................................................................................................216

xviii

List of Figures-Continued
6.27: Change in lifetime with unfolding by GuHCl for the control, WLN5-6C51_CPM and
WLN5-6C6_CPM. ...........................................................................................................218
6.28: Change in Anisotropy with unfolding by GuHCl for the control, WLN5-6C51_CPM
and WLN5-6C6_CPM. ....................................................................................................220
6.29: The direction of the dipole moment in CPM in WLN5-6C51_CPM and WLN56C6_CPMwith respect to the electric field in WLN5-6 mutant. .....................................222

xix

LIST OF ABBREVIATIONS
2PA ................................................................................................ Two-Photon Absorption
ATP7A .................. Copper-transporting ATPase 1 or Menkes Disease-Aasociated Protein
ATP7B ................... Copper-transporting ATPase 2 or Wilson Disease-Aasociated Protein
BCA ............................................................................................ Bicinchoninic Acid Assay
CCS .............................................................. Copper Chaperone for Superoxide Dismutase
CD .......................................................................................................... Circular Dichroism
COX17 ...............................................................Cytochrome c Oxidase Copper Chaperone
CPM ................................. 7-Diethylamino-3-(4`-Maleimidylphenyl)-4-Methoxycoumarin
Ctr1 ..................................................................................................... Copper Transporter 1
DLS .............................................................................................. Dynamic Light Scattering
DTT ..................................................................................................................Dithiothreitol
EDTA ................................................................................ Ethylenediaminetetraacetic Acid
GFP ............................................................................................. Green Fluorescent Protein
GuHCl .......................................................................................... Guanidine Hydrochloride
HAH1 ......................................................................................... Human ATX1 Homologue
hCTR1 .................................................................................... Human Copper Transporter 1
HSA................................................................................................. Human Serum Albumin
HSQC ................................................................ Heteronuclear Single Quantum Coherence
IPTG ...................................................................... Isopropyl β-D-1-Thiogalactopyranoside
PAGE ...........................................................................Polyacrylamide Gel Electrophoresis
PCR ........................................................................................... Polymerase Chain Reaction
xx

List of Abbreviations -Continued

PDB .......................................................................................................... Protein Data Bank
SDS ................................................................................................ Sodium Dodecyl Sulfate
SOD................................................................................................... Superoxide Dismutase
TCSPC .................................................................Time Correlated Single Photon Counting
TEV ....................................................................................................... Tobacco Etch Virus
TGN .................................................................................................... Trans-Golgi Network
TRX....................................................................................................................Thioredoxin
WLN ........................................................................ N-terminal domains of Wilson Protein

xxi

CHAPTER I
1

1.1

COPPER CHAPERONES AND TRANSPORTERS

Introduction
Copper plays a vital role in cellular biochemistry and body health. It is needed for

energy production, protection against oxidative tissue damage, production of adrenalin,
collagen and elastin. Also, it is essential for blood clotting, iron metabolism and
antioxidant protection because it acts as an electron donor or acceptor as a component of
metalloenzymes1–5.
Dietary copper is likely to be in the Cu2+ form. It is absorbed as Cu+ in the small
intestine and, to a limited extent, in the stomach. So, it needs to be reduced before uptake
at the apical membrane of the enterocyte. The major transporter of copper across the
apical membrane of the intestinal cell is Ctr1 (copper transporter 1)6. Upon copper entry
into the cell, it binds to cytosolic copper chaperones to escort copper to its target protein.
The three known Copper chaperones are CCS, COX17 and ATOX1 antioxidant protein
1(also known as HAH1)7,8. The chaperone respective protein targets are Cu,Zn
superoxide dismutase (SOD1), cytochrome c oxidase in the mitochondria and ATP7A
and ATP7B copper transporting ATPases in the secretory pathway9. Copper transporters
exist to translocate Cu(I) from the cytoplasm, but their localization is restricted to the
trans-Golgi network and internal vesicles. ATPases (ATP7A and ATP7B) traffic from the
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trans Golgi network (TGN) to cytoplasmic vesicles in response to high cellular Cu
concentrations where they efflux Cu(I) 10.
The ATP7A protein in intestinal enterocytes undergoes copper-induced
trafficking. In the response to copper perfusion of the intestine, ATP7A trafficked rapidly
to basolateral vesicles. This response of ATP7A facilitates copper delivery into the
circulation11. Mutations or deletions in the gene encoding ATP7A are associated with
Menkes disease. Menkes syndrome is an X-linked recessive disorder that causes severe
systemic copper deficiency and is usually fatal before an individual is 3 years of age12.
ATP7B is found primarily in the liver, with smaller amounts in the kidneys, brain and
placenta. It is found in the membrane of Golgi apparatus. In hepatocytes, an increase in
copper levels results in trafficking of ATP7B from the TGN to pericanalicular vesicles,
and then ATP7B recycles back to the TGN when copper levels are restored9. ATP7B also
facilitates the transfer of copper to the major plasma copper transport protein,
ceruloplasmin9,13. Inactivation of ATP7B leads to Wilson disease. Wilson disease (also
known as hepatolenticular degeneration) was first described in 1912 by S. A. Kinnier
Wilson as “progressive lenticular degeneration,” a familial, lethal neurological disease
accompanied by chronic liver disease leading to cirrhosis14. It is caused by absent or
reduced function of ATP7B protein which leads to decreased hepatocellular excretion of
copper into bile. This results in hepatic copper accumulation and injury. Eventually,
copper is released into the bloodstream and deposited in other organs, notably the brain,
kidneys, and cornea. Failure to incorporate copper into ceruloplasmin is an additional
consequence of the loss of functional ATP7B protein15.
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Wilson's disease occurs in 1 to 4 per 100,000 people. Copper takes at least five to
six years to reach damaging levels in the liver and often 15 to 20 years or more to cause
neurological damage. If untreated, Wilson's disease is fatal15.

1.2

Function and transporting of copper
Copper plays a vital role in cellular biochemistry and body health. It is needed for

energy production, and protection against oxidative tissue damage. It is essential for
production of adrenalin, collagen and elastin. It is required for growth, cardiovascular
integrity, neuroendocrine function, and lung elasticity. Nevertheless, it is essential for
blood clotting, iron metabolism and antioxidant protection because it acts as an electron
donor or acceptor as a component of metalloenzymes1–4, Table 1.1.
Table 1.1: Copper-dependent proteins and their functions16

Example
Azurin
Ceruloplasmin
Cu, Zn Superoxide dismutase
Cytochrome c oxidase
Dopamine β-hydroxylase
Hemocyanin
N2O reductase
Plastocyanin
Tyrosinase

Function
Electron transfer in respiration
Iron and copper transport
Superoxide dismutation
Electron transfer in respiration,
Reduction of O2 to H2O
Catecholamine production
O2 Transport
Reduction of N2O to N2
Electron transfer in photosynthesis
Pigment formation

Copper is present in body tissue in trace amounts, but the highest amount is found
in the liver, followed by the brain, kidney and heart. An adult body contains around 100
mg of copper3.It usually bound to protein complexes; 95% of blood plasma copper is
bound to ceruloplasmin, while the rest is bound loosely to other blood proteins such as
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albumin, transcuperin, and amino acids. However, for a given ceruloplasmin
concentration in healthy people, the total copper concentration is varying by 50 µg/dL (8
µmol/L)17.
It is recommended to have adequate copper intake, which ranges between 0.34
mg/day for 1-3 years old to 0.90 mg/day for adults18. Beef liver is considered the richest
dietary source of copper. Some beans, nuts, and legumes are particularly high in copper,
such as cashews, sunflower seeds, and cooked lentils. Dark chocolate and enriched
cereals and rice would also help add copper to diet.
Absorption of copper occurs in its ionic form in the small intestine and, to a
limited extent, in the stomach. However, intestinal absorption of copper limited by other
metal ions like zinc and cademium, and sulfide ions19,20. The presence of some amino
acids and ascorbic acid in the intestine also lower the absorption of copper21,22. Absorbed
copper carried in the blood by different transport proteins such as ceruloplasmin, albumin
and transcuprein and/or histidine23. Once it is in the blood, it is distributed in two stages;
in the first stage, most taken up by liver and kidney; in the second, it re-emerges as buried
in the ceruloplasmin. Later, after bound to ceruloplasmin, it is taken by other tissues24.
The fact that copper concentration in a mammalian liver is around 5 mg/g wet weight and
in the kidney is 7-12 mg/g wet weight is considered the highest in the mammalian
organs5. This fact may reflect that they are the first tissues where dietary copper is
deposited and that both organs synthesize and secrete ceruloplasmin24.
Basically, ceruloplasmin-copper is the source of copper for body tissues.
Ceruloplasmin exchanges its copper at the surface of cell membrane. A transmembrane
protein called CTR1(copper transporter 1) is the primary copper transporter to the
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intracellular compartments. Dietary copper is likely to be in copper(II) form; therefore, it
has to be reduced before it transports through CTR1 pore, which achieved by dietary
reductants like ascorbate and cupric reductases or some ferric reductases25.
Upon copper (I) entry into the cell, it may be channeled to a copper storage protein
known as metallothionein or binds to cytosolic copper chaperones to escort copper to its
target protein. The three known Copper chaperones are CCS, COX17 and ATOX1
antioxidant protein 1(also known as HAH1)7,8. The chaperone respective protein targets
are Cu,Zn superoxide dismutase (SOD1), cytochrome c oxidase in the mitochondria, and
ATP7A and ATP7B copper transporting ATPases in the secretory pathway9. ATPases
traffic from the trans Golgi network (TGN) to cytoplasmic vesicles in response to high
cellular Copper concentrations where they efflux copper (I) ions26.

1.3

High affinity copper uptake proteins
Ceruloplasmin is the major copper-carrying protein in the blood. Its gene in the

human called CP. It is located on the long q arm in chromosome 3 between positions 23
and 25 from base pair 148,880,196 to base pair 148,939,83127.
Ceruloplasmin, also called ferroxidase, functions to move iron from tissue into the blood
and to prepare iron for incorporation into a transferrin, which is a molecule that transports
the iron to red blood cells28.
Ceruloplasmin is made in liver and brain. The form that is made in liver called
serum ceruloplasmin, and it moves iron from most of the body except the brain because it
is not able to enter the brain. Another form ceruloplasmin is made in brain, nervous
system cells called glia, and called glycosylphosphatidylinositol (GPI)-anchored form;
5

this form is important for transporting iron in the brain and releasing it from brain
tissue28.
Ceruloplasmin carries more than 95% of the total copper in healthy human
plasma. It contains 6 atoms of copper in its structure. It possesses a copper-dependent
activity which allows it to function in oxidation of ferrous ion into ferric ion that
transferring can carry4.
The molecular weight of the human ceruloplasmin is reported to be 151 KDa29. Its
structure has been solved by X-ray structural study in 199630. It is comprised of six
cuprodexin type domains. Domains one and six are arranged to have three copper ions in
their interface. These ions form a trinuclear cluster. Domains 2, 4, and 6 have also
mononuclear sites of copper ions. In these sites, each copper ion coordinated to two
histidine, one cysteine and weakly bonded fourth ligand of methionine residue, except
that for the one in domain 2 which replaced by leucine. These arrangements of all six
copper atoms are same as in ascorbate oxidase.
The albumins are water-soluble proteins; the most common one is serum albumin.
Human serum albumin (HSA) is the most prominent protein in plasma, it concentration in
blood is about 7 M, it is synthesized in liver and exported as a single non-glycosylated
chain. HSA has an extraordinary ligand binding capacity specially for the compounds
which are not soluble in aqueous media such as unesterified fatty acids. It usually binds
up to two moles of unesteriﬁed fatty acids in normal conditions, but can accommodate up
to six moles under certain disease conditions31.
Albumin is the major zinc transporter in plasma, typically binds about 80% of all
plasma zinc. It also binds heme that is released in the bloodstream in order to transfer it to
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human hemopexin. Furthermore, HSA has a good binding capacity for water, hormones,
bilirubin, drugs and ions such as, calcium, sodium, potassium and copper. It has
enzymatic properties and function to regulate the colloidal osmotic pressure of blood32.
HSA is composed of three homologous domains. Each domain has two separate
subdomains connected by random coil33.

1.4

Copper transporter protein 1 (CTR1)
CTR1 is conserved from overall structures from yeast to human and known to have

high affinity to copper (I). Its gene was first discovered as an important gene for iron
transport in Saccharomyces Cerevisiae34. Mammalian CTR1 is a symmetrical
homotrimer, where each monomer has three transmembrane domains, extracellular Nterminal domain, and short intracellular c-terminal domain35. All nine transmembrane
domains form a pore in the lipid bilayer that is a putative for importing of copper(I)36.
This protein also imports Ag(I), which is considered as possible competitor for copper(I)
transport because both have similar outer-electron properties37. Interestingly, this protein
is also able to transport cisplatin which is a platinum anticancer drug38.
The human CTR1(hCTR1) gene is located on chromosome 9, more specifically
9q31/32

39

. It is considerably smaller than in yeast. It consists of 190 amino acids. To

transport copper ions, hCTR1 does not need ATP hydrolysis or ion gradient, which
suggest that it is not an ion pump or a secondary transport.
Structural data, functional motion, cooperative dynamics, and available mutagenesis, all
those strategies provide new insight toward hCTR1 transportation mechanism, Figure
1.1. Copper ions are transported one at a time, and the TM region of hCTR alternates
7

between four conformations40, Figure 1.1. In the first step ions do not bind to TM
domain, the Met150 and Met154 triads regulate the passing of single ion every each cycle
by controlling gating and selectivity. In the second step, activation happen due to pH shift
or ion binding and this involves conformational change at the cytoplasmic end and a
rotational movement at the extracellular end at the same time. At this point, copper ions
bind to Met154 and interactions between protonated His139 and Gly84 occur to stabilize
the change in the conformation. In the third step, another conformational change happens
in the extracellular end and makes the copper ion to be passed on to the Met150 triad
while Met154 closes the pore entrance. In the last step, copper ion passes freely through
the polar pore. After that, it is passed through the C-terminus and from there to the copper
chaperones via unrevealed mechanism.
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Figure 1.1: Transport mechanism. The three subunits are shown , with residues of interest
depicted in astiric and the copper ion in yellow.

A new low-resolution model suggests that the size of the apparent “pore” could be
modulated by small movements of TM2 or changes in the rotamer conformation of the
Met side chains. Also, hCTR1 Phe153 and Tyr147 appeared to facilitate packing of TM2
within the entrance to the pore35. Therefore, substitution of Trp for Tyr147 in hCTR1
destabilized the protein. Also, more conservative replacement by Phe or reduction of the
side chain size to Alanine yields transporters that transport copper at about half Vmax of
9

wild type hCTR41. TM1 and TM3 are packed very closely, and Gly residues of the
GlyxxxGly motif found on TM3 are critical for forming a functional and structurally
intact transporter. TM3 is more sensitive to steric bulk in yeast CTR3 than in hCTR142.
Interestingly, the larger degree of steric constraint in TM3 of yCTR3 is mirrored by what
was observed for TM1. Specifically, the TM1 component of the putative packing
interface with TM3 was relatively insensitive to Trp in hCTR1 but not in yCTR3.
Moreover, the Trp scan indicated that residues A70 and G71 for hCTR1 and A45, I49
and G50 for yCTR3 at the extracellular end of TM1 were sensitive to the introduction of
steric bulk. In addition, the results of the comparative Trp scan leave little doubt that the
‘‘chemistry’’ of copper uptake occurs along the central threefold axis of the trimer where
TM2, with some contributions from TM1 and TM3, create a copper-permeable pore
through the membrane41.

1.5

Copper metallochaperones
Metallochaperones is a term to describe any family of proteins that move metal

ions to specific metalloenzyme or cofactor via protein-protein interaction. Copper
chaperones are cytosolic peptides having CXXC metal binding motif in their N- terminal
region. They were found in bacteria, yeast, plants, and mammalian cells. ATX1, a copper
chaperone isolated from S. cerevisiae, and copZ, a chaperone in Enterococcus hirae, both
show ferredoxin-like folds βαββαβ with CXXC motif in the folded chains43. Copper (I) is
bound to two cysteine sulfur groups that form a linear bidentate ligand. So far, there are
three well-known human copper chaperones: CCS, COX17 and ATOX1, Figure 1.2.
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Figure 1.2: Copper transport pathway

1.5.1

COX17
Cox17 is the cytochrom c oxidase copper chaperone, which first identified in

yeast, it is also conserved in other eukaryotes44,45. Yeast Cox17 is a 69-residue protein
localized to both the cytosol and mitochondrial intermembrane space. COX17 homologue
protein also reported in humans46. Its structure from Saccharomyces cerevisiae was
determined and showed unstructured N-terminal region followed by two helices and
several unstructured C-terminal residues47. It contains six conserved cysteines of which
three are essential in copper coordination. These cysteines are: Cys23, Cys24, and Cys26, in
a CCXC motif

48

. COX17 binds three or four copper (I) ions in a poly nuclear cluster
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arrangement as indicated by X-ray absorption spectroscopy and luminescence data48,49.
The protein oligomerized into a dimer or a tetramer. Loaded Copper COX17 is primarily
dimeric in the cytosol, while the one localized within the intermitochondrial membrane is
predominantly tetrameric48. Oligomerization may be important for delivering multiple
copper ions.
Two other proteins COX11 and SCO1 have been implicated in copper ion
delivery and insertion into cytochrome c oxidase through in vitro experiments. These
proteins are anchored to the mitochondrial inner membrane through a transmembrane αhelix and a large soluble copper binding domain facing in the intermembrane space
where copper transfer occurs45,50. COX17 interacts with SCO1 and COX11, as it possess
number of conserved positively charged residues, which are complimentary with the
negative residues on the surface of SCO1 and COX1. Therefore COX17 is a specific
copper donor to both proteins 51. Copper metallation of these proteins is an intermediate
step in the transfer of copper to the CuA site in COX2 by SCO1 and to the CuB site in
COX1 by Cox1152.
The NMR solution structure of the partially oxidized human Cox17 shows a
completely unstructured N-terminal tail followed by two disulfide bonds, Cys25–Cys54
and Cys35–Cys44, which stabilizes a structure consists of a coiled coil helix-coiled coilhelix domain. The redox properties of the disulfide bonds maintain the assumption that
COX17 upon oxidization by Mia40 becomes partially structured and trapped in the
intermembrane space. In humans, the copper(I) ion is coordinated by the sulfurs of Cys 22
and Cys23, which is the first example of CC binding motif in copper proteins53.
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Eukaryotic cytochrome c oxidase (CcO) forms the terminal enzyme of the electron
transport chain of cells. It is located within the mitochondrial inner membrane with a 37Å
portion sticking out into the intermembrane space and a 32Å portion extending into the
matrix54,55.
Mammalian CcO assembly is composed of 13 subunits, and it is dependent on the
insertion of several cofactors necessary for function, including two hemes and several
metal ions: three copper ions, zinc, magnesium, and sodium56. Both hemes are cofactors
in subunit 1 (COX1), one of which interacts with a mononuclear copper site (CuB)
forming a heterobimetallic active site (heme a3-CuB); whereas, subunit 2 (COX2)
contains two copper ions in a binuclear center (CuA)54.

1.5.2

CCS
CCS is a chaperone for copper-zinc superoxide dismutase (SOD1). Its gene was

first identified as a gene involved in the lysine biosynthesis in yeast, named LYS7 57.
Human CCS is located in chromosome 11, more specifically 11q13. It is expressed in a
wide number of organs. It is a 70 kDa intracellular homodimer which, so far, is the
largest known metallochaperone 57. It folds into three functional domains; whereas, other
chaperones ATOX1 and COX17 represent a single domain protein. These domains are:
the N-terminal domain (domain I), central domain (domain II), and a short C-terminal
domain (domain III). The N-terminal domain is very homologous to ATX1, including its
copper binding site MxCXXC. This domain is proposed to work only under extreme
limiting conditions of copper supply58. The second domain is about 50% identical to
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SOD1 that even a single mutation targeting aspartate in the fourth potential copper ligand
D200H is sufficient to turn CCS into a SOD-like molecule with superoxide scavenging
activity59.
The major difference between domain II and SOD1 is that the former lacks two
loop-regions corresponding to the SOD1 zinc subloop and electrostatic channel loop,
which form the SOD1 metal binding sites and active site channel. As a result, there is no
metal-binding cavity in domain II.
The C-terminal domain is highly conserved among CCS from various species. It
consists of about 30 amino acid residue, including an invariant CXC motif that can bind
copper. It is crucial for the activation of SOD1 in vitro. The crystal structure of this
domain revealed that it is a disordered domain, but it is predicted to lie in the vicinity of
domain I

60

. However, some models suggested that domain III and II work together to

insert copper into the active site of the target protein SOD158,61. Based on the affinities of
domains I and III to copper(I), it has been proposed that domain I plays a role in the
acquisition of copper ions; whereas, domain III act to deliver them to SOD162. Recently,
Unger et. al.63 described surprising findings that cellular membranes play an important
role in initial copper acquisition by CCS. Their data show that SOD1 can engage bilayers,
and even CCS:SOD1 complex retains some affinity for the membrane. This finding
suggests that copper distribution to CCS, cytosolic SOD1, and potentially other
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Figure 1.3: : Model for membrane-dependent copper distribution to CCS and SOD1

CCS forms a heterodimer with SOD1, and it is believed that domain II has a role
in this interaction, as it resembles SOD1. This interaction is important to transfer copper
to the target protein. A study in mammalian cells shows that CCS is also essential to
activate mammalian SOD, but the absence of any of them is not lethal in the mouse8. The
fact that CCS is abundant in erythrocytes suggests it could be a potential marker of
copper status. Mammalians which suffer from copper deficiency have been discovered to
have a higher concentration of CCS protein.
The cytosols of eukaryotic cells contain a superoxide dismutase, which has been
remarkably resistant to evolutionary change. The human SOD1 was first characterized in
196964. It is a homodimeric molecule, which contains a copper- and zinc- binding site in
each subunit. The most prominent structural feature of the subunit of this enzyme is a
15

cylinder made of eight-stranded Greek key β-barrel fold65. It catalyzes the conversion of
superoxide anion to molecular oxygen and hydrogen peroxide.

1.5.3

ATX1-type copper chaperones
ATX1 is the first copper chaperone discovered. It was first known as a gene

expressing a protein with antioxidant activity in Saccharomyces Cerevisiae cells that
lacked SOD1 activity66. The protein was designated as antioxidant 1 (ATX1). The
antioxidant activity was then revealed in vitro to be a result of stoichiometric
consumption of superoxide by Cu-ATX1 complex, which is the reason for the
inactivation of the protein67. The physiological activity of ATX1 is to shuttle copper to
Cu-ATPase which, in turn, pumps copper ions delivered by ATX1 into the Golgi
complex for later insertion into copper enzymes68,69.
ATX1 family chaperones are highly and evolutionary conserved. After the yeast
ATX1 discovery, functional homologous chaperones were identified in a variety of
eukaryotes, including plants70, mice67, rats71, dogs72, and humans73.

In prokaryotes

copper chaperones were sufficiently studied, such as CopZ from Enterococcus hirae and
Bacillus, which deliver copper to the Cu-ATPases CopA and CopB74–76. All ATX1-like
proteins consist of approximately 70 amino acids and have a distinguishing MXCXXC
motif close to the amino terminus.
Studying of ATX1-type copper chaperones, especially bacterial CopZ and yeast
ATX1, established the concept of copper metallochaperones. They are both small and
similar in amino acid sequences to the N-terminal regions of the copper transporter
ATPases proteins, CopA in bacteria, Menkes and Wilson in humans, and Ccc2 in yeast.
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All of these proteins have the same metal binding motif associated with the ﬁrst loop of
βαββαβ (ferredoxin) structural fold. The single βαββαβ-fold of Atx1 or CopZ is
replicated once (CopA), or twice (Ccc2), or six (Menkes and Wilson) times in the
cytosolic regions of the ATPases77.
Coimmunoprecipitations and Cu dependent two-hybrid interactions proved that
ATX1 forms associations with the N-terminal region of Ccc2, and that the human
homolog Atox1(sometimes called HAH1) forms associations with the Menkes or Wilson
ATPases. Moreover, copper transfer between pairs of recombinant proteins was observed
in vitro78.
A sequence of ligand exchange reactions was proposed through the solution
structure of apo and copper (I) forms of ATX1, as well as for the apo and Cu (I) forms of
domain a of Ccc2 (Ccc2a), in addition to the X-ray crystal structure for the homodimer of
Cu(I)-HAH1, among others.
Models of docked heterodimers were obtained from the homodimer structure79
and examined by structural studies. Crystallographic and NMR studies reveal that the
loop regions in ATX1 and ATOX1 that connect the four β strands and the two α helices
are exposed to the solvent along with the binding sites43,77. Whereas, iron sulfur clusters
with similar ferredoxins and the catalytic copper sites in oxidases and oxygenases are
buried in the protein molecule43,80. Therefore, the chaperone metal binding site is well
suited to copper delivery rather than to a catalytic or electron transfer function.
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1.5.4

Putative chaperones
There are chaperones that interact with specific cuproenzymes and are believed to

transfer metal. MURR1 is a protein that is associated with Wilson protein81. Its gene
encodes a 190-amino acid open reading frame of unknown function or of known motif or
homology that is highly conserved in vertebrate species. The deletion of MURR1 gene in
animals causes hepatic copper overload

82,83

. Therefore, MURR1 is required for the

delivery of copper to the bile from Wilson protein.
Another possible copper chaperone is metallothionein (MT). It is a family of
cysteine-rich protein that has low molecular weight, 500 to 14000 Da. In yeast, they are
also known as copper metallothionein (CUP). The two widely expressed isoforms of MT,
MT-1 an MT-2, have more diverse functions and may play a role in intracellular copper
transfer and storage. In the perinatal liver, copper storage is associated with MT. When
copper is limited in liver cells, biliary excretion of copper and holoceruloplasmin
synthesis is low suggesting that MT has a role under these conditions by acting as a
copper reserve. Copper can induce MT synthesis, but zinc is more likely the
physiological inducer84,85.
The third candidate as copper chaperone is APP, a membrane protein which
contains a copper-binding site. It has been suggested that APP serves as a barrier to
copper import in the brain; this suggestion came after studies in mice. These studies
showed that in APP-null mice, the brain copper levels elevated compared to wild type
mice, while brain zinc and iron levels were unaffected86. Also, on transgenic mice that
overexpress APP, the brain copper level reduced87.
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1.6

ATOX1 (HAH1)
The human ATX1 homologue (ATOX1 or HAH1) gene is located in 5q32 and was

first expressed in 1996 by Klomp et al.88. The protein has 68 amino acid residues and a
mass of about 7.5 kDa. Its primary role is to shuttle copper to two types of P1B-type
ATPases, Menkes (ATP7A) and Wilson (ATP7B)89,90. Therefore, it is required for
proper biliary excretion of excess, as well as delivery of copper for holoceruloplasmin 91.
Moreover, other properties may be ascribed to Atox1. It may function to protect neuron
cells from oxidative stress as overexpression of ATOX1 can increase neuronal viability
under stress conditions, such as serum oxidation and deficiency92. Also, it has been
reported that it is involved in cisplatin resistance. Cisplatin is known as anticancer drug,
and it directly binds to Atox1 in the copper binding motif93.
Cells missing Atox1 have impaired movement of ATP7A in response to copper,
providing a mechanistic explanation for copper retention and elevation 94. ATP7A is
normally located in the transgolgi membrane, but when cellular copper concentration
rises it moves to the plasma membrane. Atox1-null mice show signs of
hypopigmentation. The skin distortion is due to the role of ATOX1 in copper delivery to
tyrosinase. Skin distortion is also likely due to reduced levels of lysyl oxidase, the
cuproenzyme that has a role in elastic and collagen cross-linking91.
Recently, Kohno et. al. signify a novel role of ATOX1 in prompting vascular
smooth muscle cell (VSMC) migration in mice, which specifies its role in neointimal
formation after vascular injury, as Atox1 colocalizes with ATP7A in the neointimal
VSMCs after wire injury in vivo. Therefore, Atox1 is a potential therapeutic target for
VSMC migration and inflammation-related vascular diseases95.
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1.7

Copper transporting ATPases
Copper transporting ATPases (Cu-ATPases) are members of a large family of

proteins that use energy from ATP hydrolysis to compel membrane transport of ions96.
Heavy metals in cells are typically regulated by P IB-type ATPases. Cu ATPase expressed
in yeast participates in copper insertion into Fet3, a copper dependent oxidase involved in
iron uptake and oxidation97.
The N-termini of P-type ATPases contain domains that are similar to ATX1 and
CopZ. These domains occur in one copy as in bacterial CopA, or two copies as in yeast
Ccc2, through to six copies in the human ATP7A and ATP7B ATPases. These ATPase
domains have a metal binding motif MXCXXC associated with the first loop of βαββαβ,
a ferrodoxin-like fold78.
Most of knowledge about the structure and function of P-type ATPases originates
from SERCA1, a sarco(endo)plasmic reticulum Ca2+-ATPase from adult rabbits muscle98.
Human copper ATPases, ATP7A and ATP7B, receive copper ions from HAH1
chaperone then pump them into the lumen of the golgi network for following insertion
into the ceruloplasmin88,97.
ATP7A and ATP7B are 50–60% identical. Both are phosphorylated at Ser residue(s).
Copper has a role in the regulation of the extent of a kinase-mediated phosphorylation
process99–101.

Inherited mutations in both ATP7A and ATP7B are responsible for

specific disorders of copper metabolism, Menkes and Wilson diseases, respectively102.
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1.7.1

Menkes disease protein
The gene encodes ATP7A in human is located in chromosome X in the long arm

q at position 21.1. The official name of the gene is ATPase, Cu+2 transporting, alpha
polypeptide. This gene provides instructions for making a protein that is important in
regulating copper levels in the human body. Several mutations in the gene that reduce the
production of ATP7A protein are responsible for a condition called occipital horn
syndrome. In this syndrome, the protein impairs the absorption of copper and affects its
normal distribution which, in turns, reduces the activity of copper-containing enzymes.
Therefore, symptoms related to these enzymes appear, such as loose or sagging skin,
coarse hair, and calcium deposition at the base of the skull and lose joints.
Mutations in the gene that prevent or delete the production of functional ATP7A
protein will lead to Menkes syndrome. Many of these mutations involve deletion of part
of the gene, insertion of an additional DNA blocks, or change single nucleotide. The
abnormal protein will become unable to shuttle back and forth from its location, golgi
apparatus, and stay on the membrane. Eventually, copper deficiency will reduce the
activity of certain copper-containing enzymes and copper levels will be lower in tissues,
like the brain. On the other hand, copper will accumulate in other tissues, like the kidney
and the small intestine. As a result, structure and function of skin, bone, hair, blood
vessels, and nervous system will be affected103.
The ATP7A protein is considered a large protein; it consists of 1500 residues with
total mass of about 163 kDa. The apparent mass for this protein, when it is analyzed on
denatured SDS gels, is higher 175-180 kDa, because of glycosylation99.
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The N-terminal region of ATP7A consists of six sub domains. The structures of
all of them have been determined individually by NMR and crystallography in both holo
and apo forms (Protein Data Bank accession numbers 1KVJ, 1S6U, 2GA7, 2AW0, 1Y3J,
and 1YJV)104.

1.7.2

Wilson disease protein
ATP7B is a gene located on the long q arm of chromosome 13 at position 14.3

that encode Wilson protein (Also called ATPase 2) in humans. Mutations that change one
of the amino acids in this gene alter the dimensional structure or stability of the protein,
which eventually cause Wilson disease. Introducing a stop codon, and deleting or
inserting of small segments of DNA within the gene for making ATPase 2 protein, will
result in producing low protein or even no protein produced. These types of mutations
result in severe symptoms than a single mutation. As a result of all types of mutations,
removal of excess copper from the body is impaired, and therefore, copper accumulates
to toxic levels in the liver and the brain105.
ATP7B as any P1B-type of ATPases has certain structural features: the
transmembrane domain, the ATP-binding domains, which includes two domains:
nucleotide-binding domain (N-domain) and phosphorylation domain (P-domain), and the
actuator domain (A-domain). The most important distinct feature is the presence of a
large N-terminal region comprised of six copper-binding domains, which are connected
by linkers of various lengths. It consists of 1465 residues and has a mass of about 157
kDa, but it has a mobility of a 165 kDa protein. In contrast to ATP7A, this protein is not
glycosylated99.
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The membrane portion of ATP7B has 8 transmembrane segments (TMS) with the
N- and C-termini of the protein both oriented toward the cytosol. The TMS contain the
intra-membrane copper-binding sites, Figure 1.4, to which copper is delivered from the
cytosol and from which it is subsequently exported into the lumen of intracellular
compartments. All TMS in ATP7B are necessary for the Cu-ATPase folding or function.
Furthermore, flexible connections allowing conformational changes are essential for the
Cu-ATPase transport activity. Mutagenesis in the TMS suggest that CPC motif in TMS 6,
NY motif in the TMS 7, and MxxS motif in TMS 8 are likely to contribute to copper
coordination during transport99.
Topologically, TM5–TM8 are closely equivalent to TM3–TM6 of the Ca2+ATPase (SERCA1), H+-ATPase, or sodium and potasium-ATPase. It is believed that
TM4–TM8, along with the cytosolic part, form part of a conserved functional core found
in all P-type ATPases104.
The ATP-binding domain of Cu-ATPases is located between TM6 and TM7, as
all P-type ATPases, it contains conserved sequence motif D-K-T-G-T-[LIVM]-[TIS] in
the P-domain. During ATP hydrolysis, the invariant aspartate residue accepts γ-phosphate
from ATP bound in the N-domain and becomes reversibly phosphorylated with the
formation of an acylphosphate as intermediate. During cation transport, intrinsic
phosphatase activity subsequently dephosphorylates the aspartate residue, as part of the
catalytic cycle104,106,107.
The actuator domain Cu-ATPases is formed by a cytosolic loop, located between
TM4 and TM5, contains a highly conserved T/SGE motif that inserts in the cleft between
the N- and P-domains during hydrolysis of ATP. Studies in SERCA revealed the role of
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the invariant glutamate residue is to activate water molecule during dephosphorylation.
Other than that, the entire actuator domain rotates and regulates the release of the ion to
the luminal site108–110.
The C- terminal region is approximately 90 residues, and interesting sequence
motif of tri-leucines LLL in ATP7B has been observed preceded by a cluster of negative
residues DDDGD. Mutation of two of the leucines to alanines results in trapping ATP7B
in the vesicles, and not in plasma membrane. It could be the hydrophobic LLL and the
negative cluster work together to retain ATP7B in vesicles or to regulate the rate of
protein trafficking between intracellular compartments111.
One of the important cytosolic portions of Cu-ATPases is the N terminal region.
The N-terminal copper binding domain is composed of 6 homologous sub-domains
(WLNs). Each of these six domains has ~72 residues and is connected to one another by
linking regions of various lengths: 11 residues between WLN1 and WLN2, 42 residues
between WLN2 and WLN3, 30 residues between WLN3 and WLN4, 57 residues
between WLN4 and WLN5, and 8 residues between WLN5 and WLN6. Triple resonance
NMR experiments show that each domain has the βαββαβ fold and houses a copperbinding site, GMXCXXC, in which both invariant cysteines of the CXXC motif
coordinate Cu(I)112. Residues 58-130 comprise domain 1, 143-215 domain 2, 256-327
domain 3, 357-428 domain 4, 429-485 the flexible linker, 486-556 domain 5, and 565632 domain 6. The sub-domains 5 and 6 are connected by a short linker, and their metalbinding sites are spatially far apart113.
ATP7B is known to interact with other proteins: the copper chaperone HAH1,
COMMD1, glutaredoxin1, and the p62 subunit of dynactin114,115. In all cases, the N-
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terminal segment of ATP7B has been identified as the site of interaction. It has also been
shown that this region interacts in a copper-dependent manner with the cytoplasmic
nucleotide-binding/phosphorylation domain of ATP7B, with copper decreasing the
interaction. An intact and functional N-terminal region is also required for the copperinduced phosphorylation of ATP7B which is, in turn, required for vesicular trafficking116.

Figure 1.4 :The major functional domains of Wilson protein
The transmembrane portion of Wilson protein is composed of 8 transmembrane segments (dark
red) that form intramembrane copper-binding site(s). The ATP-binding domain is composed of
the P-domain (purple) and the N-domain (orange) and together with the A-domain (turquoise) is
responsible for enzymatic cycle (ATP binding, hydrolysis, phosphorylation, and
dephosphorylation). The N-terminus domain has six metal (Cu)-binding subdomains (WLN 1-6,
pink).

1.8

Copper transfer from HAH1 chaperone to Cu-ATPase
Human copper chaperone, HAH1, delivers copper ions to CuATPases, ATP7A and

ATP7B, which pump the ions into the lumen of the Golgi complex for later insertion into
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the ceruloplasmin. This copper transport occurs, both in the normal copper metabolism
and in the high influx of copper, under copper metabolism disturbance.
In vivo, HAH1 transfers copper to all six domains in the truncated protein117,118.
Although, it forms a detectable Cu(I)-mediated complex only with metal binding
domain1 and 4 of ATP7A119,120 and WLN1, WLN2, and WLN4 of ATP7B118. This study
implies that the rest of domains, WLN5 and WLN6, which are necessary for metal
transport across the membrane, may take delivery of copper from other WLNs. In fact,
copper transfer has been shown between WLN1 and WLN4, and WLN4 and
WLN5113,121. On the other hand, mouse ATP7B lacks functional WLN4, which makes
hypothesis regarding copper transferring from WLN4 to other WLNs complicated122.
Copper transfer between HAH1 and the N-terminal domains requires particular
interactions that result in the formation of copper-WLN adducts123–125. The facts that
HAH1 has the same overall fold as the individual copper binding subdomains, and the
presence of complementary charges at the surface of HAH1 and some subdomains,
suggest that HAH1 form adducts with the subdomains and transfer copper via ligand
exchange79,126,127.
The crystallographic studies reveal a structure of two HAH1 monomers bridged
by a copper. This model could be such an intermediate in copper transfer79. Some studies
carried out on yeast ATX1 indicate that ATX1 binding site interact directly to P-type
ATPases. The interaction happens between the copper-bridged ATX1dimer and the Ptype ATPase using one cysteine of the later. Then a series of two and three copper (I)
centers are formed leading to the transfer of copper to ATPase26,67,124. A few Years later,
Wernimont et. al. suggested a mechanism for copper exchange between HAH1 and
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human Cu-ATPases. In the first step, holo-HAH1 with two coordination copper (I) center
interacts with an apo metal binding domain of the ATPases, ATP7A or ATP7B. Then the
apo domain binding site donates a cysteine to form a third primary bond to copper. One
of the bonds between the HAH1 cysteine is broken and rapidly forms a bond with the
cysteine on the ATP7A or ATP7B. Eventually, the HAH1 copper ion transfers to the
ATP7A or ATP7B and HAH1 dissociates from the complex79, Figure 1.5.

Figure 1.5: The proposed mechanism of copper transfer between HAH1 (left, green) and a
domain of the Wilson or Menkes protein (right, blue).

Walker et. al., in a Cys-labeling studies for a full N-terminal domain, suggested
that Cu-ATOX1 preferentially delivers copper (I) to WLN2. They also demonstrated a
specific role of WLN2 in the first step of HAH1 delivery of copper to Wilson protein,
due to high binding affinity between HAH1 and WLN2. They also believe that binding of
27

copper to WLN2 works as a switch which allows the access of the HAH1 to other metal
binding domains rather than a specific entrance to copper128. On the other hand, NMR
experiments showed that ATOX1 can form a Cu-dependent adduct with not only WLN2,
but also with WLN4, when presented as individual domains121. WLN4 was also preferred
by Cu-ATOX1 for copper delivery in a construct of WLN3-4 by forming an ATOX1-CuWLN4 adduct129. Other NMR experiments involved a construct with all six WLN
domains, suggest WLN1, WLN2, and WLN4 formed adducts with Cu-ATOX1, whereas
WLN3, WLN5, and WLN6 did not form a detectable adduct but became metalated by
ATOX1118.
Similar NMR experiments performed on the construct of WLN3-4, were
previously performed on WLN5-6 construct. These experiments revealed that Atox1 did
not interact with these domains, but, instead, Cu-loaded WLN4 could interact with
WLN6 in the WLN5-6 construct and form a Cu-dependent heterocomplex121.
However, In Cu-chelator competition experiments using a construct of all metal binding
domain in Wilson protein, the affinity for Cu-Atox1 of the individual Cu site appeared
similar, and therefore, delivery could occur to all domains123.
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CHAPTER II
2

2.1

MATERIALS AND EXPERIMENTAL METHODS

Introduction
This chapter will explain and list the reagents and chemicals, enzymes and

biological kits, instrumentation, notations of proteins, solution compositions, and
procedures. Also, this chapter will explain the protein expression, purification, and gel
electrophoresis for the proteins investigated in this research which are WLN5-6, WLN46, and WLN3-6. Moreover, this chapter will present an overview about the physical
properties of proteins, such as fluorescence and circular dichroism.

2.2

Kits, chemicals and reagents
All chemicals and reagents used met molecular grade standards. Water used in all

experiments was Milli-Q water with conductivity of 18.2 MΩ/cm purified using US Filter
PURELAB plus UV/UF (Millipore). The water and media for cell culture were
autoclaved for 30 minutes at 121˚C. List of all chemicals used along with the purity and
the supplier are in Table 2.1.
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Table 2.1: Chemicals and reagents

Chemical/Reagents
13

Catalog
number

C Glucose
N Ammonium chloride
Acrylamide
Agarose, ultrapure
Amonium persulfate

CLM-1396-1
NLM-467-1
A0268205
16500-100
BP179-100

Ampicillin
Bis-Acrylamide

A-9518
BP171-25

15

Boric acid
BP168-1
Bromopheno blue
B-6131
Coomasie brilliant blue R-250 20278
CPM
765860
Dibasic potassium phosphate
39076
Dibasic sodium phosphate
S-5136
Dithiothritol (DTT)
1758-9030
EDTA
H45476
Glycerol
Guanidine Hydrochloride
G3272-500G
Glutathione, reduced
HEPES
BDH4518-1KGP
Imidazole
A10221
IPTG
1758-1400
Kanamycin sulphate
420311
Magnesium chloride
BP214-500
MEM Vitamins
11120-052
MES
BDH4544
Methanol
Monobasic
potassium 4008-01
phosphate
Monobasic sodium phosphate BP330-1
Potasium chloride
Sodium chloride
BDH0286-500G
Sodium dodecyl sulfate (SDS) 15525-017
Sodium hydroxide
S612-3
TEMED
BP150-100
Trizma base
T6066-1KG
Tryptone
12111-1
Xylene cyanol FF
BP565-10
Yease Extract
DF0127071
Agar
J637-5
Trichloroacetic acid
BDH0310-500G
Dextrose
BP350-1
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Purity

Supplier

99 %
99 %
> 99%
Ultra pure
Electrophoresis
grade
≥92.5 %
Electrophoresis
grade
≥99 %

Cambridge Isotope
Cambridge Isotope
Acros Organics
Invitrogen
Fisher Scientific
Sigma-Aldrich
Fisher Scientific

99 %
≥ 99.8 %
100.3%

Fisher Scientific
Sigma Aldrich
Thermo scientific
Invitrogen
J.T.Baker
Sigma-Aldrich
Inalco Sas
Mallinckrodt chemicals
Fisher Scientific
Sigma-Aldrich
Sigma-Aldrich
VWR
Alfa Aesar
Inalco Sas
Calbiochem
Fischer Scientific
Invitrogen
VWR
Sigma Aldrich
J.T.Baker

98 %

Fisher Scientific

99 %
> 99.5%

VWR
Gibcobrl
Fisher Scientific
Fisher Bioreagents
Sigma Aldrich
Mo Bio labs
Fisher Scientific
Fisher Scientific
Midsci
VWR
Fisher Scientific

99.5 %

99.7 %
99.9 %
> 99.5 %
> 99 %
≥ 99.9 %
99 %
≥ 99 %

≥ 97 %
≥ 99.9 %
Biotech grade

99 %
≥ 99.8 %

Table 2.2: Enzymes, biological reagents and process kits

Biomolecules/Kits

Catalog #

Supplier

1 Kb DNA Ladder
BamH1
BglII
Benzonase
BugBuster® Protein Extraction
KOD Hot Start DNA Polymerase
MinElute PCR Purification Kit
pET32Xa/LIC Kit
QIAprep Spin Miniprep Kit
QIAquick Gel Extraction Kit
Rainbow Protein Marker
Quick Change II Site-Directed
Mutagenesis Kit
Bio-Rad Protein Assay Reagent
BCATM Protein Assay Kit
Isoelectric Focusing Calibration
Kit Broad PI(pH3-10)
Rosetta DE3 Competent Cells
NovaBlue
GigasinglesTM
Competent Cells
BL21DE3 Competent Cells
LMW Gel filtration Calibration
Kit
HMW Gel Filtration Calibration
Kit
XL-10 Gold Competent Cells
ATP7B gene

N3232S
N3231S
R0144S
70746
70584-4
71086-3
28004
70072
27106
28706
RPN800E
200521-5

NEB
NEB
NEB
Novagen
Novagen
Novagen
Qiagen
Novagen
Qiagen
Qiagen
GE
Stratagene

500-0006
23225
17-0442-01

Bio-Rad Laboratories Inc.
Thermo Scientific
Amersham Bioscience

70954-3
71227-3

Novagen
Novagen

69450
17-0442-01

Novagen
Amersham Bioscience

TEV gene

2.2.1

Amersham Bioscience
200517-4
Stratagene
Generous donation from Dr. Jonathan Gitlin, University of
Washington
Kind gift from Dr. Timothy A. Cross, National High
Magnetic Field Laboratory, Florida State University.

Protein notations and primers
Forward and backward primers were designed for amplification of the gene in

interest in order to clone it into the preferred vector, and primers used for mutations are
listed in Table 2.3 with their number of base pair (bp), GC content percentage, melting
point Tm, and their sequences. The primers were purchased from, Integrated DNA
Technologies, Inc. (Coralville, Iowa).
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The name, notation, and the residues in ATP7B corresponding to each protein are listed
in Table 2.4.

Table 2.3: PCR primers

Primer

bp

%
GC

Tm
Sequence 5`-3`
basic

WLN3-6
(Forward)

54

56

75.2

5`- GGT ATT GAG GGT CGC GAG AAC CTT TAT
TTC CAG GGC GTG GTC ACC CTC CAA CTG -3`

WLN3-6
(Reverse)

51

53

73.4

5`- AGA GGA GAG TTA GAG CCT CAC TGG GCC
AGG GAA GCA TGA AAG CCA ATT TCC -3`

WLN4-6
(Forward)

45

51

70.9

5`- GGT ATT GAG GGT CGC GAG AAC CTT TAT
TTC CAG GGC ACA TGC AGT -3`

WLN4-6
(Reverse)

51

53

73.4

5`- AGA GGA GAG TTA GAG CCT CAC TGG GCC
AGG GAA GCA TGA AAG CCA ATT TCC -3`

WLN5-6
(C499S,C502S)*
(C15S,C18S)#

41

46

67.5

Forward: 5`- GAT CAA AGG CAT GAC CAG TGC
ATC CAG TGT GTC TAA CAT AG -3`
Reverse: 5`- CTA TGT TAG ACA CAC TGG ATG
CAC TGG TCA TGC CTT TGA TC-3`
Forward: 5`- CAG GGA TGA CCA GCG CGT CCA
GCG TCC ACA ACA TAG AG -3`
Reverse: 5`- CTC TAT GTT GTG GAC GCT GGA
CGC GCT GGT CAT CCC TG -3`
Forward: 5`- GCA CCG CAG AAG GCC TTC TTA
CAG ATC AAA GGC ATG ACC -3`
Reverse: 5`- GGT CAT GCC TTT GAT CTG TAA
GAA GGC CTT CTG CGG TGC -3`
Forward: 5`- GAG ATC AAG TAT GAC CCA TGC
GTC ATC CAG CCC CTC GAG -3`
Reverse: 5`- CTC GAG GGG CTG GAT GAC GCA
TGG GTC ATA CTT GAT CTC -3`

WLN5-6
(C575S,C578S)* 38
(C91S,C94S)#

61

72

WLN5-6
(C490A)*
(C6A)#

39

54

69.7

WLN5-6
(E535C)*
(E51C)#

39

56

70.8

GFP (Forward)

50

54

73.6

5`- GGT ATT GAG GGT CGC GAG AAC CTT TAT
TTC CAG GGC ATG GTG AGC AAG GG -3`

GFP (Reverse)

49

53

72.9

5`- AGA GGA GAG TTA GAG CCT CAC TTG TAC
AGC TCA TCC ATG CCG TGG GTG A -3`

*
#

Residue number in ATP7B
Residue number in WLN5-6

43

Table 2.4: Notations of proteins

Notation
WLN3-6

Residues in
ATP7B
256-633

TRXTEVWLN3-6

256-633

WLN4-6

355-633

TRXTEVWLN4-6

355-633

WLN5-6

485-633

Y532H
V536A
L492S
WLN5-6C51

485-633
485-633
485-633
485-633

WLN5-6C51_CPM
WLN5-6C6

485-633
485-633

WLN5-6C6_CPM
GFP
TEV

485-633

Name
N-terminal metal binding domains three
through six
N-terminal metal binding domains three
through six with fusion thioredoxin tag
and TEV protease digestion site
N-terminal metal binding domains four
through six
N-terminal metal binding domains four
through six with fusion thioredoxin tag
and TEV protease digestion site
N-terminal metal binding domains five
through six
Y532H mutation in WLN5-6
V536A mutation in WLN5-6
L492S mutation in WLN5-6
Six mutations in WLN5-6 C490A,
C499S, C502S, E535C, C575S, C578S.
WLN5-6Cys51 bound to CPM at C535
Four mutations in WLN5-6, C499S,
C502S, C575S, C578S
WLN5-6Cys6 bound to CPM in position
Green Fluorescent Protein
Tobacco etch Virus Protease

Table 2.5: Plasmids and their vectors properties

Size
of
Size
of
inserted
Tag
plasmid
gene

Resistance

pET 32
Xa/ LIC

5926

Thioredoxin

Ampicillin/carbenicillin

pWLN4-6

pET 32
Xa/ LIC

5926

Thioredoxin

Ampicillin/carbenicillin

pWLN5-6
pGFP

pET 24 d+
pET 32
Xa/ LIC

5307
5926

No tag
Thioredoxin

Kanamycin
Ampicillin/carbenicillin

Plasmid

Vector

pWLN3-6

1134 + 21
for TEV
site
831 + 21
for TEV
site
453
714 + 21
for TEV
site
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2.3

Instrumentation
Instruments which used in the research, manufacturers, and their applications are

listed in Table 2.6. Columns for FPLC are listed in Table 2.7.
Table 2.6: Instrumentations and their manufacturer and applications

Instrument
AKTA FPLC
UV/VIS
spectrophotometer
Jasco
spectropolarimeter
Sorval centrifuge

Model #
18-1900-26
DU-7400

Manufacturer
GE lifescience
Beckman

CD J815

Jasco

RC 5B plus

Application
Protein purification
Nucleac acid and
protein analyzer
CD measurements

Thermofischer
scientific

Concentrating
protein and cell
culture spinning
MJ research
PCR
New
Brunswick Growing cultures
scientific
Eppendorf
Plasmid purification
Edinburgh
Two
photon
fluorescence
and
lifetime
measurements
Shimadzu
UV
scan
for
proteins
Hitachi
Fluorescence scan

Minicycler
PTC 150
Controlled environment
incubator shaker
Minispin plus centrifuge 5415
Fluorimeter
FL 900

UV-VIS
scanning UV2101PC
spectrophotometer
Fluorescence
F-2500
spectrophotometer
Glove box

Vacuum atmosphere Anaerobic
company
environment
CDP corp
Up-conversion
mesurements
Pharmacia
Isoelectric focusing

Fluorescence
up- FOG 100
conversion system
Phastsystem separation 280578
and control unit
pH benchtop meter
Orion 3 star pH Thermo
electron
benchtop
corporation
Analytical balance
PG603-SDR
Mettler Toledo
Analytical balance
AT400
Mettler Toledo
DynaPro dynamic light
Wyatt Technology
scattering
Corporation
Thermal imaging system FTI-500
Pharmacia Biotech
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Adjusting pH of
buffers
Weighing > 0.01 g
Weighing > 0.1 mg
DLS of proteins
View
DNA
Agarose gel

in

Table 2.7: Columns used with AKTA FPLC to purify proteins
Column

Function

Resin

DEAE
sepharose

Anion
exchange

Diethylamino
ethyl
sepharose

HisPrep

His-tag
affinity

Desalting
column
Superdex
75 pg
Superdex
200 HR

Details

Binding
buffer
FF XK 20
mM
26
MES, 10
mM DTT,
1
mM
EDTA,
pH=6.0-6.3

Eluting
buffer
20
mM
MES, 10
mM DTT,
1
mM
EDTA,
1M NaCl,
pH= 6.06.3
50
mM 50
mM
HEPES, 30 HEPES,
mM
300-500
Imidazole, mM
500
mM Imidazole,
NaCl, pH 500 mM
=7.5
NaCl, pH
=7.5
Desired buffer

Protein
purified/usage
WLN5-6
Y532H
WLN5-6Cys51
WLN5-6Cys6

Sepharose

FF
16/10

TEV
WLN3-6
WLN4-6
GFP

Buffer
exchange
Gel
Filtration

Superdex G25 superfine
Superdex 75
prep grade

HiPrep
26/60
Hiload
26/60

High
resolution
gel
filtration

Crosslinked
10/30
agarose and
dextrane

All investigated
proteins
50 mM HEPES, 200 All investigated
mM NaCl, 5-10 mM proteins
DTT, pH = 7.5
50
mM
phosphate All investigated
buffer, 150 mM NaCl, proteins
pH = 7.0

The solutions and buffers that needed were prepared as recommended and their
compositions are listed in Table 2.8.
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Table 2.8: Solutions and buffers

Solution
DNA sample buffer (6X)

Composition
0.25% Bromophenol blue, 0.25% xylene cyanol FF, 30%
glycerol, distilled water
Luria-Bertani (LB) broth
10 g Bacto-tryptone, 10 g NaCl, 5 g Bacto-yeast extract,
1 L milliQ water.
TBE buffer (5X)
54 g Tris base (FW=121 g/ mol), 27.5 g Boric acid
(FW=61.83 g/mol), 20 ml EDTA ( 0.5 M, pH=8), up to 1
L milliQ water, pH=8.0.
SDS sample buffer (6X)
7 ml Tris (0.5M, pH=6.8), 3 ml Glycerol, 1 g SDS, 0.93 g
DTT, 1.2 mg Bromophenol Blue.
SDS cathodic buffer (5X)
0.5 M Tris base, 0.5M Tricine, 0.5 % SDS, pH = 8.25
SDS anodic buffer (5X)
1M Tris, pH= 8.9
SDS staining buffer
0.2% Coomassie blue R-250 dye, 50% Methanol, 7%
Glacial acetic acid, 43 % distilled water.
Gel drying solution
350 ml Ethanol, 40 ml, Ethylene glycol, 50 ml Glycerol,
600 ml distilled water.
Agarose gel
0.8 % Agarose, 40 ml TBE buffer (1X).
SDS separating gel (12.5 8.3 ml Acrylamide/Bis-acrylamide (30 % / 0.8%), 5 ml
%)
Tris (1.5M, pH8.8), 0.2 ml Ammonium persulfate (10
%), 0.2 ml SDS (10 %), 0.008 ml TEMED, 6.26 ml
distilled water
SDS stacking gel (5%)
1.7 ml Acrylamide/Bis-acrylamide (30 % / 0.8%), 1.25
ml Tris (1 M, pH6.8), 0.1 ml Ammonium persulfate (10
%), 0.1 ml SDS (10 %), 0.01 ml TEMED, 6.8 ml distilled
water.
M9 salts (5X)
15 g KH2PO4, 42.5 g Na2HPO4.2H2O, 2.5 g NaCl, up to
1 L milliQ water, pH =7.3-7.5, solution filtered through
0.22 µm then autoclaved.
Minimal media
1 ml MgSO4 (1M), 0.3 ml CaCl2 (1M), 1 ml MEM
vitamin mix, 5 ml 15NH4Cl (0.2g/ml), 10 ml glucose (
0.2g/ml), 200 ml M9 salts (5X), diluted to 1 L and
autoclaved
IEF staining solution
A. 0.2 % (w/v) CuSO4 in 20 % glacial acetic acid
B. 60% methanol
C. 0.4 g Coommassie blue R-250, 400 ml H2O, and
600 ml mwthanol
IEF drying solution
5 % glycerol, and 10 % glacial acetic acid
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2.4
2.4.1

Procedures
Construction of WLN3-6 plasmid
WLN3-6 gene was amplified using pET32Xa/WLN1-6 plasmid as template,

which was prepared by Dr. Joshua Muia1. Amplification was performed by PCR reaction
using KOD hot start DNA polymerase (Novagen) protocol, Table 2.9. Mutagenic primers
were designed so that the forward primer encodes Tobaco Etch Virus (TEV) protease
recognition site, Table 2.1. Both forward and reverse primers include a sequence
compatible with LIC cloning into pET32Xa/LIC vector. “Xa” designates the Factor Xa
cleavage site. LIC notation refers to the Ligation Independent Cloning, a method that
facilitates the directional cloning of PCR products without the use of restriction enzymes,
digestion, or ligation reactions.
Table 2.9: KOD hot Start DNA polymerase protocol

Sample preparation
Solution

V (µL)

Reverse primer ( 5µM)
Forward primer ( 5µM)
dNTP (2 mM)
MgSO4 (25 mM)

1.78
2.56
5.0
3

10 X Buffer for KOD
5
Template (WLN1-6)
1
KOD hot start DNA 1
polymerase
Autoclaved water
35.66

PCR parameters
Steps ( T( C))
1234-

Activation (95 C )
Denaturation (9 C)
Annealing (53 C )
Extension ( 72 C)

Repeat steps 2-4
Store ( C)

duration
3 min
20 sec
30 sec
1 min 40
sec
30 cycles
infinity

The PCR product corresponding to WLN3-6 gene expected to have 1130 bp. 0.8
% Agarose gel was used to confirm the results of the PCR. The results showed other
products beside the one that is expected for WLN3-6, Figure 2.1. Therefore, the PCR
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reaction performed again and the gel exposed to UV light at lower energy (365 nm) then
the band corresponding to WLN3-6 gene was excised. The excised pieces of gel were
purified using a gel extraction kit from Qiagen, then quantified using Agarose gel, Figure
2.2.

Figure 2.1: 0.8 % Agarose gel showing PCR product of WLN3-6 amplification

0.2 pmol of the pure insert was treated with T4 DNA polymerase as described in
Table 2.10. The solution then was mixed and incubated at 22 C for 30 minutes. Then the
enzyme deactivated by incubation at 75 C for 20 minutes. 2 µL of T4 DNA polymerase
treated PCR insert was then ligated to a microliter of Xa/LIC vector at 22 C for 5 minutes
before a one microliter of 25 mM MgSO4 added and incubated for 5 minutes at 22 C.
After ligation, some of the ligation product was transformed into GigaSingles NovaBlue
cells. Positive growth was observed in the plate after leaving it in an oven overnight at
37 C. A single healthy colony was inoculated in 5 mL LB media containing 100 µg/mL
of ampicillin. The resulted cells were centrifuged, and the plasmid was extracted and
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purified using Qiagen plasmid purification kit. The plasmid was confirmed by double
digestion using BamHI and BglII enzymes, the pieces of the digestion are shown in
Figure 2.3. Then a sample was sent for sequencing in Retrogen, Inc. at San Diego, CA.
S-tag primer in addition to T7 and T7 term primers were used for sequencing. The results
show a successful sequence that aligned perfectly to the WLN3-6 gene stored in DNA
strider ® program at our laboratory.
Table 2.10: T4 DNA polymerase protocol

Solution
10 X T4 DNA polymerase buffer
25 mM dGTP
100 mM DTT
Nuclease free water
2.5 U/µL DNA polymerase
0.2 pmol of WLN3-6 insert

V (µL)
2
2
1
13.6
0.4
1

Figure 2.2: Purification of PCR product of WLN3-6 gene amplification: (A) gel photo after
excised WLN3-6 gene. (B) gel after purification of the gene
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Figure 2.3: Digestion of WLN3-6 plasmid

2.4.2

Transformation, expression and purification of WLN3-6
WLN3–6 protein was expressed by transforming pET32TEV/WLN3–6 plasmid

into Rosetta (DE3) competent cells. A single colony was inoculated in an LB culture
contain ampicillin (100 µg/ml). The culture was induced with a final concentration of
1mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) when the optical density at 600 nm
reached 0.6-0.8. Protein induction was performed for 3-4 h and cells were harvested by
centrifugation.
The TRXTEVWLN3–6 fusion protein was extracted by freezing and thawing the
cell pellet three times followed by the addition of BugBuster® (Novagen) protein
extraction reagent. The high viscosity due to DNA and RNA release was lowered by
adding 20 KU/mL of Benzonase (Novagen). The supernatant containing soluble proteins
was separated from cell debris by centrifugation. The supernatant was decanted and
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loaded onto the HisPrep FF 16/10 (nickel chelating sepharose column) with high affinity
for poly-histidine tagged protein. The expressed fusion protein, TRXTEVWLN3–6
possessed the six poly-histidine tag (-HHHHHH-) that was utilized in the purification.
The tagged bound protein was eluted by an imidazole gradient from the column. The
protein was further purified by gel filtration, and then prepared for fusion protein
cleavage. Fusion protein has mass of 58 kDa, lane E in
Figure 2.4.

To remove the TRX and His-tags from WLN3–6, the purified protein was
exchanged into TEV buffer and quantified by the BCA protein assay (Pierce). The
cleavage mixture has the ratio of 1mg of TEV protease per 80 mg of the protein to be
cleaved. The mixture was incubated at room temperature for 16 h. The cleaved protein
was loaded onto the HisPrep column and the flowthrough fractions that contained
WLN3–6 protein were collected and purified by gel filtration using Superdex 75. The
purity was determined by SDS-PAGE,
Figure 2.4. WLN3-6 protein appears in final purification step as band around 40 kDa. The
yield quantified by BCA protein assay was almost 20 mg/ L culture.
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Figure 2.4:12.5 % SDS-PAGE gel shows steps of WLN 3-6 expression and purification

A, non-induced pellet. B, after 4 hours induction. C, freeze/thaw extract. D,
TRXTEVWLN3-6 after HisTrap column. E, TRXTEVWLN3-6 after gel filtration. F,
digestion with TEV protease. G, WLN3-6 protein after HisTrap column. H, WLN3-6
after gel filtration
2.4.3

DNA plasmid, Cloning and Purification of WLN4-6
WLN4-6 gene was amplified by PCR reaction using KOD hot start DNA

polymerase (Novagen) protocol. Mutagenic primers were designed so that the forward
primer encode Tobaco Etch Virus (TEV) protease recognition site. Both forward and
reverse primer including sequence compatible with LIC cloning into pET32Xa/LIC,
Table 2.3. The template encoding the N-terminal portion of ATP7B was prepared by Dr.
Joshua Muia1. The PCR product was produced using annealing temperature of 58 C then
purified after it was excised from the gel. 0.2 pmol of the pure PCR product was then
treated with T4 DNA polymerase before it was ligated to pET32 Xa/LIC vector as was
performed for WLN3-6. The protein was expressed and purified by the same methods
used for WLN3-6. Results of: PCR product after purification, plasmid digestion, SDS-
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PAGE for protein purification steps, and pure protein are shown in Figure 2.5, Figure 2.6,
Figure 2.7, and Figure 2.8, respectively.

Figure 2.5: 0.8 % Agarose gel shows purified PCR product of amplifying WLN4-6 gene

Figure 2.6: Digestion of WLN4-6 plasmid
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Figure 2.7: 12.5 % SDS-PAGE showing purification steps of WLN4-6
A, non-induced. B, after 4 hours induction. C, freeze/thaw extract. D, TRXTEVWLN4-6 after
HisTrap column. E, TRXTEVWLN4-6 after gel filtration. F, digestion of protein using TEV
protease.

Figure 2.8: SDS-PAGE gel shows pure WLN4-6 protein
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2.4.4

DNA plasmid, Cloning and Purification of WLN5-6
The plasmid of WLN5-6 was constructed by Dr. Muia1. It was ligated into

pET24d+ vector, which contains a gene resistance to the antibiotic Kanamycin. 10-50 ng
of the plasmid was transformed into 100 µL of NovaBlue cells, incubated in ice for 20
min then heat shocked at 42 °C for 30 seconds then immediately incubated in ice for 2
minutes. 1000 µL of LB broth was added to the cell and incubated at 37 °C with shaking
at a rate of 225 rpm. An hour later, the cells were centrifuged at 7000 rpm for 2 minutes.
The pellet were then gently resuspended in about 250 µL of the LB and plated in LB/agar
plate containing 30 µg/mL of Kanamycine. The plate was incubated at 37 °C overnight.
One colony of the plate was inoculated into 5 mL autoclaved LB media. Kanamycin was
added to a total concentration of 30 µg/mL then incubated at 37 °C overnight in a shaker
at 225 rpm. Overnight, the cells were grown and became dense so they were centrifuged
and resuspended using 250 µL of P1 buffer from QIAprep spin miniprep plasmid
purification kit, 250 µL of P2 buffer was added and the tube was flipped several times
then 350 µL of N3 buffer was added. The tube was flipped 4 to 5 times and centrifuged at
13000rpm for 10 minutes. The supernatant was then applied to the spin column and
centrifuged for one minute. The column was then washed by adding 500 µL buffer PB
and centrifuged for another minute. Another wash for the column was performed by
adding 750 µL PE buffer and centrifuging for 1 minute. The flow-through was discarded
then the column was centrifuged for another minute. To elute the plasmid, the spin
column was placed in a clean 1.5 mL microcentrifuge tube and 50 L of EB buffer were
added to the center of the spin column let stand for two minutes then centrifuged for a
minute. The plasmid then stored at

20 °C.
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2.4.5

Transformation, expression and purification of WLN5-6
20 ng of WLN5-6 plasmid was transformed into 5 µL of Rosetta2(DE3) cells. The

cells were incubated on ice for 15 minutes prior to heat them at 42 °C for 25 seconds. The
cells then were incubated again in ice for 2 minutes. 250 µL of LB was added and the
tube contains the cells and LB was incubated at 37 °C for an hour with shaking at a rate
of 225 rpm. An LB/Agar plates containing 30 µg/ml kanamycine was used to plate the
cells. The plate was then incubated at 37 °C overnight.
One fresh colony from overnight plate was inoculated for each 5 mL LB media. I
usually use 4 inoculations to make sure that I will have growth in at least one culture
tube. Kanamycin antibiotic were added to each LB media used for the growth in a
concentration of 30 µg/mL. The tubes were incubated at 37 °C in the shaker for 6 hours
then each tube transferred to a flask contains 100 mL of LB and same as before incubated
at the same temperature for 2.5 hours. The LB in each flask then transferred to another
one liter LB and incubated at the same temperature until the OD at 600 nm reaches
between 0.6-0.8. At that value of OD, an aqueous solution of 1M of IPTG was used to
add IPTG to a final concentration of 1 mM in each flask. Three hours later the cells were
harvested by centrifugation at 5000 rpm at 4 °C to obtain the pellet. The pellet was then
stored at – 20 °C for later purification.
WLN5-6 protein was expected to have an isoelectric point of 4.9 as calculated by
DNA StriderTM 1.3f16. Therefore at pH 6.0 it will have a net negative charge for the side
chains and so ion exchange chromatography can be used to purify the protein. DEAE
column is an anion exchange resin and so it was used to purify the protein. For further
purification of the protein gel filtration chromatography was also used.
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The cells from the frozen pellet were lysed by repeated freeze and thaw cycles.
The cells were frozen for one minute in liquid nitrogen and thawed under cold tap water
while keeping them in a centrifuge bottle. After 5 cycles, the pellet were resuspended
with the pipet pump and extraction buffer (20 mM MES/Na, 1 mM DTT, 0.1 mM EDTA,
pH=6.0), 5 ml buffer were added per 1 gram pellet. 2 uL of Benzonase nuclease (2.5 KU)
was also added and then the solution agitated at 4 C for 30 minutes. Insoluble cell debris
was removed from soluble protein in the supernatant by centrifugation at 15000xg for 20
min at 4

C. The supernatant containing protein was then recovered for protein

purification.
Purification of WLN5-6 was performed by using DEAE-Sepharose anion
exchange column. The column was washed with elution buffer (20 mm MES/Na, 0.1 mM
EDTA, 5mM EDTA, 1 M NaCl, pH =6.3) and pre-equilibrated by low salt washing
buffer (20 mm MES/Na, 0.1 mM EDTA, 5mM EDTA, pH =6.3). The supernatant, 20 ml,
was then loaded into the column at a flow rate of 2 ml/min. The unbound proteins were
washed out of the column by passing the washing buffer through the column until the UV
absorbance returned to baseline. Then the protein eluted with the elution buffer. The
fraction containing WLN5-6 were identified by SDS-PAGE (15 %). The fractions were
collected and concentrated by Amicon device with a 3,000 MWCO membrane. WLN5-6
was further purified by gel filtration. The concentrated sample (< 10 ml) was injected in
equilibrated Hiload 26/60 Superdex 75 column at a flow rate of 2.5 ml/min. The protein
was then eluted using HEPES buffer (50 mM HEPES, 200 mM NaCl, 10 mM EDTA, pH
= 7.5). SDS-PAGE confirmed the purity and BCA assay used to measure protein
concentration. Approximately, 30 mg of protein was produced per liter LB culture.
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2.4.6

Tobacco etch virus (TEV) protease expression and purification
Tobacco etch virus (TEV) protease is the common name for the 27 kDa catalytic

domain of the nuclear inclusion a (NIa) protein encoded by the tobacco etch virus. TEV
protease is a site-specific protease with a canonical recognition site, Glu-Asn-Leu-TyrPhe-Gln-Gly. Cleavage occurs between the Gln and Gly, resulting in a Gly at the amino
terminus of the protein of interest. TEV protease is an ideal choice for removal of tags
from fusion proteins in the research and production of recombinant protein 2.
TEV protease that used to remove the tag from WLN3-6 and WLN4-6 was
produced in our laboratory from a vector, kindly, supplied by Dr. Tim Cross of the
National High Magnetic Field Laboratory. The protein plasmid was transformed to
Rosetta 2 cells and the cells grown in LB media at 37 ˚C until the OD600 reached 0.6-0.8,
then IPTG was added to a final concentration of 1 mM. Four hours later, the cells were
harvested at

˚C by centrifugation. The pellet were thawed then re-suspended in 35 ml of

50 mM sodium phosphate buffer, 0.3 M NaCl, pH=8.0 and lysed by sonication at 12
pulse for 5 minutes.
The supernatant was collected by centrifugation at 15000 rpm for 20 min. the
resulting supernatant was loaded onto Ni2+ affinity column equilibrated with equilibrium
buffer (50 mM phosphate buffer, 0.3 M NaCl, pH=8.0, 10 mM Imidazole). The column
was then washed with the washing buffer (50 mM phosphate buffer, 0.3 M NaCl,
pH=8.0, 10 mM Imidazole) and then eluted with the elution buffer (50 mM phosphate
buffer, 0.3 M NaCl, pH=8.0, 250 mM Imidazole). SDS-PAGE was used to confirm the
purity of the TEV, Figure 2.9. The eluted fraction was concentrated prior to load into
Desalting column and then eluted with 50 mM Tris-HCl, pH 8.0, 0.5 mM EDTA. The
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eluted fractions were concentrated using Amicon device with 3000 Da cut-off membrane
and then BCA assay was performed, and then glycerol and DTT were added to a final
concentration of 50 % and 5 mM, respectively. Protein then was stored for later use at -80
˚C in 500 l increments.

Figure 2.9: TEV purification steps. A, cell extract. B, flowthrough. C, eluted protein

2.4.7

1

H,15N NMR HSQC for WLN3-6, WLN5-6

NMR 1H,15N-HSQC experiments of 15N-NMR labeled protein is a good spectrum
to start with to test whether a protein is folded and assess the quality of the spectrum to
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see whether it is worth recording other spectra and possibly proceeding on to other, more
expensive labeling schemes.

The plasmid for proteins in interest was transformed into Rossetta 2 (DE3) cells.
The following day fresh colonies were inoculated into 5 ml LB then incubated at 37 C for
10 hours. 10 µL of the media were transferred into 30 ml of minimal media containing
the proper antibiotic. The media were incubated at 37˚C with shaking (250 rpm)
overnight. The next day the minimal media were transferred to 470 ml minimal media
that also contain antibiotic. When OD600 reached 0.6-0.8 the cells were induced by adding
IPTG to a final concentration of 1 mM and the temperature reduced to room temperature.
22 hours later, the cells harvested by centrifugation at

˚C and 5000 rpm. The pellet was

formed then saved at -20 ˚C for later purification. The purification of each protein was
conducted as described earlier for WLN3-6 and WLN5-6 in section 2.4.2 and section
2.4.4, respectively.
Around 600 µL of 0.5 mM of protein required for obtaining 1H,15N-HSQC. The
proteins have been analyzed in 800 MHz NMR instrument at University of Notre Dame
in Indiana. The results are shown in Figure 2.10. Spectra for all the proteins show that it
is possible to proceed to more experiments.
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Figure 2.10: 1H,15N-HSQC results for WLN5-6 and WLN3-6
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2.5
2.5.1

Biophysical properties of proteins
Dynamic light scattering
When light impinges on matter, the electric field of the light induces an oscillating

polarization in the molecules. Consequently, the molecule gives a secondary source of
light and scatters the light. If the source of light is monochromatic and coherent, as in
laser light, then a time-dependent fluctuation in the scattered intensity is observed. This
fluctuation is because of the Brownian motion, which makes the distance between the
scattered molecules in the solution is continuously changing with time. Brownian motion
is the random movement of particles due to collisions caused by the bombardment of the
solvent molecule that surrounded the particles. As a result, a Doppler shift between the
frequency of the incident light and the frequency of the scattered light is observed; this
change is related to the size of the particles3. Then electrodynamics and theory of timedependent statistical mechanics help to obtain information through the characteristics of
the scattered light about molecular dynamics and the structure of the scattering
molecules.
Dynamic light scattering (DLS), also called photon correlation spectroscopy, is a
non-invasive technique to measure the speed of particles and molecules undergoing
Brownian motion. This motion is influenced by the particle size, sample viscosity, and
the temperature. Small particles at high temperature have rapid Brownian motion3.
Velocity of the Brownian motion is defined by the translational diffusion coefficient (D)
which, in turn, can be converted to particle size through Stokes-Einstein equation,
equation ( 2.1 ).
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( 2.1 )

Where, dh is the hydrodynamic radius, which defined as the diameter of a hard sphere
that has the same average of translational diffusion coefficient as the particle being
measured, kB is the Boltzmann’s constant, η is the viscosity, and T is the temperature in
Kelvin4.
The translational diffusion coefficient (D) depends not only on the size of the
particle, but also on any surface structure, in addition to the concentration and kind of
ions in the medium. Ions and their concentrations affect the thickness of the electric
double layer (Debye length, K-1), which then changes the particle diffusion speed and the
apparent particle’s size. Moreover, the conformation of the polymer can be affected due
to the factors mentioned above, which can modify the apparent size by quite a few
nanometers. The amount of scattered light is related to the particle size. The intensity of
the scattering is related to the sixth power of the particle diameter. There are two
terminologies used for the studying of scattering light: static light scattering and dynamic
light scattering. In static, the experiment probes the time-average intensity of the
scattered light, while in dynamic light scattering, the fluctuations in light intensity are
probed.

2.5.1.1 Description of how DLS works
If an immobile cuvette containing sample is illuminated by a laser with a frosted
glass screen to view the sample cell, a classical speckle pattern will be seen. This speckle
has dark and bright blobs due to destructive and constructive phases of the scattered light,
Figure 2.11. Because the particles in the system undergo Brownian motion, the speckle
pattern is observed where the spot of each speckle is seen to be in continuous motion.
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This is because the phase addition from the moving particles is constantly evolving and
forming new patterns. The rate at which these intensity fluctuations occur will be rapid
for small particles and slower for large particles. Then a device called digital auto
correlator measures the degree of similarity between two signals, or one signal with itself
at varying time intervals. If the signal intensity is compared with itself at certain time,
then there is perfect correlation, as the signals are identical. The degree of correlation
ranges between (1.00) and zero where, perfect correlation is designated by unity (1.00)
and no correlation is designated by zero (0.00). However, when the signal is derived from
Brownian motion, which is a random process, the correlation reduces with time. The
correlation ranges from nanoseconds or microseconds. The correlator constructs a
correlation function G(τ) of the scattered intensity, equation ( 2.2 ):
G(τ) = <I(t).I(t+τ)>

( 2.2 )

Where τ is the sample time difference of the correlator.
For monodisperse particles in Brownian motion, the correlation function is an
exponential decaying function of τ, equation ( 2.3 ) :
G(τ) = A[1 + B exp(-2Γτ)]

( 2.3 )

Where A is the baseline of the correlation function, and B is the intercept of the
correlation function.
Γ = D q2 , where D is the translational diffusion coefficient, q is the wave vector
q = (

π n / λo) sin (θ/2), where n is the refractive index of dispersant, λo is the

wavelength of the laser, θ is the scattering angle.
For polydisperse samples, the equation is written as:
G(τ) = A(1 + B g1(τ) 2) where g1(τ) is the sum of all the exponential decays contained in
the correlation function.
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Figure 2.11: Schematic representation of speckle pattern. Applications of DLS to proteins

Because scattering intensity is proportional to the sixth power of the molecular
radius, DLS became a valuable and sensitive technique to trace protein aggregates. The
presence of a small amount of aggregate will cause significant change in the mean
hydrodynamic radius and in the percentage polydispersity. DLS can also be valid in
thermal stability studies by the measurement of the size and the scattering intensity as a
function of temperature. The heat influences the denaturation of protein and leads to
enormous aggregates on top of increases in the scattering intensity.
If DLS is measured in high concentrated solutions, then the radiation may scatter
many times, as the scattered centers are grouped together. This effect is called multiple
scattering; it is deterministic more than a random phenomenon, therefore, the randomness
of the interaction tends to be averaged out by large number of scattering events.
Concentrated protein, which is charged, could increase the repulsion forces between
molecules due to the reduction in the intermolecular distance. That, in turn, increases the
diffusion speed, and so, decreases the apparent size. This leads to the importance of the
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dynamic Debye plot. This plot is actually a measurement of diffusion coefficient at
several concentrations of the sample in order to determine the diffusion coefficient at
infinite dilution. Also, this plot provides information about the intermolecular interaction
in a given solution. Repulsive interactions cause faster motion while attractive
interactions induce slower motion.

2.5.2

Fluorescence
Fluorescence is a radiative decay from the singlet state of molecules known as

chromophores. The process require three steps; excitation, excited-state lifetime, and
florescence emission, illustrated in Figure 2.12. In excitation, the molecule absorbed a
photon of energy ( υEx) to produce an electronic singlet excited state S1. The excited state
last for nanoseconds, typically 1-10 ns, during this time, the fluorophore interacts with its
molecular environment or/and undergoes conformational change. As a result, the excited
state loses some of its energy, therefore, became relaxed to a lower singlet excited-energy
state. The fluorescence emission originates from the lower singlet excited state of S1 and
a photon of (hυEm) is emitted making the fluorophore return back to its original ground
state5. Under the same conditions, the fluorescence emission spectrum of fluorophore will
have the same profile no matter what the excitation wavelengths were; only the intensity
will change. This independency on the excited state is due to the dissipation of energy
during the excited-state lifetime. The fluorescence technique is considered very sensitive
because it is continually repeates the fluorescence process to generate thousands of
detectable photons, unless the fluorophore is bleached.
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Figure 2.12: Fluorescence process

Fluorescence measurements are broadly classified into two types: steady-state
measurements and time-resolved measurements. The most common type is the steadystate measurements where a continuous beam of light is used to illuminate the sample and
the intensity of the emission spectrum is observed. The second type of measurements,
time-resolved, is used to measure the intensity decays or anisotropy decays. In these
measurements the sample is exposed to a pulse of light which whose width is typically
shorter than the decay time of the sample. This type requires a high-speed detection
system to measure the intensity or anisotropy in the nanosecond timescale. Steady-state
and time-resolved measurements are related, since steady-state observation is the average
of the time-resolved phenomena over the complete intensity decay of the sample. This
information is lost during the averaging process and so it is important to have timeresolved measurements.
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Monitoring of time-resolved emission can be performed using time-correlated
single-photon counting (TCSPC)6,7. In this technique, the sample is excited with pulses
from a laser or a flash lamp, then the detection system monitors the time difference
between the excitation pulse and the first fluorescence photon from the sample. This
measurement requires that only one photon is observed for a large number of excitation
pulses. In this case, an extremely low count rate must be ensured such that the system
operates in single photon counting mode. Under this condition, statistics mimic the
poisson distribution and a true time-resolved emission profile is obtained. A schematic
diagram of a TCSPC experiment can be represented in Figure 2.13.
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Figure 2.13: Schematic diagram of TCSPC setup

An excitation pulse (optical pulse) is split into two fractions, one part is used to
excite the sample and the other part is used to generate a start pulse in the start PMT or
photodiode. The optical signal at the start PMT generates an electrical START pulse,
which is then running through a constant fraction discriminator (CFD) to START the
input of time to amplitude converter (TAC) to initialize the charging operation. The other
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part of the optical pulse excites the sample and gives rise to an emission of photons.
These photons are then detected by STOP PMT to generate an electrical STOP pulse. The
STOP pulse pass through another CFD and a variable delay line before it routed to the
TAC. On receiving the STOP signal, TAC stops its charging operation and generates an
electrical output, having an amplitude proportional to the time difference (∆t) between
the START and STOP pulses reaching the TAC. The TAC output pulse is then fed to the
input of a multi channel analyzer (MCA) through an analogue to digital converter (ADC).
The ADC generates a numerical value corresponding to the TAC output pulse and thus
selects an appropriate channel of the MCA and the count is added to the channel. The
above cycle (from excitation to data storage) is repeated a large number of times and as a
result a histogram of the counts versus the channel number of MCA is generated. It
represents the true emission decay, when the collection rate of emission photons by the
STOP pulse is very low, as illustrated by the statistical treatment6,7.
The emission decay observed has to be de-convoluted with the instrument
response to get the actual lifetime. The instrument response function (IRF) is measured
using a scatterer placed in place of the sample. The width of IRF function depends on the
excitation source and detection systems used.

2.5.3

Fluorescence anisotropy
Anisotropy measurements are based on excitation of fluorphores by absorbing

photons of polarized light whose electric vectors are aligned parallel to the fluorophores
transition moment. This photoselective excitation results in a partially oriented
population of fluorophores in partially polarized fluorescence emission. The relative
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angle between the excitation and emission moments determines the maximum anisotropy.
Anisotropy (r) is directly related to polarizability (p), equations (2.4 ) and ( 2.5 ) :
–

,

(2.4 )

( 2.5 )

The polarized fluorescence, gradually, returns to its unpolarized fluorescence,
depending on rotational diffusion and other factors. Rotational diffusion occurs during
the lifetime of the excited state, and so, displaces the emission dipole of the fluorophore.
The excited state lifetime is about 1-10 ns. In fluid solutions, the fluorophores rotate
broadly many times during the excited lifetime, since it rotates in 50-100 ps. Therefore,
the orientation of the polarized emission is randomized and the anisotropy value
approaches near zero. Another factor that can decrease the anisotropy is the transfer of
the excitation between fluorophores. However, the effect of rotational diffusion can be
decreased if the fluorophore is bound to a macromolecule, which usually has a high
rotational correlation time. In this case, assuming no other processes result in loss of
anisotropy, the expected anisotropy is given by the Perrin equation 8 (2.6 ).

(2.6 )

r0 is the anisotropy in the absence of rotational diffusion, and θ is the rotational
correlation time for the diffusion process. Based on that, binding the fluorophore to a
protein will slow the the probe’s rate of rotational motion. The smaller the proteins the
shorter the correlation times and therefore an expected a lower anisotropy; however, large
proteins can have low anisotropy if they are bound to a long-lifetime fluorophore. The
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most important point here is that measurement of fluorescence anisotropy is sensitive to
factors that affect the rate of rotational diffusion.
Actually, for any fluorophore randomly distributed in solution, with one-photon
excitation, the value of r0 must be within the range of -0.20 to 0.40 for single photon
excitation. A special condition needs to be applied for measuring fundamental anisotropy
in order to avoid rotational diffusion. The probes are usually examined in solvents that
form a glass at low temperature such as propylene glycol and glycerol, and in diluted
solutions. The commonly used solvent for measuring fundamental anisotropy is
propylene glycol at -60 to -70 C. In these conditions, the fluorophore remains immobile
during the lifetime of the excited state. Therefore, the measured anisotropy value (r0)
provides a measure of the angle between the absorption and the emission dipoles (β)9.
The fundamental anisotropy is given by equation (2.7 ),
(2.7 )

where the angle (β) varies with the excitation wavelength, and consequently, the
anisotropy will change. The reason for this change is due to the rotation of the absorption
transition moment. As the excitation wavelength changes, the fraction of light absorbed
by each transition will change too.
The anisotropy is usually independent of the emission wavelength, because the
emission always occurs from the lowest singlet state. The anisotropy spectrum is a plot of
anisotropy versus excitation wavelength of a fluorophore in a solution, where solvent
relaxation does not occur. If solvent relaxation or emission occurs from more than one
state and shows a different emission spectra, then in these cases the anisotropy can be
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dependent upon emission wavelength10. And so, anisotropy decreases with increasing
wavelength because the average lifetime is longer for longer wavelengths.

2.5.4

Measurements of fluorescence anisotropies
There are two methods used to measure fluorescence anisotropy, the L-format and

the T-format, Figure 2.14. In the L-format method, a single emission channel is used,
while in the T-format, two separate detection systems are used to detect the intensities of
the parallel and perpendicular components.
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Figure 2.14: L and T format to measure fluorescence anisotropies
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Emission
Polarizer 2

In the L-format, each one of the four intensities needs to be measured separately. While
in the T-format, a pair of the fluorescence intensities pairs can be measured
simultaneously. Therefore, measurements in the T-format are faster than in the L-format.
To measure the fluorophore anisotropy and to minimize the background, the measured
intensities are corrected to the reference by subtracting the intensities of the reference
sample from measured sample. The reference, usually, contains all components of the
sample with the exception of the fluorophore. Also, having sample components that
produce low fluorescence compared to the fluorophore minimizes the background signal.
The excitation wavelength used to measure anisotropy should give the strongest emission
intensity, unless at that wavelength there is greater emission of the background11.
The total intensity is given by (IVH + 2 IVV) which reflect the sum of the
fluorophore intensity along the three axes; however, the intensity measured is not
proportional to the total intensity or either intensities. It is actually proportional to another
combination of vertical and horizontal intensities. To make the anisotropy proportional to
the total intensity, the excitation polarizer is oriented in the vertical position and the
emission polarizer is oriented 5 .7 (the magic angle) from the vertical. At this orientation
the perpendicular intensity is twice the intensity of the horizontal, since cos2 5 .7 =
0.333 and sin2 5 .7 =0.667. Another important factor that should be considered during
fluorescence anisotropy measurements is the alignment of the excitation and emission
polarizers. Both should be exactly positioned in the vertical and the horizontal
orientations.
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2.5.5

Two-photon absorption
Two-photon absorption (2PA) is a non-linear process, where in two photons

absorbed simultaneously to excite the molecule from its ground state to a higher state.
The transition energy for this process is equal to the sum of the energies of the two
photons absorbed. This phenomena was first described theoretically in 1931 by Maria
Goppert-Mayer12, in her doctoral dissertation. She concluded that the energy absorbed by
the two photons is similar to that of a one photon that spans the combined gap. Thirty
years later, and after the invention of the laser, the phenomenon was observed by Franken
et. al. and experimentally verified by Kaiser and Garrett in a Europium-doped crystal, and
then observed in a Cesium vapor13.
Two-photon absorption is a rare phenomena, therefore, an intense laser beam is
used to observe its effect. The rate equation for the 2PA is second-order in the photon
flux and a first-order in the concentration of molecules, equation ( 2.8 ),
( 2.8 )

δ is the two-photon absorption cross section, NTP is the number of molecules per unit
volume in the excited state due to 2PA, NGS is the number of molecules in the ground
state, F is the photon flux (number of photons per unit area and time, light intensity), and
t is the time.
The great interest in two-photon absorption is due to several aspects; the first is
due to the advantages of two-photon excitation instead of one-photon. Excitations with
two-photons of near infrared wavelength during 2PA process lower the scattering effect.
According to Rayleigh’s law of scattering, equation ( 2.9 ), doubling the excitation
wavelength (λ) will reduce the scattering effect (σs) 16 times 14–16.
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σs α 1/λ4

( 2.9 )

The second aspect of the 2PA is its ability to increase the penetration depth, and
so, to reduce the focusing volume in materials. Also, 2PA depends on the polarization of
the excitation light. This is because it is involved in two different transition moments, as
well as different states17,18.

2.5.6

Ultrafast fluorescence spectroscopy via upconversion
Fluorescence spectroscopy is widely used for studying the structure and function

of proteins. In particular, the fluorescence lifetime of the chromophore in protein, such as
tyrosine and tryptophan, is important to study protein interactions. This is due to its
sensitivity to subtle environmental changes19, and to local conformational changes20,21, in
addition to processes accompanied with translational and rotational motion, via
anisotropy decay22. The majority of fluorescence decay changes happen within a few
picoseconds to nanoseconds, which requires a very short light pulse. The development of
ultrafast lasers such as the Ti:sapphire laser enables studies of

proteins in the

subpicosecond timescale.
In 1975, Maher and Hirch used a new nonlinear technique to mix the fluorescence
excited by an ultrafast laser pulse with another laser pulse in a nonlinear crystal such as
Potasium Dihydrogen Phosphate (KDP) and β-Barium Borate (BBO) to generate sum or
difference frequency radiation23. The significance of this technique is the ability to
provide time resolution equivalent to the pulse width because the mixing process occurs
merely for the period of the existence of the second laser pulse. As a result, delaying the
gate pulses with a mechanical stage leads to an “optical boxcar approach”. This
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technique, called sum frequency generation (also known as fluorescence upconversion),
was first applied in biochemical research by Halliday and Topp in 197724.
The basic concept of the time resolution mechanism using the upconversion
technique is based on a cross-correlation between the fluorescence and the probe laser
pulse, Figure 2.15. At initial time (t = 0), the sample is excited by an ultrafast laser pulse,
which could be a second or third harmonic pulse, with a frequency of
fluorescence from the sample

. When the

and the probe laser pulse arrive together at time t = τ

both are cofocused into a nonlinear crystal such as BBO. The crystal usually is oriented at
an angle with respect to the fluorescence and laser beams. When the probe laser pulse is
present in the crystal, only at that time, the sum frequency photons are generated. The
probe laser pulse works as a “light gate” and gives time resolution within the laser pulse
width. Varying the delay τ of the probe laser beam is used to trace the time evolution of
the fluorescence.
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Figure 2.15: Schematic diagram of upconversion

The sum frequency generation is a “parametric process”, where the energy is
conserved and the interaction of light with matter leaves the matter unchanged25, equation
( 2.10 ).
( 2.10)

is the photon frequency. For sum frequency to occur efficiently a condition called
“phase matching” must be satisfied, as given in equation (2.11)
( 2.11 )

Where,

are the reduced Planck’s constant and the angular wavenumber,

respectively. The subscripts s, p, and F denote the sum frequency generation, probe laser
beam, and the fluorescence beam, respectively.
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The quantum efficiency for phase matched sum frequency generation is
proportional to probe pulse peak power and square of crystal thickness, but inversely
proportional to the focal spot25. BBO has a wide phase-matching wavelength, from 250 –
2000 nm, for mixing with 800 nm. Also, BBO has high damage threshold and low group
velocity mismatch. The mismatch between the group velocity of the probe and
fluorescence pulse may lead to temporal broadening of the generated sum frequency
pulse. Therefore, BBO is preferred for UV upconversion experiments for subpicoseconds
pulses26. In our experiments, to excite Tyrosine, we used THG and BBO crystal, and the
layout for studying Tyrosine is shown in Figure 2.16.

Figure 2.16: Scheme for fluorescence upconversion measurements. THG is the third
harmonicgenerator,BBOisβ-Barium Borate, L1-L3 are lenses, M1-M4 are mirrors and D
is the diaphragm
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2.5.7

Circular dichroism
Circular Dichroism (CD) is an absorption spectroscopy uses circularly polarized

light. CD is the difference in the absorption between the left-handed and right-handed
polarized light, equation (2.10). It exhibited in molecules that contain one or more chiral
chromophores.
(2.10)

λ is the wavelength and A is the absorbance. CD usually is measured over a range of
wavelengths. UV-CD is mostly applied to study the structure of small organic molecules,
DNA, and Proteins, while UV/VIS CD is used to study charge transfer in protein-metal
complexes. The CD signal can be positive, or negative, depending on the selective
absorption of circularly polarized light. Circular polarized light is produced when two
linear polarized lights wave are out of phase with respect to each other by a quarter-wave.
This can be achieved by a quarter-wave plate; the orientation of this plate will slow one
of the linear components with respect to the other by quarter-wave, and therefore, change
their refractive indices. The result will be either left circular polarized light (LCPL), or
right circular polarized light (RCPL).
Chiral molecules are non superimposible mirror-image isomers. These
enantiomers are identical in their photophysical properties, except for their interactions
with polarized light and other chiral molecules. A solution of chiral molecules is
birefringence, or an anisotropic medium in which right and left circularly polarized light
propagate in different speeds. A linearly polarized wave is a superposition of two
different handed circularly polarized waves, with equal amplitude and phase. When it
passes through a birefringent medium, the phase relationship between the circularly
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polarized wave changes, and the resultant linearly polarized wave rotates. This
phenomenon is called optical rotation, and when it is measured as a function of
wavelength it is called optical rotatory dispersion spectroscopy (ORD).
However, when the linear polarized light passes through an optically active sample, the
amplitude of the less absorbed component will be larger than the more strongly absorbed
component. Therefore, when the amplitudes are combined, an ellipse forms rather than a
circular shape. The degree of ellipticity (θ) is defined as the tangent ratio between the
minor and major axes of the elliptic.

Linearly polarized light has zero degrees of

ellipticity, while fully LCPL has a positive 5 ellipticity and RCPL has a negative 5 .
Since optical rotation is associated with the change of the phase that is due to the
change in the refractive index, it is observed at all wavelengths. CD is associated with the
change in the absorbencies of LCPL and RCPL, and it is observed only at wavelengths
where a chiral molecule absorbs light. CD and ORD can be interconverted by KramersKronig transformations relation, equation ( 2.11 )27:
( 2.11 )

Molar ellipticity is reported in deg.cm2.dmol-1 or deg.M-1.m-1 and calculated as in
equation (2.12 ):
(2.12 )

Where

is in mdeg, c is the concentration in molar, and

is the pathlength in cm. The

values of molar ellipticity can be converted to a molar extinction coefficient by equation
(2.13 ):
(2.13 )
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2.5.8

Circular dichroism for biological molecules
Most biological molecules are chiral, for instance proteins consist of amino acids

and 19 of the 20 common amino acids are chiral. The secondary structure of proteins,
DNA and RNA, is also chiral and contribute to the circular dichroism signal. The CD
spectrum of a protein or a DNA molecule is highly influenced by the three dimentional
structure of these macromolecules, and so, the spectrum is not a simple reflect of the
individual residues or bases28,29. Each macromolecule structure has a specific circular
dichroism signature, therefore, this can be used to classify structural elements and to
observe changes in their structure30.
The secondary structure of proteins is easily determined by CD spectroscopy in
the far-UV region (190-250 nm). At these wavelengths, the peptide bond absorbs light
and the signal arises from the protein fold. The alpha helix has negative minima at 208
nm and 222 nm, and positive maxima at 190 nm. Beta sheets show a negative peak at 218
nm and a positive peak at 196 nm. The random coil has a positive peak at 212 nm and a
negative one at around 195 nm, Figure 2.17. The CD signal determines the structure
based on the average of the entire molecular, but it cannot determine which specific
residues are involved in each secondary structure portion.
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Figure 2.17: CD for proteins of different secondary structure
http://www.proteinchemist.com/cd/cdspec.html

In the near-UV spectral region (250-350 nm), CD can be useful to determine the
tertiary structure of proteins. In this region aromatic amino acids and disulfide bonds are
the chromophores and their CD signals are sensitive to the overall protein tertiary
structure. Tyrosine residues are responsible for the signal from 270-290 nm,
phenylalanines are responsible for the signal from 250-270 nm, while tryptophan residues
are responsible for the signals from 280-300 nm. Disulfide bond signals are broad and
weak signals spread throughout the entire near-UV region. Therefore, the presence of
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significant signals in the near-UV region is an indication of a well-defined folded protein.
However, the signals in this region are weak, relative to the far-UV region32.
The CD signal for proteins are usually expressed in mean residue ellipticity [θ]MR,
equation (2.14 ). This unit reports the molar ellipticity for individual protein residues to
make it easy to compare different proteins which differ in molecular weight.
(2.14 )

CMR is the mean residue concentration and can be calculated in two different ways,
either by multiplying the molar concentration of protein ( C ) by the number of residues
(N) or by dividing the concentration of protein in unit of gram per liter over the average
amino acid residue weight, which is 113, equation (2.15 )33.

(2.15 )

2.6
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CHAPTER III
3

3.1

BIOPHYSICAL PROPERTIES OF WLN3-6, WLN4-6 AND WLN5-6

Introduction
The understanding of the structure and stability of Wilson disease protein will shed

light into the copper transport mechanism and the effect of mutations on it. Among the
three major domains of Wilson disease protein, the N-terminal domain is the largest one
and plays a major role in copper acquisition and transport. The N-terminal region of
Wilson protein has about 650 amino acid residues, and it has a mass of about 72 kDa. It
consists of six metal binding domains; each one has a conserved GMT/HCXXCXXXIE
motif except that the thereonine residue in the in the third domain is replaced by histidine.
Each domain has a pair of cysteines, which are two residues away from each other, that
bind copper ions. Each of the metal binding domains has around 70 amino acids, and a
mass of around 7 kDa1,2.
All these domains are linked with chains of various lengths. The longest one is
between domains 4 and 5, consisting of 57 residues. The linker between domains 2 and 3
is also long, but it is only 40 amino acids. Linkers between 1 and 2, and 5 and 6 are the
shortest with 12 and 8 amino acids, respectively. The linker between domains 3 and 4 is
30 amino acids. The structure of the N-terminal metal binding domains (WLN1-6) has
not been determined yet. NMR structures of individual metal binding domains from the
highly homologous human copper-transporting ATPase ATP7A have been determined3–5
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and some Wilson protein constructs, WLN5-61, WLN26

and WLN3-47, are also

available, Figure 3.1.
All the six N-terminal metal binding domains of ATP7A, also called Menkes
(MNK), receive copper from the cytoplasmic metallochaperone HAH18. However, the
six soluble domains interact differently with HAH1. Investigations using yeast twohybrid assays9–11 and NMR12,13 show that MNK first and fourth domains form a metalmediated adduct with HAH1 while the sixth domain is simultaneously loaded with Cu(I)
without formation of the adduct. On the other hand, in case of Wilson protein (WLN),
both the second and fourth domains can form a copper-dependent adducts with HAH114.
Interestingly, WLN5-6 can receive Cu(I) from domain 4, but not from HAH11. On the
other hand, all domains were able to receive Cu(I) from HAH1, when metal binding
cysteines were mutated to serine in five of the six metal binding motifs15.
The fact that WLN has six repeated ferrodoxin folds is really interesting, since
other species, such as bacteria or yeast have fewer domains16. Moreover, not all domains
form adducts with HAH1 or are needed for copper trafficking. Some domains accept
copper from other domains. All these facts raised the question about the biophysical
properties and the identity of each domain. In other words, why do similar domains
behave differently? And what is the importance of each domain within the whole protein?
To address these questions, biophysical properties of domains within a construct of other
domains need to be studied. Although NMR structure studies are available on a few
domains of the WLN, the biophysical properties of these domains are not well
understood. Detailed investigations can shed light on the structure and stability of these
domains. In this chapter, the biophysical properties of WLN5-6, WLN4-6 and WLN3-6
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are determined by using circular dichroism, dynamic light scattering, isoelectric focusing
gel, and mass spectrometry.

Figure 3.1: Cartoon structure of WLN3-4, WLN5-6, and WLN2
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3.2

Biophysical characterization and analysis of WLN5-6
WLN5-6 was characterized during the purification process using SDS-PAGE

(15%) in order to collect the fractions that contains the protein fractions. Mass
spectroscopy was used to determine the mass of the protein. ESI-MS showed the mass of
the protein to be 16042 g/mol, Figure 3.2 , the average mass calculated by DNA Strider®
program is 16048 Da.
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Figure 3.2: ESI-IT/MS data showing the molecular weight of WLN5-6 determined by
MagTran software
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3.3

Circular dichroism
The protein samples for CD spectra were prepared by buffer exchange into 50 mM

sodium phosphate buffer, pH 7.5. The protein concentration was determined by the BCA
assay (Pierce). Guanidine Hydrochloride (GuHCl) 8 M was prepared as a stock solution.
The refractive index of GuHCl solution was measured to accurately determine GuHCl
concentration using the following equation (3.1):
C = 57.1 7 (∆N) + 38.68 (∆N) 2 - 91.6 (∆N) 3

(3.1)

where C is the concentration of GuHC1 in moles per liter, and ∆N = (refractive index of
solution - refractive index of water)17.
The protein concentration was constant in all samples, 18 µM, whereas the
GuHCl concentration varied from 0 – 8 M. CD was acquired with a JASCO J-815 CD
Spectropolarimeter. The unfolding was monitored at 222 nm, Figure 3.3, in 0.5 M
increments
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Figure 3.3: Molar ellipticity for the unfolded WLN5-6 using GuHCl
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The denaturation profile of WLN5-6 shows a sigmoidal and a cooperative
transition from the native (N) to the denatured state (D),

. GuHCl is a salt, and

will be ionized in aqueous solution to give the positive guanidinium ion and negative
chloride ion. At low concentrations, these ions are presumed to neutralize and mask the
positive and negative charged amino acid side chains. This affect eliminates electrostatic
interactions that may stabilize or destabilize the protein.

If the protein has more

electrostatic repulsive than attractive forces then at low concentration of GuHCl,
increased protein stability may mask electrostatic repulsion. The reverse is true though18.
At high concentrations, the binding ability of the guanidinium ion is expected to
predominate despite the types of electrostatic interactions present in the protein, and
therefore, it becomes a denaturant and drives the equilibrium toward the unfolded state.
In all the unfolding processes, the high ionic strength of GuHCl solution is also expected
to contribute in masking the electrostatic interaction. The protein stability derived from
GuHCl denaturation is actually a relative estimation of the hydrophobic interactions18.
The standard free energy of unfolding

was calculated using the linear

extrapolation method. The slope (m) of the plots between

and [GuHCl] is a measure

of the ability of GuHCl and any denaturant, in general, to unfold a protein, equation (3.2).
It was also observed that the m value is proportional to the number of denaturant binding
sites exposed on unfolding19,20. The dependent variable was normalized to show the
fractional denaturation (FD), equation (3.3), Figure 3.4.
(3.2)
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(3.3)

YS is the CD signal at a specific concentration of GuHCl, YN is the CD signal for
the native protein, YD is the CD signal for the denatured protein. YN and YD for WLN5-6
is the average molar ellipticity of the native and denatured states calculated from
sigmoidal fit to the unfolding. YN is found to be (-1.99 * 106) deg.cm2.dmol-1 and YD is (3.02 * 105). Since the free energy is related to the equilibrium constant via the equation
(3.4), and Keq is independent of protein concentration, therefore it can be calculated from
the ratio of the molecules folded, equation (3.5).
(3.4)

(3.5)
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Figure 3.4: Fraction denatured of WLN5-6 as GuHCl is added
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was calculated by extrapolating the straight line to [GuHCl] = 0, giving a value

2

-1

Molar Ellipticity (deg.cm .dmol )

of 12.2 ± 0.7 kJ/mol. GuHCl concentration where FD equal 0.5 is 3.3±0.7 M., Figure 3.5.
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Figure 3.6: Thermal unfolding of WLN5-6
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The thermal unfolding of WLN5-6, Figure 3.6, closely approaches a two-state
unfolding model. The unfolding profile can be fitted to a sigmoidal fit in order to obtain
the melting temperature (Tm), which was found to be 81.5 ± 2.7 C. The two-state model
was used to determine the free energy of unfolding,
used to calculate

and

at 293 K, Figure 3.7. Keq can be

for the transition from native to denatured state,

assuming the denaturation is cooperative (no intermediates, and that

,

is independent of

temperature over the range studied). According to the van’t Hoff equation (3.6), a plot of
ln Keq versus (1/T) is a straight line with a slope of(

) and a y- intercept of (

).

(3.6)

then calculated at certain temperature by the following equation, equation (3.7):
(3.7)
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Figure 3.7: Analysis of thermal unfolding for WLN5-6
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The value of

at 293 K is calculated for WLN5-6 by the two state model, 12.7 ± 3

kJ/mol, which agree well with

3.4

which is 12.2 kJ/mol.

Biophysical characterization and analysis of WLN4-6
WLN4-6 purity was characterized using SDS-PAGE (15%), Figure 3.8. Mass

spectroscopy was also used to determine the mass of the protein. ESI-MS showed the
mass of the protein to be 29198 g/mol, Figure 3.8, the average mass calculated by DNA
Strider® program is 29192 Da.
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Figure 3.8: ESI-IT/MS data showing the molecular weight of WLN4-6 determined by
MagTran software
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3.4.1

Chemical and thermal denaturation of WLN4-6
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Figure 3.9: Unfolding of WLN3-6 by GuHCl

The denaturation of WLN4-6 by GuHCl exhibits multiple phases, Figure 3.9 . CD
data were fit to a three-state model, equation (3.8) 21, and the values of the free energies
of unfolding extrapolated to zero denaturant and the m values are given in Table 3.1. The
first transition midpoint occurs at 3.0 M GuHCl, while the second transition occurs at 5.8
M GuHCl.

The first transition state matches the transition for WLN5-6 that was

described earlier. Therefore, the second transition at a higher [GuHCl] is due to the
unfolding of domain 4. Similar results are also observed for unfolding of WLN4 and
WLN1-422.
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Table 3.1: Free energies and m values of unfolding of WLN4-6

Conversions

[GuHCl]m
(kJ/mol)
19.9 ± 2.8
35 ± 11

(kJ/mol/[GuHCl])
6.8 ± 0.9
6.1 ± 2.0

3.00 ± 0.58
5.8 ± 2.6

(3.8)

Where,

and

for the first transition from the native state to the intermediate has value of 20
kJ/mol. The second transition,

, from the intermediate state to the denatured state is

35 kJ/mol, it’s higher by 15 kJ/mol but the m-value is almost the same. m-value is the
slope of the linear fitting and represents a proportionality constant show rate of ∆G
changes with increasing [GuHCl],

The m-values are 6.8 kJ/mol and

6.1 kJ/mol [GuHCl] for first and second transitions, respectively.
Heat denaturation of WLN4-6 was performed on 3.5 µM samples in a cuvette
with a 10 mm path length. The program was set to increase the temperature from 20˚C to
95˚C at rate of 1˚C/min. The CD signal was measured at 222 nm after maintaining the
temperature at each value for 10 seconds. The signal was recorded once a minute. The
WLN4-6 thermal denaturation profile shows a sigmoidal shape that has a transition
melting point (Tm ) of 7 . ˚C, Figure 3.10. To obtain thermodynamic properties such as
∆H and ∆S, the Van’t Hoff equation was used, equation (3.6). Keq was calculated based
on the two-state model where the fraction of molecules in the denatured state is (FD) and
Keq is determined from equation (3.3) and equation (3.5), respectively.
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Plotting ln keq against 1/T gives a linear fit that can be used to obtain the change
in enthalpy (∆H) from the slope and change in entropy (∆S) from the intercept. The van’t
Hoff plot of WLN4-6 is shown in Figure 3.11. The change in entropy is 0. 5 KJ/mol, ∆H
is 156.2 KJ/mol and ∆G is 2 .51 kJ/mol. ∆G was calculated at 20˚C according to
equation (3.7). Free energy is almost that obtained for the first transition from unfolding
using GuHCl. This means that it is corresponding to the unfolding of WLN5-6, and
for WLN5-6 is half of that was obtained for WLN4-6.
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Figure 3.10: Thermal unfolding of WLN4-6
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Figure 3.11: Analysis of thermal unfolding of WLN4-6

The presence of water molecules is critical for protein folding and the
maintenance of the folded structure. Thermal denaturation of protein involves a change in
the protein structure and results in increased hydrogen bond breakage. Therefore, the free
energy change of unfolding is due to the combined effects of both protein unfolding and
hydration changes. The free energy of stability of a typical protein is only 40-90 kJ mol-1
which equivalent to very few hydrogen bonds. There are both enthalpic and entropic
contributions to the free energy that change with temperature, and so give rise to heat
denaturation. Upon thermal unfolding the interior polar and nonpolar groups become
exposed to water and so have consequential changes in the water-water interactions on
,

and
If

.
has a negative value then denaturation is favored.

and

are

generally both positive during thermal denaturation. Water naturally has more structure at
lower temperatures, and so the enthalpy of transfer of polar groups from the protein
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interior into water is positive at low temperatures and negative at higher temperatures.
This is because polar groups generate negative enthalpy change due to the ordered water
molecules that surrounded them and the increasing of molecular interactions. The
breakdown of the water structure is the major contributor to the positive change in the
overall enthalpy at lower temperatures23.

3.4.2

Isoelectric point (pI) of WLN4-6

The isoelectric point of the individual domains of the N-terminal metal binding
domains of Wilson protein vary from acidic for WLN4 to basic for WLN1. Isoelectric
focusing of pure WLN4-6 was determined by using a pH 3-9 gradient gel on a
PhastSystem Separation unit. The pI of WLN4-6 was determined to be 4.86 from linear
fitting of the broad pI protein standard migration against their pIs, in

Figure 3.12. The predicted and experimental pI of WLN5-6 is 4.96. Therefore,
WLN4 and the linker between domains 4 and 5 must have on average a pI similar to
WLN5-6. The pI of WLN4 is 3.85 as confirmed experimentally and the linker pI is 6.21
as predicted by DNA Strider™.
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Figure 3.12: Phast gel 3-9 and isoelectric focusing of WLN4-6

3.4.3

Dynamic light scattering
The hydrodynamic radius of WLN4-6 was determined through dynamic light

scattering performed in the Keck laboratory at Western Michigan University using a
DynaPro Titan instrument from Wyatt Technology Corporation. A 200 µM sample of
WLN4-6 in 50 mM Sodium Phosphate buffer was centrifuged at 15,000 rpm for 14
minutes, then the supernatant was filtered through a 0.22 µm filter. The instrument was
set up to make 10 acquisitions for 10 seconds each. Multiple measurements were
performed and the representative data were cumulatively fit, Figure 3.13.
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Figure 3.13: Autocorrelation fit of the hydrodynamic radius of WLN4-6

The value of hydrodynamic radius (Rh) obtained from the measurements was
3.53±0.4 nm. The predicted hydrodynamic radius for WLN4-6 if considered as globular
protein, which has mass of 29193 Da by the Dynamics 6.7.6 software, is 2.5 nm.
Therefore, the frictional ratio is 1.41. This ratio implies that WLN4-6 molecules have
non-spherical shape. Spherical protein should have a frictional ratio of 1.0.

3.5
3.5.1

Biophysical characterization and analysis of WLN3-6
Mass spectroscopy (MS)
SDS-PAGE was used during the purification of WLN3-6 to determine the

fractions that contain the desired protein which elute from the column and to determine
the purity of the protein. WLN3-6 migrates on SDS-PAGE on apparent mass of 40 kDa.
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WLN3-6 has 379 amino acids, and its mass calculated based on average amino acid
usage by DNA Strider® program is 39.852 kDa. MS separates proteins based on their
mass-to-charge ratio. To separate by MS, a protein is ionized in one of several ways, and
then accelerated by electric or magnetic fields. In some cases, the charged protein will
break apart to produce ions. The pattern of ions produced is dependent on the structure of
the protein so that they may be used to determine the primary structure of the protein.
Most MS instruments in use today ionize proteins in ways that minimizes protein
fragmentation to allow a true mass determination24.
WLN3-6 was prepared for MS by exchanging the buffer into water using a PD10
column (GE Healthcare). The protein concentration was determined using the BCA assay
(Pierce). A sample of 8 µM protein, 50% methanol and 0.1% formic acid was injected
into the spectrometer. The mass of the protein was determined using electrospray
ionization-ion trap mass spectroscopy (ESI-ITMS) in Dr. Andre Venter’s laboratory at
Western Michigan University. The error was within 0.01 % of the predicted mass of
39852 Da, Figure 3.14.

107

Figure 3.14: ESI-IT/MS data showing the molecular weight of WLN 3-6 determined by
MagTran software
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3.5.2

Dynamic light scattering

Dynamic Light Scattering (DLS) is used to measure hydrodynamic sizes,
polydispersities and aggregation effects of protein samples. It measures the laser light
that is scattered from dissolved macromolecules or suspended particles. Due to the
Brownian motion of the molecules and particles in solution, fluctuations of the scattering
intensity can be observed. From the correlation function, the diffusion coefficient D
(units of cm2/sec) of the molecules can be calculated by fitting the data. Finally the
hydrodynamic radius (Rh) of the particles and molecules can be calculated by equation
(3.9)25:

(3.9)
where k is the Boltzmann constant, D the translational diffusion coefficient, T the
temperature and η the solvent viscosity.
DLS interfaced with gel filtration is also used to determine the unknown molar
mass of a protein when calibrated with protein standards of known molecular weights.
The light scattering experiment for WLN3-6 was performed at the Keck Foundation
Biotechnology Resource Laboratory at Yale University. HPLC SEC Laser Light
Scattering of WLN3-6 reveals that the average molecular weight is 39220 g/mol, Figure
3.15, while the molecular mass calculated by the amino acid composition is 39852 Da.
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Figure 3.15: Mass distribution of WLN3-6 protein versus volume. The solid lines (line)
indicate(s) the trace from refractometer while "dots" are weight average MW

The hydrodynamic radius (Rh) determined from “on line” dynamic light scattering
measurement is 3.67 ± 0.12 nm, Figure 3.16. It was calculated using an autocorrelation
function fitting of the dynamic light scattering data, Figure 3.17. This value corresponds
to a translational diffusion coefficient, Dt (6.66 ± 0.22) x 10-7 cm²/sec. If we assume a
molecular weight of 39190 g/mol and a partial specific volume of 0.734 ml/g an
equivalent sphere radius, Rs, can be determined as 2.25 nm. The frictional ratio can be
determined by dividing Rh by Rs, giving a value of 1.63. If WLN3-6 were a perfect
sphere, it would have a frictional ratio very close to 1. Therefore, WLN3-6 molecules
have a non-spherical shape.
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Figure 3.16:Hydrodynamicradius(Rh)determinedfrom“online”dynamiclight scattering
of WLN3-6

Figure 3.17: Autocorrelation fit of hydrodynamic radius of WLN3-6
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3.5.3

Circular dichroism
CD is a useful tool for characterization of secondary structure and unfolding

properties of proteins and polypeptides. The spectra of proteins in the far UV produce
unique structural fingerprints dependent on the geometry of the polypeptide backbone;
there is a weak but broad nπ* transition centered around 220 nm and a more intense
ππ* transition around 190 nm26.
Circularly polarized light is separated into two vectors with equal strength with
one rotating clockwise (ER) and the other counterclockwise (EL). As the asymmetric
molecules interact with light, they absorb left and right handed circular polarized light
differently. The plane of the light is therefore rotated and the summation of ER and EL
produce a single vector that is ellipsoid giving the light a property of being elliptically
polarized. The raw data from CD spectra in millidegrees can be converted into molar
ellipticity, [θ](deg·cm2·dmol-1), by equation (3.10) with the parameters θ, millidegrees;
c, protein concentration in mol/L; l, cell pathlength in cm:
(3.10)

Usually, protein molar ellipticity is converted to a normalized value that is
independent of the length of the protein. Mean residue ellipticity (MRE) is used for this
purpose; it is the measured molar ellipticity [θ]of the molecule divided by the number of
residues in the molecule, equation (3.11).
(3.11)

The protein samples for CD spectra were prepared by buffer exchange into 50
mM Na phosphate, pH 7.5. The protein concentration was determined by the BCA assay
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(Pierce). Guanidine Hydrochloride (GuHCl) 8 M was prepared as a stock solution. The
refractive index of GuHCl solution was measured to accurately determine GuHCl
concentration using the following equation (3.12):
C = 57.1 7 (∆N) + 38.68 (∆N) 2 - 91.6 (∆N) 3

(3.12)

where C is the concentration of GuHC1 solution in moles per liter and ∆N = refractive
index of solution - refractive index of water17.
The unfolding of WLN 3–6 was performed chemically using GuHCl and
thermally by increasing the temperature from 25˚C to 95˚C, Figure 3.18. CD spectra were
acquired with a JASCO J-815 CD Spectropolarimeter. The unfolding was monitored at
222 nm.
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Figure 3.18: Unfolding of WLN3-6 by [GuHCl]

The denaturation of WLN3-6 shows multiple phases as that of WLN4-6. The
denaturation data were fit to a three-state model, equation (3.8) , and the values of the
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free energies of unfolding extrapolated to zero GuHCl (

and

corresponding m values for the two steps are given in Table 3.2 . The

of

), the

and

transitions, extrapolated to zero GuHCl provides an independent estimation of the
free energies of the

and

transitions.

Table 3.2: Free energies and m values of denaturation of WLN3-6 by GuHCl
m
(kJ/mol/[GuHCl])

[GuHCl]

(kJ/mol)

20.4 ± 4.0
24.9 ± 6.9

7.9 ± 1.6
5.1 ± 1.4

2.6 ± 0.5
4.8 ± 1.8

Conversions

Chemical unfolding shows that there is a transition around 2.6 M GuHCl probably
corresponding to the unfolding of domains WLN5-6 and WLN3 together. The second
transition occurs at 4.8 M GuHCl, perhaps due to domain 4 unfolding as noticed for
WLN4-6 unfolding. However, the intermediate in the case of WLN3-6 is less stable than
WLN4-6 when comparing the free energy of the second transition,

, this instability

could be due to the repulsion forces between the acidic residues from domain 4 and the
residues from domain 3 and the linker, but the error of this determination is high.
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Figure 3.19: Thermal unfolding of WLN3-6
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Figure 3.20: Analysis of thermal unfolding of WLN3-6

The thermal unfolding of WLN3-6 is shown in Figure 3.19. This experiment
shows a melting temperature (Tm) of 75 ˚C, which is relatively high and similar to
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WLN4. The Van’t Hoff plot of WLN3-6 is shown in Figure 3.20. The free energy (∆G)
of unfolding obtained from that plot is 21.91 kJ/mol. It is similar to that obtained for the
first transition state from unfolding using GuHCl.

3.5.4

Isoelectric point

In IEF, each protein migrates through the support layer until it is "trapped" at the
point where the pI of the protein is the same as the pH gradient formed in the support
media. IEF was used to determine the pI of WLN3-6 protein, and it was found to be 4.96,
Figure 3.21, which is same as calculated by DNA Strider program of, 4.94.
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Figure 3.21: Phast gel 3-9 and isoelectric focusing of WLN3-6
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3.6

High resolution gel filtration
High resolution gel filtration was performed in order to determine the molecular

weight, and obtain information about the shape and the radius of WLN constructs. In this
experiment, Superdex 200 HR 10/30 column (GE Healthcare), high molecular weight
calibration kit (GE Healthcare) and low molecular weight markers kit (Aldrich) were
used. The standard proteins were run individually and as a mixture, the mixture was
prepared as the recommended concentrations of proteins by the protocol GE Healthcare,
code no 28-4038-41. The void volume of the column was determined through the elution
volume of Ferritin. All proteins were diluted with elution buffer (50 mM sodium
phosphate, 150 mM NaCl, 10 mM DTT, pH = 7.2). Proteins were injected into a 100 μl
loop, and 240 μl of buffer was used to empty the loop. The flow rate was 0.4 ml/min. The
molecular weight (Mr) of proteins of interest was calculated according to a calibration
curve, Figure 3.22, plotting the logarithm of the molecular weight (Log Mr) of the
standards versus the partition coefficient (Kav), equation (3.13),
(3.13)

where

is the elution volume,

is the void volume, and

is the column volume

(which is 23.55 ml for Superdex 200 HR 10/30). Results are shown in Table 3.3. The
Stoke’s radius was determined by plotting the square root of the logarithm of partition
coefficient against the stoke’s radius of the standard proteins, Figure 3.23.
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Table 3.3: Elution volumes of the standards and the proteins

Standard
Proteins

Mr

Rst

Conc
(mg/ml)

Ferritin
Ribonuclease
A
Ovalbumin
Conalbumin
Aldolase
Carbonic
Anhydrase
WLN 5-6

440000
13700

61
16.4

43000
75000
158000
29000

WLN 4-6
WLN3-6

Ve

Kav

Log
Mr

Log
Kav

0.3
3

8.747
18.965

0.690

5.643
4.137

-0.161

0.4012

30.5
48.1
-

4
3
4
2

16.278
15.294
13.856
17.489

0.509
0.442
0.345
0.591

4.633
4.875
5.199
4.462

-0.293
-0.354
-0.462
-0.229

0.5418
0.5952
0.6797
0.4783

-

-

1

16.925

0.552

4.548

-0.258

0.5076

-

-

1
1

15.613
14.784

0.464
0.408

4.818
4.988

-0.334
-0.39

0.5776
0.6241

0.80
0.70

y = -0.3287x + 2.0474
R² = 0.9943

log K av

0.60
0.50
0.40
0.30
0.20
0.10
0.00
4.0

4.2

4.4

4.6

4.8

5.0

5.2

5.4

log Mr

Figure 3.22: Standards calibration curve of high resolution gel filtration
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0.75
0.70

y = 0.0087x + 0.2639
R² = 0.9953

0.65

√ log Kav

0.60
0.55
0.50
0.45
0.40
0.35
0.30
10

20

30

40

50

60

Rst

Figure 3.23: Calibration curve of the standard proteins Stoke’sradius

Determination of the molecular weight by high resolution gel filtration is based
into two assumptions; the proteins have spherical shape and they do not interact with the
gel. The results showed that the molecular weight of the unknowns protein was almost
two times the actual masses, Table 3.4. This indicates that the proteins either interact with
the gel itself or contaminants in the gel, or the proteins have a nonspherical shape which
makes them elute earlier than standards of the same mass. To investigate the interaction
with the contaminants in the gel, the column was washed with 0.1 M NaOH solution and
then the standards and the samples were run again. The results were reproducible and, if
there is an interaction between the gel and the proteins, then that would cause the proteins
to elute later. Based on this, an interaction of the proteins with the gel was excluded.
Interestingly, when other domains of Wilson Protein (WLN 1-4, 39783 Da and WLN 5-6,
16045 Da) were used as internal standards, the mass was close to the masses calculated
from amino acid composition and the radii were close to that measured by the dynamic
light scattering, Table 3.4. This indicates that the proteins do not have the same spherical
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shape as the standards.

This result is also supported by dynamic light scattering

experiment for WLN5-6, WLN 3-6 and WLN4-6, which show a frictional ratio of 1.26,
1.63 and 1.43, respectively.

Table 3.4: Molecular weight of proteins by high resolution gel filtration and the calculated
one by amino acid composition
Protein

Mr (Da)

Rst
(Å)

Amino acids Gel
composition Filtration
using
internal
standards

Gel
filtration
result

WLN5-6

16045

16045

33655

28.02

Gel
filtration
with
internal
standards
-

WLN4-6

29193

30840

62588

36.06

30.3

35.3 ± 0.4

WLN3-6

39854

48986

93066

41.4

37.2

36.7 ± 1.2

3.7

gel
filtration

Light
scattering

21.0 ± 0.6

Secondary structure of WLN5-6, WLN4-6 and WLN3-6
The estimation of the helical content of a protein can be estimated through the CD

signal at 222 nm by comparison to the maximum helicity (

) for the protein expected

based on the number of residues. The MRE for maximum helicity (

) is calculated by

the following equation (3.14)27, and the percentage helicity is calculated as in equation
(3.15). CD scan for all proteins discussed is shown in Figure 3.24 . The results are
summarized in Table 3.5.
(3.14)
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(3.15)

Table 3.5: Percentage of helicity for WLN5-6, WLN4-6, and WLN3-6

Protein
WLN5-6
WLN4-6
WLN3-6

# Res
150
277
379

-39333.3
-39639
-39736.1

34.9 ± 2.6
28.3 ± 1.2
20.9 ± 1.8

30000

WLN3-6
WLN5-6
WLN4-6

20000
15000

2

-1

-1

MRE (deg.cm .dmol .res )

25000

10000
5000
0
-5000
-10000
-15000
200

220

240

Wavelength (nm)

Figure 3.24: CD scan of WLN5-6, WLN4-6, and WLN3-6
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3.8

Summary and conclusion
Three constructs of N-terminal metal binding domains of WLN, WLN5-6,

WLN4-6 and WLN3-6, were characterized using mass spectrometry and dynamic light
scattering. The structure and the stability were investigated via chemical unfolding using
GuHCl and by increasing the temperature and monitoring by circular dichroism. The
frictional ratio increased as more domains are added to the constructs, and so, the
constructs are no longer spherical, which is expected due to the presence of a long linker
and the large size of the constructs. Circular dichroism measurements of the WLN5-6
showed a two state unfolding profile while WLN4-6 and WLN3-6 exhibit three state
models, Figure 3.25. Thermal denaturation of all constructs shows two states with a

Molar Ellipticity (x 10

-6

2

-1

) (deg.cm .dmol )

transition midpoint at temperature of 75 C or higher, Figure 3.26.
-0.2
-0.4
-0.6
-0.8
-1.0
-1.2
-1.4
-1.6
-1.8
-2.0
-2.2
-2.4
-2.6
-2.8
-3.0
-3.2
-3.4
-3.6

WLN5-6
WLN4-6
WLN3-6

0

1

2

3

4

5

[GuHCl]

6

7

8

Figure 3.25: Unfolding of WLN5-6, WLN4-6, and WLN3-6 by GuHCl

The chemical unfolding results for WLN5-6, WLN4-6 and WLN3-6 show lack of
cooperativity within domains. Since, adding domains did not affect the first transition in
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all constructs. However, the second transition in WLN3-6 and WLN4-6 matches the
transition for WLN4 alone. This means that WLN4 maintains its integrity in the
constructs that were studied in this research. In a previous study, the unfolding of WLN12, WLN1-3, and WLN1-422, a lack of cooperativity was observed and WLN4 also
maintains its integrity. These results suggest that WLN1-3 work as one unit and WLN5-6
work as another unit, while WLN4 operates separately. Therefore, we assume that WLN4
acts independently and can transfer copper to other domains as well as acquire copper
from HAH1.

WLN5-6
WLN4-6
WLN3-6

-1

Molar ellipticity (X10 ) (deg.cm .dmol )

-0.5

-6

2

-1.0
-1.5
-2.0
-2.5
-3.0
-3.5

30

40

50

60

70

80

90

100

T (C)

Figure 3.26: Thermal unfolding of WLN5-6, WLN4-6, and WLN3-6

The pI for all constructs is around 5, which mean they are acidic and negatively
charged at physiological pH. They all have elongated shape. The values of the
biophysical properties studied for WLN5-6, WLN4-6, and WLN3-6 are summarized in
Table 3.6.
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Table 3.6: Physical properties of WLN5-6, WLN4-6 and WLN3-6

Property
WLN5-6
Mass spectroscopy
16042
Mass
Chemical unfolding
3.27 ± 0.25
[GuHCl] N—U (M)
[GuHCl] N—I (M)
[GuHCl] I—U (M)
H2O
12.2 ± 0.7
∆G N—U (kJ/mol)
H2O
∆G
N—I (kJ/mol)
∆GH2O I—U (kJ/mol)
3.7 ± 0.19
m N—U (kJ/mol/M)
m N—I (kJ/mol/M)
m I—U (kJ/mol/M)
IEF
4.9028
pI
Thermal Unfolding
81.5 ± 2.5
Tm
0.167 ± 0.004
∆S
59 ± 1.6
∆H
12.7 ± 3.0
∆G @293 K
DLS
21.0 ± 0.628
Rh (Å)
1
Frictional ratio
Spherical
Shape
34.9 ± 2.6
Percentage α helix
(%)

WLN4-6
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WLN3-6

29198

39848

3.0 ± 0.58
5.78 ± 2.6

2.6 ± 0.51
4.8 ± 1.8

19.9 ± 2.8
35.2 ± 11.3
6.8 ± 0.9
6.1 ± 2.0

20.4 ± 0.4
24.9 ± 6.9
7.9 ± 1.6
5.1 ± 1.4

4.86

4.96

74.4 ± 0.4
0.449 ± 0.007
156.2 ± 2.5
24.6 ± 3.3

75.2 ± 0.3
0.397 ± 0.008
138.3 ± 2.87
22 ± 3.8

35.25 ± 0.4
1.41
Non-spherical
28.3 ± 1.2

36.7 ± 0.12
1.63
Non-spherical
20.9 ± 1.8

3.9
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CHAPTER IV
4

4.1

WILSON DISEASE CAUSING MUTANT Y532H

Introduction
In the previous chapter, investigations focused on understanding the structure and

stability of different domains of the Wilson disease protein. It is equally important to
study how the disease causing mutations influence stability. More than 400 mutations are
found in the ATP7B gene of Wilson disease patients. Around 28 of disease-causing
missense mutations are within the six metal-binding domains. Interestingly, 18 are in
domains 5 and 61. Several mutations in the metal binding domains cause the disease as
they affect the interaction between ATP7B and metallochaperones HAH1 and
COMMD1. For example; G85V, L492S, G591D, and A604P result in increased binding
of ATP7B to COMMD1. A486S and Y532H mutations also have increased interaction
slightly but it was not reproducible2. On the other hand, a decrease in the interaction with
HAH1 was observed3,4. HAH1 is actually part of the copper metallation pathway and
intracellular copper efflux.
The fact that Wilson protein has six similar metal binding domains has been the
subject of many investigations. Based on solution structures of individual metal binding
domains, they all have a similar ferrodoxin-like fold like that of the HAH1; however,
genetic and biochemical data imply that the six domains are not functionally equivalent,
and that they function to finetune and regulate the copper transport activity5,6. As part of

128

our efforts to understand the role of the six metal binding domains in the N-terminus of
Wilson protein, our laboratory studied interaction between a construct of WLN5-6 and
the ATOX1chaperone and two other domains, domains 2 and 47. Based on that study, a
pathway was proposed for copper delivery and it was shown that ATOX1 forms a
protein-protein adduct with domains 2 and 4 as observed via NMR. Mutants in domains 5
and 6, specifically L492S and Y532H, have shown a change in the level of interaction
between the ATP7B and ATOX12,8. We assume that missense mutations in the Nterminus of Wilson protein destabilize protein folding structure and disrupt the network
of atomic contacts between domains. So, it is important to understand the structural
stability of the mutants.
Studying protein folding or structure is extremely complicated in vivo especially
in eukaryotic cells. Therefore, protein folding has been widely studied in pure proteins in
vitro using mainly biophysical techniques. These techniques include fluorescence
resonance energy transfer9,10 or intrinsic fluorescence of tryptophan and tyrosine
residues11. Most investigations normally probe the tryptophan fluorescence12,13.
Unfortunately, WLN5-6 does not possess any tryptophan but it possesses three tyrosine
residues, which are fluorescent but not as strongly fluorescent as tryptophan. In most
studies, steady-state fluorescence of tryptophan or tyrosine is used which provides an
ensemble average of interactions around the chromophore. On the other hand, timeresolved fluorescence measurements can provide specific information about the hydrogen
bonding or other ligand-ligand interactions that play a crucial role in quenching the
excited state lifetimes. Lifetimes with femtosecond resolution can interrogate the very
fast interactions that are not observed with nanosecond time resolution. Femtosecond
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time-resolved studies with intrinsic tryptophan fluorescence are difficult with high laser
energy of UV excitation ( i.e 266 nm ) which degrade the tryptophan easily by
multiphoton ionization14. On the other hand, WLN5-6 has three tyrosine residues and
multiple tyrosine residues of a protein can serve as localized probes of structural changes
during thermal and chemical unfolding through ultrafast time-resolved fluorescence
spectroscopy. Our femtosecond time-resolved fluorescence measurements on tyrosine
show little degradation during 266 nm laser irradiation. This system is unique to be
probed with femtosecond measurements.
Two disease causing-mutants, V536A and L492S, were studied by another
laboratory member15. These mutants were incorporated in WLN5-6 construct. The
mutants are less stable than the wild type based on the

unfolding values. However,

tyrosines in V536A exhibit a faster decay and sub picosecond lifetimes relative to wild
type or other mutants. In this study, another important disease-causing mutant, Y532H, is
investigated, Figure 4.1, and its unfolding was monitored by circular dichroism. Also, we
applied tyrosine emission and time-resolved fluorescence spectroscopy to understand the
change in the tertiary structure of this mutant.
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Figure 4.1: Cartoon structure of WLN5-6 (PDB:2EW9), and WLN5-6 Y532H (Tyr48
replaced by His)

4.2
4.2.1

Experimental methods
Expression of Y532H
Site-Directed Mutagenesis was used to produce the three mutant’s plasmids of

WLN5-6, V536A, L492S and Y532H15,16. All primers for mutagenesis were designed
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based on the QuickChange® II XL Site-Directed Mutagenesis kit manual. They were
purchased from, Integrated DNA Technologies, Inc. (Coralville, Iowa). The sequences of
the plasmids were confirmed by DNA sequencing, Retrogen Inc. (San Diego, CA).
WLN5-6 and its mutant, Y532H, were transformed into Escherichia Coli strain Rosetta2
(DE3) cells. A single colony was grown in LB containing Kanamycin antibiotic (30
μg/L). When the OD600 reached 0.6-0.8, cells were induced with 1 mM IPTG at 37 °C
with shaking at 250 rpm for 2-3 h. Then cells were harvested by centrifugation. Cell
pellets were extracted by the freeze-thaw method. Proteins were extracted with 20 mM
MES buffer pH 6.3 containing 1 mM EDTA and 5 mM DTT. For purification, each
protein was passed through a DEAE-Sepharose anion exchange column then gel filtration
( Hiload 26/60 Superdex 75). SDS-PAGE confirmed the purity of the protein. Protein
concentration was measured by the BCA assay.

4.2.2

Circular dichroism
Protein samples were unfolded using Guanidine Hydrochloride (GuHCl) at

different concentrations ranging between 0-8 M. Each sample contains 5 mM Sodium
Phosphate buffer and were equilibrated at room temperature for 2-3 hours. CD
measurements in the UV (190-300 nm) region were recorded on a JASCO J-815. A
quartz cuvette of path length 1 mm was used. Each spectrum was the average of three
scans. Protein concentrations were in the range of 12 - 30 µM. After subtracting the
appropriate blanks, molar ellipticities were calculated using equation (4.1):
(4.1)
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θobs is the observed ellipticity in millidegrees, “c” is concentration of protein (mole per
liter) and “l” is the path length in centimeters. Thermal unfolding were performed using
2-3 micromolar of the protein in a 1 cm path length cuvette, temperature were increased
one degree per minute from 20˚C to 95˚C.

4.2.3

Fluorescence spectroscopy
Optical absorption measurements were carried using Shimadzu UV 2101 PC

absorption spectrometer. Fluorescence measurements were carried out by using a F900
Edinburgh Spectrofluorimeter and a Hitachi F-2500 Spectrofluorimeter with a
rectangular cell of 4 mm path length. Time-resolved fluorescence measurements were
carried out using femtosecond fluorescence up-conversion using the third harmonic of Ti:
Sapphire laser as an excitation source. Emission was recorded at 340 nm, the Exalite dye
was used to optimize the fluorescence upconversion setup with a 266 nm excitation.
Protein concentration for all the steady-state fluorescence measurements was 2 µM. The
excitation wavelength of 270 nm was used while the emission spectra were recorded
from 280 to 450 nm with 5- and 10-nm slit widths for excitation and emission,
respectively.

4.2.4

Quantum yield
The fluorescence quantum yield (ΦF) is the ratio of photons absorbed to photons

emitted through fluorescence. In other words, the quantum yield gives the probability of
the excited state being deactivated by fluorescence rather than by another, non-radiative
mechanism. The most reliable method for recording ΦF is the comparative or relative
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method of Williams et. al17, wherein standard samples with known ΦF values are used.
Essentially, solutions of the standard and test samples with identical absorbance at the
same excitation wavelength can be assumed to be absorbing the same number of photons.
Hence, a simple ratio of the integrated fluorescence intensities of the two solutions
(recorded under identical conditions) will yield the ratio of the quantum yield values.
Since ΦF for the standard sample is known, then the ΦF for the test sample is easy to be
calculated by equation ( 4.2 ):
η
η

( 4.2 )

fluorescence emission curve for the
sample and the standard, respectively.

and

are the absorbance of the standard and

sample, respectively. η and ηs are the refractive index of the solvent for the sample and
the standard respectively. Here, the quantum yields were measured with respect to free
tyrosine fluorescence.

4.3
4.3.1

Results and discussion
Circular dichroism
Mutations of Tyrosine 48 in WLN5-6 to Histidine (Y532H) were studied using

circular dichroism (190-300 nm), and samples were unfolded with GuHCl and heat. The
far UV CD scan can monitor α-helix structure, Figure 4.2, since a canonical α-helical
protein like myoglobin has minima at 222 nm and 208 nm. The molar residue ellipticity
expected for a protein of 150 amino acids is -39333.3 deg·cm2·dmol-1 based on the signal
at 222 nm and equation (3.14). The molar residue ellipticity for Y532H at 222 is -9471.6,
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therefore, the percentage of α-helix is 23.5±1 %. The wild type has α-helix percentage of
34.9±2.6 %. This decrease indicates disruption in the α-helix region in the mutant due to
the substitution of a histidine residue instead of a tyrosine in position 48. The side chain
of tyrosine, specifically the hydroxyl group, was involved in a network of contacts that
maintains the helical structure at domain 57,16.
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Figure 4.2: CD scan for Y532H

The CD signal was also monitored at 222 nm for the same protein after gradually
increasing the temperature to 90˚C. As shown in Figure 4.3, the signal changes little
before 50˚C then it starts to increase and levels off at 90˚C. A sigmoidal fit for the data
shows a Tm at around 79±2. ˚C. The Tm value is slightly lower than the value obtained
for the native protein, 81.5 ± 2.6˚C, Figure 3.6. After incubating the protein at 90˚C for 5
minutes, a CD scan was performed and compared to the scan for the same sample before
unfolding, Figure 4.4. The signal at 222 nm increased noticeably, and the signal at 208
nm decreased and slightly shifted to lower wavelength. This could be due to increasing
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amount of random coil structure. However, the protein was able to recover some of its

Molar Ellipticity (deg.cm 2.dmol-1)

original structure after cooling down to 20˚C.
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Figure 4.3: Thermal unfolding of Y532H monitored at 222 nm
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Figure 4.4: CD scan for folded and unfolded sample of Y532H
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Unfolding of Y532H using GuHCl is shown in Figure 4.5. The protein starts to
unfold at a lower concentration of GuHCl, 1 M and then completely unfolds at around 5
M. [GuHCl] at the midpoint (Cm), is 2.8 ± 0.1 M. The free energy of unfolding was
obtained using the linear extrapolation method, Figure 4.6.

is 10.6 ±1.55 kJ/mol,

and the m-value is 3.34 ± 0.37 kJ/mol/M. The m-value reflects the dependence of free
energy on the concentration of denaturant and the area of the hydrophobic residues that
are accessible to the solvent. Y532H has slightly higher values of m,

, and Cm ,

compared to wild type WLN5-6.
Y532H has a higher free energy of thermal unfolding than WLN5-6, Figure 4.7,
of 13.5±3.5 kJ/mol. If we consider the error of the free energy values, then the values for
both thermal and chemical unfolding are not far from each other, energy values are
summarized in Table 4.1.
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Figure 4.5: Unfolding of Y532H by GuHCl monitored at 222 nm
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Table 4.1: Free energies of unfolding WLN5-6 and Y532H obtained from chemical and
thermal unfolding

WLN5-6
3.30 ± 0.7
12.2 ± 0.7
81.5 ± 2.7
12.7 ± 3

Cm
Tm

4.3.2

Y532H
3.2 ± 0.6
10.6 ± 1.5
79 ± 2.4
13.5 ± 3.5

Fluorescence measurements
Tyrosine fluorescence of Y532H was monitored through an emission scan (λ

ex

=

275 nm). 20 µM Y532H at different concentrations of GuHCl ranging between 0 – 7 M
were prepared and equilibrated at room temperature for 2 hours. A CD scan for the
samples was obtained from 300 to 190 nm, Figure 4.2. The Tyr fluorescence was
monitored often at 270 nm and the emission from 280 – 450 nm was recorded, Figure
4.8.
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Figure 4.8: Emission scans of Tyrosine in Y532H at different [GuHCl]
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Figure 4.9: Fluorescence counts at 310 nm for Y532H at different [GuHCl]

The tyrosine emission at 310 nm increases while the protein unfolds, Figure 4.9.
However, when the protein started to unfold, at 2.5 M GuHCl, the fluorescence suddenly
decreases, levels off, then increases again up to 7 M GuHCl. In the folded state the
fluorescence of the Tyrosine is quenched, presumably due to hydrogen bonding of the
tyrosyl hydroxyl group.
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Figure 4.11: Fluorescence counts at 310 nm for WLN5-6

In the wild type, shown in Figure 4.10 and Figure 4.11, the fluorescence increases
wherein the Y532H fluorescence rate decreases as the protein unfolded.
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4.3.3

Quantum yield
Tyrosine has a quantum yield of 0.14 and it was used as a standard to obtain the

quantum yield for WLN5-6 and Y532H. Diluted samples of Tyrosine, WLN5-6, and
Y532H, in 5 mM sodium phosphate buffer (pH 7.5), were prepared so the absorbance at
275 nm is equal to 0.1, Figure 4.12. The emission scans were recorded from 285-550 nm
for all three samples, Figure 4.13. The value of the refractive index for all samples was
assumed to equal the value for the buffer, 1.333. Y532H exhibits more fluorescence than
the wild type. The fact that Y532H has a higher quantum yield (1.5 fold), Table 4.2, than
the wild type suggests that Y532, in the wild type, acts as a self quencher for the protein,
and once it replaced with Histidine, the quenching effect was removed. Probably the
tyrosine residue in position 532 of WLN5-6 has the most important role among all three
tyrosine residues for non-radiative processes and so its quenching is more significant.

Table 4.2: Quantum yields of WLN5-6 and Y532H

Tyr
WLN5-6
Y532H

Area
101894.6
23987.72
36542.64

J (A275)
0.097
0.100
0.098

QY
0.14
0.032
0.050
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Figure 4.12: Absorbance scan for quantum yield measurements of WLN5-6 and Y532H
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Figure 4.13: Fluorescence scans of WLN5-6 and Y532H for quantum yield measurements
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4.3.4

Ultrafast time-resolved fluorescence spectroscopy
Time-resolved

fluorescence

decays

were

obtained

using

femtosecond

fluorescence up-conversion after excitation at 266 nm and the emission monitored at 300
nm. One important factor to note in this study is that the protein is stable and all kinetics
were reproducible even after long exposure to the laser. This is one of the first studies to
use fluorescence upconversion to monitor the tyrosine fluorescence in a protein. This
paves the way to use ultrafast time-resolved fluorescence spectroscopy to probe specific
amino acid interactions in proteins. The fluorescence decay of the protein is faster than
for the free tyrosine, and Y532H is faster than WLN5-6, Figure 4.14. The lifetime for
free tyrosine is 1.4 ps, Y532H is less than 0.2 ps and for WLN5-6 it is 0.35 ps, Table 4.4.
Since typically tyrosine residues in the proteins are buried and in a constrained
environment, their decay will be slower. However, the tyrosines in Y532H have a fast
decay and this could be due exposure of the two tyrosines to the solvent after the third
tyrosine (Y532) have been removed.
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Figure 4.14: Fluorescence decay of WLN5-6, Y532H, and Tyrosine

4.4

Comparison of Y532H to other mutants V536A, and L492S
Several other mutants of Wilson disease were studied by Marzijarani15, and these

mutants were incorporated in WLN5-6 using site directed mutagenesis. These mutants
are V536A and L492S (V52A and L8S in WLN5-6), Figure 4.15. They were unfolded
using GuHCl, Figure 4.16, and the

for all these mutants and the wild type were

obtained as described in section 3.3 and are summarized in Table 4.3.
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Figure 4.15: Cartoon structure of WLN5-6 (PDB:2EW9) showing the position of V536 and
L492
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Figure 4.16: Unfolding of WLN5-6, Y532H, L492S, and V536A by GuHCl monitored at
222nm

V536A has a transition midpoint of 3.0 M GuHCl which is less than the wild type
of 3.3 M. The ΔGH2O and m values show that V536A secondary structure is less stable
than wild type. The mutation is on the surface of the protein and Alanine is less
hydrophobic residue than Valine, so the mutation affects the Van der Waals interactions.
The position of the mutation is in the loop between β3 and α2 of domain 5, Table 4.3.
Y532H has almost the same unfolding profile as the wild type. The ΔGH2O value is lower
than the wild type but higher than L492S and V536A, perhaps because the position of the
mutation in Y532H is in interface of domains 5 and 6, and not really in the hydrophobic
core.
L492S has a lower stability based on ΔGH2O value. It was predicted because of the
replacement of the hydrophobic leucine residue with highly hydrophilic residue serine.
This mutation definitely alters the stable interaction between the hydrophobic residues
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and so lowers the helicity of the mutant as compared to the wild type. L492S has the

MRE (deg.cm 2.dmol-1.res-1)

lowest helicity among the mutants, Figure 4.17.
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Figure 4.17: CD scan of WLN5-6, Y532H, V536A, and L492S

The CD data shows similar unfolding behavior for L492S and Y532H, compared
to V536A. However, all the mutations have an effect on the structure and on the
conformational stability of the protein. The mutations lowered the free energy value of
unfolding and the transition midpoint which means the mutants are less stable than the
wild type. Dynamic light scattering experiments for V536A and Y532H show almost the
same hydrodynamic radii as WLN5-6 (data not shown) 15,16. We expect that the mutations
do not alter the tertiary structure, but do affect the ionic and hydrogen bonds interaction
in the mutants, and lead to a molten globule structure.
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Table 4.3: Free energy, m values, and Cm calculated from CD measurements at 222 nm

Sample

∆GH2O (kJ/mol)

WLN5-6

12.2 ± 0.7

3.7 ± 0.2

3.3 ± 0.3

WLN5-6 V536A

8.6 ± 0.7

3.4 ± 0.2

2.5 ± 0.3

WLN5-6 L492S

7.1 ± 0.50

2.8 ± 0.2

2.6 ± 0.2

WLN5-6 Y532H

10.6 ± 1.5

3.34 ± 0.4

3.2 ± 0.6

m (kJ/mol/M)

Cm (M)

Quantum yield and time-resolved fluorescence spectroscopy measurements were
performed for all the mutants. In contrast to Y532H, the L492S quantum yield is lower
than wild type. Therefore, this mutation lets Y532 have a highly quenching effect on the
fluorescence of other tyrosines and increases the energy transfer to Y532. In the case of
the tyrosine lifetime, tyrosines in WLN5-6 and mutant V536A exhibit a difference in the
magnitude of the picosecond tyrosine lifetime, Figure 4.18 and Table 4.4. This is
probably due to the fact that the movement and rotation of tyrosine residues are limited
and they are buried in WLN5-6. This means that the fluorescence energy is being utilized
by the mutant in different processes. Interestingly, the decay for L492S is similar to the
wild type, since Y532 is still present and the tyrosine interactions are not altered.
Table 4.4: Lifetimes of WLN5-6, mutants, and free tyrosine in 50 mM phosphate buffer pH
7.0, at room temperature

Sample

Lifetime (population %)

Tyrosine

1.4 ps (46.1 %), >10 ps (53.9 %)

WLN5-6

350 fs (76.7 %), >10 ps (23.3 %)

WLN5-6 V536A

360 fs (97.7 %), 1.5 ps (1.9 %), >10 ps (0.4 %)

WLN5-6 L492S

350 fs (77.5 %), >10 ps (22.5 %)

WLN5-6 Y532H

<200 fs (95%), 1.5 ps ( 1%), > 10 ps (4%)
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This quenching is not due to exposure by the solvent, otherwise the lifetime will
be similar to the free tyrosine. Tyrosine residue lifetimes can be quenched via hydrogen
exchange and non-radiative pathways. Since the tyrosine residues in L492S mutant have
almost the same lifetime as the wild type and Y532H, then it means that tyrosine Y532
alone is not responsible for the emission of the protein. However, it has a role in the
quenching in the V536A mutant. Mutation of Valine to Alanine perturbs the structure and
allows more interaction and energy transfer to Y532.
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Em: 340 nm
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Figure 4.18: Fluorescence decay of Tyrosine, WLN5-6, and the mutants (Y532H, L492S,
and V536A)

4.4.1

Mechanism of ultrafast fluorescence quenching in disease causing mutations
In the case of wild-type protein, the three tyrosine residues form a unique triad

with interactions between them, Figure 4.19. This leads to energy transfer between them
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and less non-radiative relaxation. It has to be mentioned that the hydrogen bonding
interactions between the tyrosines in WLN5-6 are also responsible for some amount of
quenching of the fluorescence that was reflected in their faster lifetimes compared to that
of free tyrosine. V536A influences the interactions around Y532, leading to ultrafast
excited state decay. This triad of tyrosines is very important for the stability of the protein
and ultrafast fluorescence measurements allowed us to begin understand their important
role.

Figure 4.19: Cartoon structure of WLN5-6 showing the hydrogen bonding between Y48
(Y532), Y75 (Y559) , and Y110 (Y594)

4.5

Summary and conclusion
The mutation of Y48 in WLN5-6 (Y532H) has no significant effect in the stability

of the protein as there is no huge difference in the free energy of unfolding. By
investigating the NMR structure of WLN5-6 (PDB:2EW9), we noticed that all the
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tyrosines in WLN5-6 (in positions 48, 75, and110) are connected together through
hydrogen bonds directly or indirectly, Figure 4.19. Y48 is bonded to the
backbone/peptide bond Y75 and Y48 has 51 NOEs ( Nuclear Overhauser Effects ) based
on the NMR structure of WLN5-67,16. On the other hand, Y75 has a hydrogen bond with
N81 that connects with K123, which also has a H-bond with Y110. Y75 and Y110 are
responsible for the fluorescence of the protein while Y48 is quenching the fluorescence,
when replaced by Histidine. Mutant V536A and Y532H affected the rates of the
fluorescence decay which means both perturb the influence of Y48. Present results have
conclusively demonstrated the importance of a tyrosine triad in WLN5-6. We have
provided a new way to monitor specific interactions in proteins with ultrafast timeresolved spectroscopy.

4.6
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CHAPTER V
5

5.1

GREEN FLUORESCENT PROTEIN UNFOLDING

Introduction
In this work, protein unfolding is being used as a tool to estimate and compare the

stability of the N-terminal metal binding domains in Wilson’s protein. We used CD
(Chapter 3), and intrinsic Tyrosine fluorescence (Chapter 4) as tools to monitor the
unfolding. In this chapter, we propose a new tool to monitor protein unfolding, based on
the change in the two-photon absorption (2PA) cross-section during unfolding. To test
our hypothesis, we used protein with a well-known structure and a chromophore buried in
the core of the protein. Therefore, we chose green fluorescent protein to test our model.
Green fluorescent protein was discovered in 1962 by Osamu Shimomura1
accidently, when he was isolating a blue luminescent protein from the jellyfish Aequorea
victoria that he named Aequorin. The jellyfish glowed green instead of blue, due to the
absorbance of the protein’s blue light by a second jellyfish protein called later green
fluorescent protein (GFP). In 1979 Shimomura showed that GFP contained a special
chromophore

that

absorbs

and

emits

light2.

The

chromophore

is

a

p-

hydroxybenzylideneimidazolinone formed from residues 65–67, which are Ser-Tyr-Gly
in the native protein. The formation mechanism is divided into three steps, Figure 5.1; the
first step is the folding of the GFP protein. The second step is rapid cyclization and
dehydration. The last step, which is the rate determining step, is the oxidation by oxygen
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of the Tyrosine side chain3,4. This formation process is auto-catalytic; no enzyme or
cofactor is required. However, it is thermo sensitive above 30℃. Holo GFP is
thermostable.

Figure 5.1: Formation of GFP chromophore

The structure of GFP consists of eleven beta strands that form a beta-barrel and
an α-helix that runs through the center of the barrel. The chromophore is also located in
the center of the β-barrel. The structure classification of the GFP is β-can5,6, Figure 5.2.
Folding of the protein into a β-can structure protects the chromophore from solvent and
solvent-quenching effects. This also, prevents other proteins from accessing the
chromophore region and interferrring with spontanuous chromophore formation. The
GFP structure highlights the importance of the entire protein in the function of the
chromophore, as any deletion in the amino acid sequence leads to diruption of
chromophore formation.
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Figure 5.2: Cartoon structure of GFP, (PDB: 1GFL)

GFP consists of 238 amino acids and its wild type excitation peaks are at 395 nm
and 475 nm with extinction coefficients of roughly 30,000 M-1 cm-1 and 7,000 M-1 cm-1,
respectively. Excitation at 395 nm leads to a decrease over time of the 395 nm excitation
peak and a reciprocal increase in the 475 nm excitation band. This may be due to the
photoisomerization effect with irradiation of GFP by UV light. GFP has an emission peak
at 508 nm.
GFP is the first known example of the Förster cycle within a protein core

5–7

in

which the fluorophore in the GFP protein absorbs a photon at 395 nm which makes the
tyrosine residue (Tyr66) more acidic and then loses a proton. The produced anionic
fluorophore will absorb a photon at 475 nm and finally emit a photon at 508 nm and
accept a proton to return to its original state. The physical studies of native GFP reveals
that it is very resistant to denaturation requiring 6 M guanidine hydrochloride at 90˚C or a
pH of <4.0 or >12.08. The biological role of GFP is to transduce the blue
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chemiluminescence of the protein aequorin into green fluorescent light by energy
transfer. Since fusion of GFP to any protein does not alter the function or location of that
protein, the gene has become a useful tool for making chimeric proteins of GFP linked to
other proteins where it functions as a fluorescent protein tag9,10. Another important
character of GFP is that it tolerates N- and C-terminal fusion to a broad variety of
proteins. It has been expressed in many species: bacteria12, yeast13, slime mold11, plants14,
drosophila15, zebrafish16, and in mammalian cells17. GFP works as a noninvasive
fluorescent marker in living cells which allows wide range of applications where it may
function as a cell lineage tracer18, reporter of gene expression12, or as a measure of
protein-protein interactions19.
Folding of the protein into the β-can structure protects the chromophore from
being solvent accessible and so eliminates solvent-quenching effects. GFP chromophore
fluorescence is quenched upon protein denaturation, presumably by exposing the
chromophore to the aqueous solvent environment20. Therefore, the green fluorescence is
used as an insightful probe of the folding of the protein. GFP needs to fold efficiently in
order to function and inefficient folding is known to limit its use in some applications21.
Much research has been conducted on the folding of this protein, either in vitro or
in vivo. A model in which GFP folds through several intermediates states has been
proposed through the acid-denatured state22. Some studies monitored the chromophore
fluorescence to measure the folding and unfolding kinetics while others use NMR to
analyse structural dynamics23–25. Static and kinetic FTIR, UV/vis and fluorescence
spectroscopy were also used for pressure-induced refolding and unfolding monitorating26.
Single-molecule force spectroscopy was used to drive GFP molecule from the native state

157

to the unfolded state and quantitative analysis of force distributions along with the the
lifetimes has led to a detailed picture of a complex mechanical unfolding27,28. In a recent
study, fluorescent proteins have shown to enhance 2PA cross-section, which was
attributed to the local electric field around the chromophore29. When a protein unfolds,
the electric field around the chromophore changes as the chromophore experiences a new
environment. So, we would like to use this change to monitor the unfolding of proteins.
In this investigation, we have carried out measurements to test this hypothesis and and
develop a new technique to monitor the proteins unfolding. With the development of this
technique, a way to image the folded and unfolded forms of proteins is quite feasible. In
addition to 2PA cross-sections, we will use ultrafast fluorescence lifetimes to follow the
unfolding of GFP.

5.2
5.2.1

Experimental methods
Plasmid generation
GFP gene, from Aequorea coerulescens, was amplified using KOD Hot Start

DNA Polymerase (Novagen ®) By using a pAcGFP1-N1 vector (clontech) as a template
and appropriate primers (with TEV site in the forward primer) which are compatible with
pET 32 Xa/LIC vector, Table 2.3. The amplification reaction and the PCR parameters are
shown in Table 5.1 and
Table 5.2.
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Table 5.1: KOD hot start DNA polymerase reaction

Component

Volume

1- Template cDNA, pAcGFP1-N1(10ng/μlinTEbuffer)

1 μL

2- Forwardprimer1(10μM)

1 μL

3- Reverseprimer1(10μM)

1 μL

4- Buffer for KOD (10 X)

5 μL

5- dNTPs (2 mM)

5 μL

6- MgSO4 (25 mM)

3 μL

7- PCR grade water

33 μL

8- KODhotStartDNApolymerase(1U/μL)

1 μL

Table 5.2: PCR parameters for amplifying GFP gene

Parameters
1- 95˚C
2- 95˚C
3- 70˚C
4- Steps 2-3
5- 4˚C

Time
2 minutes
20 seconds
24 seconds
30 cycles
infinity

0.8 % Agarose gel was used to verify the amplification of the desired gene. The
gene is 723 bp. The product was purified using Qiagen PCR purification kit and
quantified using the intensity of the bands through exposure to UV light in an ethidium
bromide stained gel. 0.2 pmol of purified insert was treated with T4 DNA polymerase to
generate compatible overhangs. The following component was assembled in a small PCR
tube, Table 5.3.
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Table 5.3: T4 DNA polymerase reaction for GFP

Component

Volume

Purified PCR product

1 μl

10X T4 DNA polymerase buffer

1 μl

25 mM dGTP

1 μl

100 mM DTT

0.5 μl

Nuclease-free water

6.3 μl

2.5U/μlT4DNApolymerase

0.2 μl

The reaction was incubated at 22˚C for 30 minutes. Then the enzyme was
deactivated by incubation at 75˚C for 20 minutes. The reaction tube was then chilled on
ice and 0.5 μl of vector was added to 2 μl of the treated insert, and incubated at 22˚C for
5 minutes prior to the addition of 0.5 μl of EDTA solution (25 mM). The produced
plasmid was transformed into Novablue Giga Singles cells. The plasmid was purified and
digested with BamH1 and BglII to assure the ligation of the insert to the vector. Three
plasmids were sent for sequencing to Retrogen Company, CA. using S-tag, T7 and T7
term primers. The 6700 bp (approximately) plasmid is called pET32TEVLIC-GFP.

5.2.2

Expression and protein purification
pET32TEVLIC-GFP was transformed into of BL21(DE3) cells. A single colony

was removed from a previously transformed agar plate using an inoculation loop. The
loop was inserted and stirred to release the cells into a 50 mL culture tube containing 5
mL LB media and 100 mg/L ampicillin. The tube was then placed in the shaker to
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incubate for

hours at 37˚C at a speed of 220-230 rpm. The culture tube then was

transferred to a 500 mL flask containing 100 mL LB media and 100 mg/ L ampicillin.
The flask was incubated in the shaker at the same temperature and speed previously used
(vide supra). Two hours later, the LB media in the flask was transferred to one liter LB
media containing 100 mg/L ampicillin. The flask was placed in the shaker at 37˚C at a
speed of 220-230 rpm. The optical density (OD600) was checked at regular intervals to
evaluate cell growth using a Beckman/Coulter DU 730 Life Science UV/Vis
Spectrophotometer. When the OD600 reached approximately 0.6-0.8, cells were induced
with isopropyl ß–D-1-thiogalactopyranoside (IPTG) to 1 mM. Immediately after adding
IPTG, the temperature of the shaker was lowered to 28-30˚C. Four hours later, cells were
collected using a Sorvall RC-5B superspeed centrifuge (5,000 rpm) for 20 minutes and
stored at -20˚C for later purification.
The expressed protein contains 6x-His-tag so it was purified using nickelsepharose affinity chromatography and gel filtration chromatography. Five grams of cell
pellet was frozen in liquid nitrogen for two minutes and then thawed under cold water for
30 minutes. The freeze/thaw cycle was repeated 5 times. Then the pellet was resuspended in 25 mL BugBuster® (Novagen) extraction reagent. A few microliters of (25
KU) benzonase were added to the extract to decrease cell lysate viscosity by digesting
chromosomal DNA. The solution was centrifuged at 15,000 rpm for 20 minutes (SS-34
rotor). The supernatant was loaded into His Trap FF 16/10 column in order to start
protein binding. The column was attached to an ATKA FPLC system. The column was
washed with 140 mL (7 CV) equilibrium buffer contains 50 mM Potassium Phosphate,
500 mM Sodium Chloride, and 30 mM Imidazole at pH of 7.5. The protein has a visible
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green color which makes it easy to determine the binding of the protein to the column.
The protein was eluted with buffer containing 50 mM potassium phosphate, 500 mM
Sodium Chloride, and 300 mM Imidazole, pH 7.5. The protein was further purified using
gel filtration chromatography. The eluted protein was concentrated by an Amicon
ultrafiltration device with a 3000 Da MWCO membrane at ˚C to reduce the volume of
pooled fractions to 6 mL.
Concentrated solution was injected into a HiLoad 16/26 Superdex 75 prepgrade
column using the FPLC system. Prior to injection, the column was equilibrated with 640
mL (2 CV) of 50 mM MOPS (3-(N-morpholino)propanesulfonic acid), 200 mM sodium
chloride, 10 mM DTT, pH 7.2. The protein was eluted as a sharp peak at 165 mL after
injection; the total CV was 320 mL. Protein containing fractions were concentrated to 7
mL using an Amicon device (vide supra). The purified GFP fusion solution was injected
onto a desalting column to change the buffer into the buffer for TEV protease proteolysis.
The TEV protease buffer contains 50 mM Tris-HCl, 0.5 mM EDTA and 1mM DTT, pH
8.0 (or. The protein concentration was determined using the BCA assay. TEV protease
was added to the protein solution in the TEV protease buffer as a ratio of 1:80, TEV
protease:protein. After addition of TEV protease the solution was incubated at room
temperature overnight.
Purification of the digested GFP-fusion protein was completed using HisTrap, and
Superdex 75 gel filtration fitted to FPLC (Amersham Biosciences, Piscataway, NJ). To
separate the GFP from the His-tag, the digested GFP solution was loaded into a clean
HisTrap column and then GFP was eluted by using the equilibration buffer that contains
50 mM Potassium Phosphate, 500 mM Sodium Chloride, and 30 mM Imidazole, pH 7.5.
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Fractions containing GFP were collected, concentrated, and further purified by gel
filtration with Superdex 75 column as before. The protein eluted at around 200 mL after
injection in a CV of 320 ml. The fractions containing the protein were collected,
concentrated, and desalted against 50 mM Potassium Phosphate buffer, pH 7.5. The
protein was quantified using the BCA assay. By the end of the purification, 10 mg of the
protein was obtained, then stored in phosphate buffer at -20˚C. The extinction coefficient
of the protein in water at 280 nm is equal to 23505 M-1cm-1 and this value was used for
assaying the protein. The yield of the protein is 2 mg per gram pellet, and approximately
10 mg per one liter of culture. The protein purity of GFP was identified by SDS-PAGE,
Figure 5.3 and mass spectrometry, Figure 5.4. The induction for protein expression was
at 28-30˚C. The yield could be potentially increased if the induction temperature was at
room temperature instead of 28-30˚C. However, the formation of the chromophore
depends on the temperature of the induction.
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Figure 5.3: 15 % SDS-PAGE showing GFP after purification

5.2.3

Unfolding of GFP
A solution consists of 16 μM GFP protein mixed with varying amounts of GuHCl

range from 0 M (control) to 3.0 M. All samples were equilibrated for 48 hours at ˚C
prior to the spectroscopic measurements. Steady state fluorescence and circular dichroism
were used to follow the denaturation of the GFP. Data points were acquired at room
temperature using the same protein concentration in an appropriate GuHCl concentration.

5.2.4

Fluorescence spectroscopy
Optical absorption measurements were performed on a Shimadzo UV 2101 PC

spectrometer. Fluorescence measurements were carried out by using F900 Edinburgh
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Spectrofluorimeter and a Hitachi F-2500 Spectrofluorimeter with a rectangular cell of 4
mm path length. Time-resolved fluorescence and fluorescence anisotropy of unfolded
protein samples and the control samples were performed using femtosecond fluorescence
up-conversion. Polarization of the excitation beam for the anisotropy measurements was
controlled using a Berek compensator and the sample is continuously rotated in a cell
with 1 mm thickness. The polarizer was alternated between parallel and perpendicular
orientations to the excitation polarization, with a dwell time of 30 s in each position to
correct for excitation intensity drifts. The emerging light was imaged onto a
microchannel plate photomultiplier detector (MCP-PM; Hamamatsu R1712U-03).
Fluorescence decays were collected using standard TCSPC electronics in 1K channels at
0.0675 ns/ch. Instrument response function (IRF) was measured using Raman scattering
from water. The excitation average power was around 0.9 ± 0.005 mW. 2PA crosssections (δ) measurements were performed using a method employed by Rebane et al30.
A Coumarin 485 solution in methanol was used as reference. A neutral density filter was
used to change the power as the power dependence is measured.

5.3
5.3.1

Results and discussion
Mass spectrometry
The GFP protein produced is a mutant that differs from the native protein by

having a Valine residue in the second position at the N-terminus. Also, it has an extra
Glycine residue due to TEV cleavage at position -1. It consists of 240 amino acids, and
its sequence is shown below:
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GFP sequence
GMVSKGAELF TGIVPILIEL NGDVNGHKFS VSGEGEGDAT YGKLTLKFIC
TTGKLPVPWP TLVTTLSYGV QCFSRYPDHM KQHDFFKSAM PEGYIQERTI
FFEDDGNYKS RAEVKFEGDT LVNRIELTGT DFKEDGNILG NKMEYNYNAH
NVYIMTDKAK NGIKVNFKIR HNIEDGSVQL ADHYQQNTPI GDGPVLLPDN
HYLSTQSALS KDPNEKRDHM IYFGFVTAAA ITHGMDELYK
SYG: Amino acids which form the chromophore

The average mass of the protein calculated by DNA® Strider Software is 26931
Da. When chromophore forms, after dehydration and oxidation, the protein loses a mass
of 18 Da. So, the expected mass for GFP is 26912 Da. The mass spectrum shown in
Figure 5.4 shows a major component of a mass of 26904 Da.
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Figure 5.4: ESI-IT/MS data showing the molecular weight of GFP determined by MagTran
software
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5.3.2

Steady state optical properties
The absorbance and the emission scans of a pure diluted sample (20 μM) of GFP

are shown in Figure 5.5. The absorption spectrum shows two maxima, at 280 nm and at
475 nm. The absorbance at 280 nm is due to the aromatic amino acids. GFP has 12
tyrosines, 13 phenylalanines, and one tryptophan residue. The absorbance at 475 is due to
the chromophore at its anionic form. The emission due to chromophore is observed at
505 nm when the protein excited at 470 nm. Note that the biophysical parameters of this
protein from Aequorea coerulescens are not identical to the original GFP isolated from
Aequorea victoria
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Figure 5.5: Absorbance scan and emission scan of GFP, Excitation wavelength is 470 nm
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When the protein unfolds in guanidine hydrochloride, another absorbance peak
appears at 380 nm while the absorbance at 475 nm decreases until the protein totally
unfolds in 3.0 M GuHCl. This new peak is due to the neutral form of the chromophore, so
the chromophore converts from its anionic form to its neutral form due to exposure to the
solvent, Figure 5.6. However, the absorption band at 380 nm grows in is slower than the
decrease of the 475 nm band, which suggests that the non-fluorescent state is not formed
directly from the fluorescent state20. 1.6 M GuHCl is the concetration where 50 % of the
protein is unfolded and so half of the chromophore is on its neutral form and half is on its
anionic form. At that concentratation of GuHCl, absorbance value at 475 nm is 1.5 fold
more than the absorbance at 380 nm.
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Figure 5.6: Absorbance scan of GFP at different [GuHCl] and the inset represents the
absorbance for each sample at 480 nm and 380 nm

The neutral form of the chromophore does not fluoresce, and this is observed
when the fluorescence decreases as the protein is denatured; inotherwords percentage of
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the neutral form of the chromophore decreases, Figure 5.7. The fact that denatured GFP
is not fluorescent and its absorption spectrum is significantly different from native GFP
implies that noncovalent interactions of the chromophore with its local environment have
a great influence on the spectral characteristics, and that fluorescence is mediated by
amino acids close to the chromophore in the tertiary structure of GFP.
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Figure 5.7: Emission scan of GFP at different [GuHCl], the inset showing the fluorescence
counts for each sample at 507 nm

The quantum efficiency of the chromophore does not change significantly until the
protein totally unfolds, at 2.4 M GuHCl, Figure 5.8. The quantum efficiency was
calculated according to the following equation ( 5.1 ):
( 5.1 )

Fs and As are the fluorescence and the absorption of a sample at certain concentration of
GuHCl, and F0 and A0 are the fluorescence and the absorption of protein without GuHCl.
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Figure 5.8: Quantum efficiency of GFP

5.3.3

Circular dichroism
GFP consists of 11 β-sheets (PDB ID: 1GFL), therefore it’s CD scan shows a

minima at 215 nm as expected, Figure 5.9.
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Figure 5.9: CD scan for GFP
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300

A CD scan was also obtained for each GFP sample prepared at various concentration of
GuHCl. The GFP concentration was maintained at 32 µM for all samples, Figure 5.10.
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Figure 5.10: CD scan of GFP at different [GuHCl], inset shows the molar ellipticity at 215
nm

5.3.4

Fluorescence lifetime
Time-correlated single photon counting (TCSPC) method was used to measure

the fluorescence lifetime31. In this method the sample was excited at 370 nm using the
laser source (section 2.5.2). The sample was excited periodically and the fluorescence
decay profile was reconstructed from multiple single photon events collected over many
cycles. The emission scan was recorded at 510 nm.

The instrument response

fluorescence (IRF) was obtained using aluminum foil to insure total scattering of the
light. The fluorescence decay was added to the IRF and the deconvolution decay fitted
using single, bi-, or tri-exponential fitting, as needed, according to equation ( 5.2 ).
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( 5.2 )

The fluorescence lifetime was fitted to a single exponential for samples of 0 M
GuHCl through 1.2 m GuHCl. At higher GuHCl concentration, the fitting was
multiexponential and the average lifetime was calculated according to equation (5.3)
(5.3)

Where

are two decay lifetimes while

are corresponding

amplitudes.
The fluorescence lifetime of GFP is measured as 3.3 ± 0.1 ns, Figure 5.11. During
denaturation, the fluorescence lifetime did not change significantly at lower concentration
of GuHCl or at higher concentration of GuHCl. However, the fluorescence intensity
decreases at higher concentrations. A constant fluorescence lifetime with decreasing
fluorescence intensity implies that the number of fluorescent protein molecules decreases
during denaturation but not the character of the fluorescent state. Between 1 M and 1.6 M
GuHCl, the lifetime decreases drastically due to the exposure of the chromophore to the
solvent. Conformational changes of the amino acids far from the chromophore did not
affect the fluorescence intensity since they do not make the chromophore solvent
accessible.
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Figure 5.11: Lifetime of GFP chromophore at various GuHCl concentrations

5.3.5

Fluorescence upconversion
Time-resolved fluorescence and fluorescence anisotropy of GFP were studied

using femtosecond fluorescence upconversion. The upconversion system used in our
experiments was obtained from the CDP system, FOG100, in the laboratory of Dr.
Ramakrishna Guda at Western Michigan University. The system uses frequency doubled
light from a mode-locked broad band Ti-sapphire laser (Spectra Physics, Tsunami, 710920 nm). Samples of about 1.0 absorbance unit are continuously rotated in a rotating cell
which is 1 mm thick to avoid the degradation of the sample. Horizontally polarized
fluorescence emitted from the sample was upconverted in a nolinear crystal borate using
a beam pump at 800 nm, which first passed through a variable delay line, Figure 2.16.
Time-resolved fluorescence anisotropy

measurement was carried out with

parallel and perpendicular excitations whose polarization is changed with a Berek
compensator. Fluorescence anisotropy is calculated from traces obtained after parallel
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( Ipar) and perpendicular (Iper) excitation with the following equation, based on the ratio of
difference between parallel and perpendicular polarized emissions over the magic-angle
fluorescence, equations ( 5.4 ) and ( 5.5 ).
( 5.4 )

( 5.5 )

The G factor accounts for the differences in sensitivities for the detection of emission in
perpendicular and parallel polarized configuration.
The fluorescence emission decay indicates the depolarization of the chromophore.
The main reason for the depolarization is molecular rotation or energy transfer to another
molecule with a different orientation32. The chromophore absorbs the light that is parallel
to its absorption dipole. When polarized light is used to excite a sample, only a subset of
molecules will be excited. Brownian motion causes this subset to become disordered
(partially polarized). With sufficient time the fluorescence will arise from randomly
oriented molecules. Monitoring both parallel and perpendicular planes of polarization
enables us to follow this path from order to disorder that caused by Brownian motion32.
Fluorescence anisotropy is useful in obtaining information regarding molecular
size and mobility of the chromophore, because the molecular motion depends on
molecular confinement, and the size of the molecule. An exponential decay of
fluorescence intensity at 510 nm is observed in the investigated concentration range of
GuHCl. As shown in Figure 5.12, the fluorescence intensity decreases faster at higher
concentrations of GuHCl. This decrease is due to the change in local environment when
the protein is unfolded. Although the chromophore is covalently bonded to GFP and
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located at the center of the barrel, unfolding by 1.4 M GuHCl significantly changes the
local environment around the chromophore and makes it accessible to the solvent. At
higher concentrations of GuHCl, the chromophore becomes fully exposed to solvent and
the anisotropy decreases drastically and becomes independent of GuHCl concentration.
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Figure 5.12: Fluorescence decay traces as a function of increasing Guanidine hydrochloride.
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Figure 5.13: Anisotropy values of GFP at various [GuHCl]
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The anisotropy value calculated for the folded GFP was about 0.40, Figure 5.13,
and did not significantly change during unfolding, as expected, since the chromophore is
bound to the backbone and no energy transfer to, or from other ligands is possible.

5.3.6

Two-photon absorption
The power dependence of the fluorescence detected at 850 nm excitation was

determined from a log-log plot of the fluorescence signal at 510 nm versus incident peak
power, shown in Figure 5.14. The induced fluorescence obeyed power-squared intensity
dependence as indicated by the measured slope of 1.98, thereby confirming the existence
of two-photon absorption. GFP excitation at 800 nm yielded the fluorescence spectra
displayed in Figure 5.15. The characteristic GFP bands had a peak at 507 nm, and were
almost indistinguishable from those observed for one photon fluorescence at 400 nm
excitation. The 2PA at 800 nm yielded more fluorescence relative to excitation at 400 nm
in the range of 0 – 1.2 M GuHCl, then decreased to reach a value lower than 1 at 0 M
GuHCl at 3.0 M, Figure 5.15.
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5.3.7

Two-photon absorption cross-section
Two-photon absorption cross-sections (δ) measurements were performed using a

method employed by Rebane et al30, equation (5.6) .
(5.6)

Where,

, and

are the fluorescence intensities of two-photon absorption

of the sample at a certain [GuHCl] in the folded state.

and

are the

fluorescence intensities of one-photon absorption at a certain [GuHCl] and in the folded
state.
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Figure 5.16: Two-photon absorption scan of GFP at different [GuHCl], inset shows the
relative 2PA cross-section

The 2PA cross section of samples at 0, 1.0, 1.6 and 2.6 M GuHCl were measured
as the wavelength was scanned from 710 – 880 nm. The sample at 2.6 M GuHCl showed
almost a constant value over all wavelengths measured. For samples 0, 1.0, and 1.6 M
GuHCl, the value increased as the wavelength increased. The samples of 0 M and 1.0 M
exhibit a lower 2PA cross-section than 1.6 M, Figure 5.16. Since the electric field is

179

related to the 2PA cross section (δ) the relative change of the electric field should be the
same, as shown in Figure 5.17. The 2PA cross section (δ) is directly related to the change
in the dipole moment from the ground state to the excited state (µge). And the latter is
related to the change in the local electric field ( ), equation (5.7):
(5.7)

In the initial state of unfolding the dipole moment of the GFP chromophore is
parallel to the local electric field in the beta barrel. When GuHCl is added to the protein
sample, the electrostatic interaction from its ions enhances the electric field around the
chromophore. After the protein completely unfolds, the chromophore no longer feels the
electric field and so it drops dramatically.
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Figure 5.17: Change in local electric field in GFP as it unfolds
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5.4

Summary
GFP was cloned into the pET-32 Xa/LIC, and expressed as a fusion protein, then

purified using His Tag affinity column and gel filtration. The protein is a monomer with a
mass of 27 kDa. Unfolding of GFP by GuHCl was monitored by CD. 50 % was unfolded
at around 1.6 M GuHCl. The anionic form of the GFP chromophore absorbs light at 480
nm and emits light at around 508 nm. During the unfolding, the neutral form of the
chromophore increases which was noted by its absorbance at 380 nm. As the protein
unfolds the chromophore fluorescence is quenched due to solvent accessibility. The
fluorescence lifetime and the fluorescence intensity both decrease while unfolding in a
profile similar to that obtained by the change in the CD signal.
The 2PA cross-section increased to reach its maximum at around 1.6 M of
GuHCl, and then dropped to a value lower than the initial value. This is due to the change
in the local electric field around the chromophore and to the change in the chromophore
state. Initially, the chromophore is in its anionic form and its dipole moment seems to
slightly align with the local electric field. In the initial stages of unfolding, the anionic
form of the chromophore experiences additional electrostatic interactions that amplify the
electric field around it. However, when the protein is unfolded completely, the
chromophore becomes neutral and the protein loses its beta barrel structure and no
influence of electric field is seen in the 2PA cross-sections. These results have shown that
the 2PA cross-sections of chromophores can be used as markers to study proteins
unfolding. The ratio of two-photon to one-photon fluorescence can also be used to image
the folded, unfolded or mis-folded forms of proteins. In addition, ultrafast fluorescence
measurements were able to monitor the unfolding of GFP quite effectively.
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CHAPTER VI
6

6.1

MONITORING THE UNFOLDING OF THE N-TERMINAL DOMAINS 5-6
OF WILSON DISEASE PROTEIN USING EXTRINSIC FLUOROPHORE

Introduction
Novel techniques of two-photon absorption (2PA) and ultrafast fluorescence to

monitor protein folding/unfolding were demonstrated with a case study of GFP in chapter
5. With this background, we have utilized the same techniques to study the folding and
unfolding of WLN5-6. It is well established in the literature that fluorescence
spectroscopy is an important tool for tackling protein folding because of its sensitivity
and applicability1. Natural intrinsic fluorescence from the tryptophan, and to lesser extent
from tyrosine residues, is used to monitor the tertiary structure of proteins in solution and
can provide information on conformational changes of proteins during unfolding. Also,
we have shown with GFP, that it is possible to use the linear and nonlinear optical
properties of chromophores to study the unfolding (Chapter 5). However, for WLN5-6,
there is no intrinsic chromophore that can be accessed with the fundamental Ti:Sapphire
laser. An alternative approach is to use extrinsic fluorescence where a fluorescent dye is
added to the protein. Extrinsic dyes can be covalently bound to the protein through the
thiol group of the cysteine or through the amine group of the α-amino terminus or the εamine group of lysine2–4. However, there is a risk that added dye may affect the
conformational stability, aggregation tendency and interfere with the interaction of other
ligands with the protein5. Therefore, fluorescence from a protein using a protein’s
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intrinsic fluorescence is the preferred approach to monitor conformational changes.
Fluorescence signals can provide information regarding conformational changes in
proteins due to changes in the polarity around the fluorophor probe, the emission spectra
can shift to shorter or longer wavelength, fluorescence anisotropy 6,7, emission maximum,
fluorescence lifetime, fluorescence anisotropy, and rotational correlation time8.
In this work, it is shown that two-photon absorption is a valid method to monitor
protein unfolding (Chapter 5), and GFP unfolding is investigated by the two-photon
absorption cross-section method. In this chapter, I investigate the unfolding of WLN5-6
construct by a new method, in addition to the time-resolved fluorescence techniques, such
as anisotropy and fluorescence decay. The unfolding of WLN5-6 was monitored through
extrinsic fluorescence rather than intrinsic fluorescencece because it has no tryptophan
residue in its sequence. It has three tyrosine residues and five phenylalanine residues,
which are weak fluorophores compared to tryptophan and need a high excitation energy
which may cause them to degrade.
The probe used is a thiol-reactive reagent called, 7-diethylamino-3-(4'maleimidylphenyl)-4-methylcoumarin (CPM). CPM contains a maleimide group that
forms a covalent bond with the cysteine residue. Figure 6.1 shows the structure of CPM
and the covalent bond formed.
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Figure 6.1: CPM dye structure and covalent bond formation between maleimide group and
thiol group

Two constructs of WLN5-6 were produced via a series of site-directed
mutagenesis experiments in order to obtain two protein constructs that possesses only one
cysteine in each ferrodoxin fold, at positions 6 and 51, Figure 6.2. Position 6 is located in
the β1 sheet of domain 5 while position 51 located in the loop between β3 and α2 of
domain 5. CPM then was bound to the protein, and the resultant dye-protein system was
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unfolded using GuHCl and the unfolding was monitored by CPM fluorescence. All other
cysteines at positions 15, 18, 91, 94 were mutated to serine.

Figure 6.2: Cysteine positions in both constructs of WLN5-6
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6.2
6.2.1

Experimental methods
Construction of plasmid pET24dWLN5-6C51
The gene encoding WLN5-6 was amplified and cloned into pET24d9 producing

pET24dWLN5-6 by Dr. David Achila, a previous laboratory member. It was used to
produce both mutants with only one cysteine residue in the sequence, one mutant has the
cysteine at position 51 (WLN5-6C51) and the second has a cysteine at position 6
(WLN5-6C6).

The

pET24dWLN5-6C6,

resultant

plasmids

respectively.

are

called

pET24dWLN5-6C51

pET24dWLN5-6C51
was

constructed,

and
from

pET24dWLN5-6, by performing 6 mutations targeting 5 cysteine residues and one
glutamate residue in order to have only one cysteine residue at position 51. A mutant of
pET24dWLN5-6 with 7 mutations, which targeted the five cysteins and glutamate at
positions 51 and 127, was available in the laboratory, as a starting point10. The cysteines
were mutated to serines and selected glutamate was mutated to cysteine. This plasmid
was used as template to produce pET24dWLN5-6C51 by performing two mutations,
C127E and S6A, as shown in the scheme in Figure 6.3.
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Figure 6.3: Constructions of WLN5-6C51

Mutations were performed using QuikChange® II XL Site-Directed Mutagenesis
Kit (Stratagene, La Jolla, CA). All required primers (forward and reverse) were designed
as recommended (Table 2.3). First, cysteine at position 127 was altered to glutamate,
(C127E). The sample was prepared as described in Table 6.1, then 1 µL of pfuUltra HF
DNA polymerase (2.5 U/µL) was added. The sample was overlaid with 30 µL mineral oil
and placed in PCR thermocycler machine. The thermocycle parameters, shown in Table
6.2, were carried out. After segment 3 was finished, about 2.5 hours, 1 µL of Dpn I (10
U/µL) was added to the solution below the mineral oil layer and was mixed well by
pumping it up and down with a micropipette. The resultant sample was incubated for 1
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hour at 37 C and then chilled on ice, prior to transformation into XL 10-Gold competent
cells. The competent cells were thawed on ice for 5 minutes, then 2

L of β-

Mecaptoethanol mix was added to the cells for higher efficiency of transformation. After
incubating the cells for 10 minutes, 2 µL of Dpn I-treated DNA was added to the cells.
The cells were incubated in ice for another 30 minutes. Then the cells were heat shocked
by incubating the tube in 2 C for 30 seconds and then immediately incubated on ice for
2 minutes. 500 L of pre-heated SOC medium was added to the tube and then incubated
at 37 C for 1 hour with shaking at 250 rpm. 250 µL of the transformed cells were plated
in the LB/Agar plate containing 30 µg/mL of Kanamycin. The plate was incubated at
37 C for 18 hours. After incubation, about 100 colonies were grew on the plate. A single
colony was inoculated in a 5 mL LB autoclaved medium (contains 30 µg/mL
Kanamycin). Then the tube was incubated at 37 C with shaking for 16 hours. The cells
then were harvested by centrifugation and the plasmid was purified using QIAGEN ®
QIAprep spin Miniprep Plasmid Purification protocol.
The cell pellet was suspended in 250 µL of buffer P1, then 250 µL of buffer P2
was added and the tube was inverted for 4-6 times. 350 µL of buffer N3 was added and
the tube was inverted for 4-6 times. The solution then was centrifuged at 13.5 rpm for 10
minutes. Supernatant was decanted into the spin column then centrifuged for 1 minute.
The flow through was poured away and 750 µL of buffer PE was added to the spin
column, then centrifuged for 1 minute. Again, the flow through was poured away and
then the spin column was centrifuged for another 1 minute. The spin column was placed
in a clean eppendorf tube and 30 µL of EB buffer was added to the column. Then it was
let stand for 2 minutes before being centrifuged for 1 minute and the flow through that
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contained the pure plasmid was collected in the eppendorf tube and stored at – 20 C. The
plasmid was analyzed on 0.8 % agarose gel. A 1000 ng sample was sent to Retrogen, Inc.
(San Diego, CA) for sequencing using T7 and T7-term primers. After confirming the
success of the mutation, the resulting plasmid was used as a template for the
incorporation of the second mutation, S6A. In order to incorporate the second mutation,
S6A, a solution was assembled as described in Table 6.1, and PCR was performed as,
Table 6.2. The mutation and the native plasmid purification were performed as stated
previously.

Table 6.1: Sample preparation for mutations in WLN5-6C51 and WLN5-6C6

Construct

WLN56C51

WLN5-6C6

10 X

DNA

Forward

Reverse

Reaction

Template

primer

primer

buffer

10-50 ng

125 ng

125 ng

(μL)

(μL)

(μL)

(μL)

C127E

5

3

1.087

S6A

5

4

C15,18S

5

2

dNTP

Quick

MilliQ

mix

Solution

H2O

(μL)

(μL)

(μL)

1.11

1

3

35.8

1.036

1.047

1

3

34.9

1.0

1.0

1

3

37

Mutation
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Table 6.2: Thermocycle parameters for mutagenesis

Segment

Cycles

Temperature

Time

1

1

95 C

1 min

2

18

95 C

50 sec

60 C

50 sec

68 C

6.5 min

3

1

68 C

7 min

4

1

C

20 min

In the mutant, pET24dWLN5-6C51, cysteine 6 was mutated to encode alanine
rather than serine, because when mutated to serine the protein folded improperly10. The
protein sequence of WLN5-6C51 is listed below, and the incorporated amino acids are
shown in yellow.
WLN5-6C51 sequence
MAPQKAFLQIKGMTSASSVSNIERNLQKEAGVLSVLVALMAGKAEIKYDP
CVIQPLEIAQFIQDLGFEAAVMEDYAGSDGNIELTITGMTSASSVHNIES
KLTRTNGITYASVALATSKALVKFDPEIIGPRDIIKIIEEIGFHASLAQ

6.2.2

Expression and purification of WLN5-6C51 protein
pET24dWLN5-6C51 was transformed into Rosetta 2 (DE3), and then grown on

LB/agar plate containing 30 μg/mL kanamycin. A single colony was inoculated in a 5 mL
LB medium, scaled up to 1 L, and the protein expression was induced with 1 mM IPTG.
After 3 hours of induction, protein was harvested by centrifugation and extracted from

193

the pellet using the freeze-thaw method. The extraction buffer consists of 20 mM Mes,
pH 6.0, 0.1 mM EDTA, and 5mM DTT. The pI of the protein is around 5, according to
IEF and DNA strider® prediction, and so, at pH 6 it is expected to possess an overall
negative charge. WLN5-6C51 purification was achieved by passing the supernatant of the
extraction step through a DEAE-Sepharose anion exchange column. The negativelycharged proteins will bind to the column, and the positively-charged proteins will pass
through. Bound protein was eluted using the extraction buffer, except that 1M NaCl was
added to it. The fractions that contain the protein were identified using SDS-PAGE, then
collected and concentrated. The protein was further purified by gel filtration using
Superdex 75 column (GE Healthcare). The buffer contained 50 mM HEPES, 200 mM
NaCl, 5 mM DTT, pH 7.5. The protein eluted at around 200 ml. The fractions containing
the protein were collected and concentrated. The buffer was exchanged to 50 mM sodium
phosphate buffer, pH 7.5, using a desalting column. The protein was concentrated using a
3000 MWCO membrane in an Amicon device and stored at – 20 C.

6.2.3

Binding WLN5-6C51 to CPM dye
WLN5-6C51 was reacted with CPM using a general procedure suitable for

binding most thiol-reactive probes. In this process, 50-100 µM of WLN5-6C51 was
dissolved in 50 mM sodium phosphate buffer at pH 7.5 at room temperature. In pH range
of 7.0-7.5, the thiol group of the cysteine is sufficiently nucleophilic, while the amines
groups are protonated and unreactive. The CPM dye was dissolved in DMSO just
immediately prior to use, to about 1-10 mM. The dye is not stable when exposed to light,
therefore aluminum foil was used to wrap it and prevent exposure to the light. 10-20
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moles of dye were added per mole of protein. The dye was added dropwise with gentle
stirring. The reaction was allowed to proceed for 2 hours at room temperature, then for 17
hours at

C. The reaction mixture was protected from light all the time. Upon

completion of the reaction, excess reduced glutathione solution was added to the reaction
mixture and stirred for 30 minutes in order to consume excess CPM dye. The mixture
was concentrated using an Amicon ultrafiltration device with a 3000 MWCO membrane
to a volume of 2.5 mL. This reduced volume was passed through a PD-10 column (GE
Healthcare) to separate the CPM-modified protein from free CPM dye and exchange the
buffer into 50 mM sodium phosphate buffer. The protein then was concentrated again and
quantified using the BCA assay. Almost 75% of the protein was recovered. The labeled
protein mass spectrum was obtained to verify the binding of the dye.

6.2.4

Cloning, expression and purification of WLN5-6Cys6 protein
Four mutations were performed on pET24dWLN5-6 plasmid to prepare a protein

with only one cysteine residue at position 6. At this position the cysteine is expected to be
partially buried between domain 5 and 6. A plasmid of WLN5-6 containing two
mutations was available in the laboratory10, and was used as a template to produce the
above mentioned mutants. The two mutations changed the two cysteines at positions 91
and 94 to serine, Figure 6.4. To change C15 and C18 to serine, one site directed
mutagenesis reaction with QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene)
was performed. Both mutations were completed using one set of primers, Table 2.3. The
final plasmid construct had 4 mutations, cysteine 15, 18, 91, and 94 changed to serine,
and therefore the plasmid contains only one cysteine at position 6.
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Figure 6.4: Scheme represents the mutations performed for WLN5-6C6

The plasmid was sequenced to verify mutation incorporation. The resultant
plasmid was transformed into Rosetta2(DE3), and plated on the LB/agar containing 30
μg/mL kanamycin. A single colony was inoculated into 5 mL LB, scaled up to 1 L, and
the protein expression was induced with 1 mM IPTG final concentration. After 3 hours,
the protein was harvested by centrifugation and extracted from the pellet using a freezethaw method. Protein purification was performed by DEAE-Sepharose anion exchange
and gel filtration by Superdex 75 column.
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The protein has 149 amino acid residues. The protein sequence is shown below. The
protein has an average mass of 15984 Da, verified by Electrospray ionization-ion trap
(ESI-IT) mass spectrometry, performed in Professor Andre Venter’s laboratory at
Western Michigan University. This protein was then bound to CPM dye as described for
WLN5-6C51, Section 6.2.3.

WLN5-6C6 sequence
MAPQKCFLQIKGMTSASSVSNIERNLQKEAGVLSVLVALMAGKAEIKYDP
EVIQPLEIAQFIQDLGFEAAVMEDYAGSDGNIELTITGMTSASSVHNIES
KLTRTNGITYASVALATSKALVKFDPEIIGPRDIIKIIEEIGFHASLAQ

6.2.5

Circular dichroism
The mutant proteins, WLN5-6C51 and WLN5-6C6, and their dye bound forms

were unfolded using GuHCl. The unfolding was monitored by circular dichroism (CD).
Protein solutions of 20-30 μM were prepared with various GuHCl concentrations,
ranging from 0 to 8 M, then equilibrated at room temperature for at least 2 hours prior to
CD measurements. A CD scan from 300 nm to 190 nm was performed; each scan was the
replicated and averaged 3 times. The secondary structure was monitored at 222 nm using
a J-815 CD Spectropolarimeter with a rectangular cell of 1 mm path length.
Guanidine hydrochloride (GuHCl) stock solution of 8 M was used for preparing
various GuHCl concentrations. Its concentration was accurately determined from
refractive index measurements described elsewhere11.
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6.2.6

Fluorescence spectroscopy
Steady-state

measurements,

time-resolved

fluorescence

and

fluorescence

anisotropy were performed as described in Section 5.2.4. Two-photon absorption crosssection (δ) measurements were performed using a method employed by Rebane et al12.

6.2.7

Quantum yield
The emission spectra of the WLN5-6C51 at 0, 0.5, and 4 M GuHCl as well as

C485 were measured upon excitation at 370 nm. For quantum yield analysis, the
absorbance of all samples was fixed at around 0.1. C485 in methanol was used as the
standard. The refractive index for the dye in solution was considered the same as that of
water.

6.3
6.3.1

Results and discussion
Measuring of quantum yield of WLN5-6C51_CPM
The fluorescence quantum yield (ΦF) is the ratio of photons absorbed to photons

emitted through fluorescence. In other words the quantum yield gives the probability of
the excited state being deactivated by fluorescence rather than by another non-radiative
mechanism. The most reliable method for recording ΦF is the comparative or relative
method of Williams et. al.13 which involves the use of standard samples with known ΦF
values. Essentially, solutions of the standard and test samples with identical absorbance at
the same excitation wavelength can be assumed to be absorbing the same number of
photons. Hence, a simple ratio of the integrated fluorescence intensities of the two
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solutions (recorded under identical conditions) will yield the ratio of the quantum yield
values. Since ΦF for the standard sample is known then the ΦF for the test sample is easy
to be calculated.
The ΦF for three samples of WLN5-6C51_CPM was measured. These samples are
at 0, 0.5 and 4 M GuHCl. The comparative dilute method was used and the following
equation, equation (6.1), was applied.
(6.1)

Where

fluorescence emission curve

for the sample and the standard, respectively.

and

were the absorbance of the

standard and sample, respectively. η and ηs are the refractive index of the solvent for the
sample and the standard, respectively. The standard that has been used for the quantum
yield measurements is C485 dye and the results are summarized in Table 6.3.

Table 6.3: Quantum yield measurements of WLN5-6C51_CPM at 0, 0.5 and 4 M guanidine
hydrochloride
Area

RI

Sample

O.D

ID

(370 nm)

C485

0.096

4.0E+08

1.328

1.7646

-

0M

0.089

1.4E+09

1.330

1.7689

3.47036

0.5 M

0.099

1.7E+09

1.340

1.7956

0.1

1.5E+09

1.390

1.9321

O.D

Area

4M

(Q.Y)
(

(

)
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)

(

)

-

(

)

-

0.160

1.078

1.0024

0.600

4.09509

0.97

1.0175

0.646

3.83492

0.96

1.0949

0.645

6.3.2

Mass spectrometry
Mass spectrometry was used to ensure the incorporation of the mutations and to

show absence of post translational modifications for both proteins, WLN5-6C51 and
WLN5-6C6. The average mass expected for WLN5-6C51 based on its sequence is about
15927 Da. The mass spectrum, Figure 6.5, shows a peak with a mass of 15926 Da which
corresponds to the protein. However, another peak shows a mass of 15795 Da. This mass
corresponds to WLN5-6C51 without the initial methionine. It is estimated that about 60
% of mature proteins lose their first methionine 14.

Figure 6.5: ESI-IT/MS data showing the molecular weight of WLN5-6C51 determined by
MagTran software
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The CPM dye has a mass of 402 g/mol. when it bound to the protein, the protein mass
became 16320 g/mol as shown in Figure 6.6.

Figure 6.6: ESI-IT/MS data showing the molecular weight of WLN5-6C51_CPM
determined by MagTran software

Similar observation was obtained for WLN5-6C6. It is calculated average mass is
15985 Da. The mass spectrum shown in Figure 6.7 indicates a peak at 15985 Da, peak A,
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corresponds to the protein while the peak at 15853 Da indicates the protein when the
methionine was lost.

Figure 6.7: ESI-IT/MS data showing the molecular weight of WLN5-6C6 determined by
MagTran software

The mass spectrometry shows that both proteins, with and without methionine, bound to
CPM dye and the mass spectrum is shown in Figure 6.8
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Figure 6.8: ESI-IT/MS data showing the molecular weight of WLN5-6C6_CPM determined
by MagTran software

6.3.3

Circular dichroism

6.3.3.1 WLN5-6C51 and WLN5-6C51_CPM
The unfolding of WLN5-6C51 protein was monitored by CD. The unfolding
profile shows a two state model, and at 2.7 M GuHCl half of the protein molecules are
unfolded, Figure 6.9. The least-squares linear extrapolation regression was used to
determine at the thermodynamics parameters of the protein, Figure 6.10. The results
show a free unfolding energy of 9.67 ± 0.46 kJ/mol. There are no significant differences
between the unfolding of the wild type and this mutant. Therefore, the 6 mutations that
were incorporated to WLN5-6C51 (C15S, C18S, C91S, C94S, C6A, and E51C) did not
change the folding properties. This result was different when C6 was mutated to serine10.
This result may indicate that C6 interacts with hydrophobic residues. So, when mutated
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to a hydrophobic residue, such as alanine, the interaction was not affected. Therefore,
WLN5-6C51 maintains a native-like structure. Serine, which has an –OH moiety, is more
polar and so disrupts the native hydrophobic interactions that stabilize the protein.
Labeling WLN5-6C51 with CPM did not affect the folding of the mutant. It
actually stabilized it slightly. WLN5-6C51_CPM maintains 50 % of its folded structure at
3.1 M GuHCl compared to 2.7 M prior to labeling, Figure 6.11. The literature indicates
that labeling could stabilize the protein if it binds to a hydrophobic region15–17. The free
energies for both the mutant and the labeled protein are almost the same when the range
of the error is considered. The free energy for the mutant is 9.67 ± 0.46 kJ/mol, while
after labeling it is 9.3 ± 0.52 kJ/mol, Figure 6.12.
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Figure 6.9: CD signal for the unfolding of WLN5-6C51 by GuHCl
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6.3.3.2 WLN5-6C6 and WLN5-6C6_CPM
The unfolding of WLN5-6C6 was monitored by CD, Figure 6.13. In this mutant,
the four cysteines in the metal-binding sites of WLN5-6 were changed to serine.
Obviously, the mutations did not affect the folded state of the protein or the unfolding
profile, probably, because the cysteines were located in the loops and not in the core of
the protein. Therefore, they are not interacting with other residues. Also, the free energy
calculation shows higher free energy comparing to the other mutant, WLN5-6C51, Figure
6.14. The free energy is 15.36 ± 0.65 kJ/mol. The mutant also remains stable and folded
even after labeling it with CPM as shown in Figure 6.15 . Its free energy was determined
to be 15.14 ± 0.49 kJ/mol, Figure 6.16.
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Figure 6.13: CD signal of the unfolding of WLN5-6C6 by GuHCl
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6.3.4

Steady-state measurements

6.3.4.1 WLN5-6C51_CPM
The steady state absorption and fluorescence measurements were obtained using
the parameters Section 6.2.6. A quartz cuvette with a width of 4 mm was used for the
measurements. A free CPM dye absorbs light with excitation maxima at 384 nm and
emission maxima at 469 in methanol solvent18. However, the fluorescence of the dye is
sensitive to the environment. In this chapter, the change in the emission intensities and in
the emission maxima of the CPM attached to the protein were used to follow the
unfolding of the proteins. The steady-state measurements of the dye attached to the
protein were performed on the same samples that were prepared for the CD
measurements. So, all the samples contained the same concentration of the protein, 20-30
µM, while GuHCl were varied from 0 – 7.5 M, in 5 mM phosphate buffer.
The absorption spectrum and the fluorescence spectrum of the dye for WLN56C51_CPM are shown in Figure 6.17 and Figure 6.18, respectively. The absorption
maxima increased slightly while the protein was unfolding. This change was due to the
change in the environment around the CPM probe while unfolding. The CPM dye
became more exposed to the solvent, therefore its absorbance increased and shifted
toward longer wavelength, probably due to an increase in the refractive index of the
solution when GuHCl concentration increased. The fluorescence was measured
immediately after the absorption was measured. It also showed the same trend for the
absorption. The emission maxima (apex) increased from 468 nm to the folded protein to
480 nm for the unfolded protein, Figure 6.18, which reflects an increase in the quantum
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efficiency for the excited dye molecules when they are not constrained by protein
structure.
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Figure 6.17: Absorption scan of WLN5-651_CPM at various [GuHCl]
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The dye was also excited using laser light at 800 nm to measure the two-photon
absorption fluorescence. The logarithm of the fluorescence intensity was plotted against
the logarithm of the power to ensure that the excitation was due to the absorption of two
photons. The slope of the plot had value of about 2, as shown in Figure 6.19 . Similar to
one-photon fluorescence, the fluorescence from two-photon absorption increases with the
unfolding of the protein, Figure 6.20 and Figure 6.21.
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Figure 6.19: log-log plot for two-photon absorption measurements
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6.3.4.2 WLN5-6C6_CPM
The absorbance of WLN5-6C6_CPM was also measured in the same way as for
the WLN5-6C51_CPM. Similar results were obtained: the absorbance maxima increased
and shifted to a longer wavelength, Figure 6.22. The fluorescence changed in the same
way, but the folded protein has longer maxima. The fluorescence maximum for the
folded protein was 473 nm and started to increase with the addition of GuHCl until it
reached 478 nm, Figure 6.23. Two-photon absorption was also performed on the samples
using a laser to excite the samples at 800 nm, Figure 6.24. When the enhancements of
two-photon and one-photon fluorescence were compared, two-photon fluorescence was
more than one photon, Figure 6.25.
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6.3.5

Two-photon absorption cross-section
A control was prepared by binding CPM dye to a free cysteine residue in order to

compare the behavior of the CPM dye bound to the protein, with respect to the dye not
bound to the protein. The dye was dissolved in DMSO then an excess of cysteine was
added to the dye solution and stirred for two hours at room temperature and in a dark
environment. The product, Cys-CPM, was used as a control for the spectroscopic
measurements of protein systems that bound to CPM.
Different solutions of GuHCl solutions were prepared (from 0 M - 8 M), and the
dye concentration in all GuHCl solutions were constant. All the experiments that were
performed for the labeled proteins were applied for the control under the same conditions.
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The two-photon absorption (2PA) cross-section for the control, WLN56C51_CPM, and WLN5-6C6_CPM at different GuHCl concentrations were shown in
Figure 6.26. The two photon absorption cross-section (δ) was measured as the ratio
between the intensities of the two-photon fluorescence (I2P) and the intensities onephoton fluorescence (I1P) as in the following equation (6.2):
(6.2)

2PA cross-sections increased as the protein unfolded; this change was due to the
change of the dipole moment of the dye which was produced because of the change in the
electric field. 2PA increasing means that the dye dipole moment was working against the
electric field of the protein. Therefore, 2PA cross-section can be used to image the local
electric field in the protein through the dipole moment measurements of the fluorophore.
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Figure 6.26: Two-photon absorption cross-section for the control, WLN5-6C51_CPM and
WLN5-6C6_CPM
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6.3.6

Time-correlated single photon counting
The fluorescence lifetime of the CPM probe was measured through time-

correlated single photon counting (TCSPC). The samples were excited with 370 nm
pulsed laserlight. The emission decay was observed and the signal de-convoluted using
the instrument response to obtain the actual lifetime. The instrument response function
(IRF) was obtained from measuring the emission decay for a scattered sample; usually it
was either a turbid solution or a piece of aluminum foil placed in the sample holder. The
acquired emission decay curves were fitted to either single or multi-exponential decay
equation, based on the fluorescence decay profile, equation (6.3):

(6.3 )

The change in lifetimes for the control, WLN5-6C51_CPM, and WLN56C6_CPM is shown in Figure 6.27. The lifetime for the folded state of both constructs
was relatively higher than the unfolded form of the proteins. However, WLN56C51_CPM has a higher lifetime than WLN5-6C6_CPM, 3.3 ns and 2.8 ns, respectively,
while the control has a lifetime of 1.7 ns. This is due to the change in the local
environment around the CPM probe. When the probe was in a very constrained
environment with few ionic interactions, or hydrogen bonding, and with no accessibility
to the solvent, its fluorescence lifetime was higher. Therefore, the control has lower
lifetime than the CPM bound to the proteins. However, WLN5-6C51_CPM appeared to
be in the most constrained environment. In the case of the control, the fluorescence
lifetime was continuously increasing with the addition of GuHCl. That is due to change
in the pH and an increase in the electric constant. When CPM dye was bound to the
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protein, its fluorescence lifetime decreases as the protein starts to unfold despite high
GuHCl concentration. The effect of GuHCl did not overcome the effect of having the
probe in a constrained environment until the protein completely unfolded. Then the
bound CPM behavior seemed to be similar to the control, Figure 6.27.
3.4
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Figure 6.27: Change in lifetime with unfolding by GuHCl for the control, WLN56C51_CPM and WLN5-6C6_CPM

6.3.7

Fluorescence upconversion
Fluorescence upconversion was used to study time-resolved polarized

fluorescence of the CPM dye at femtosecond timescales. The sample was constantly
rotated in a 1 mm cylindrical cell. Long, intermediate, and short scans for both parallel
and perpendicular decays were measured in order to calculate anisotropy based on
equation (6.4):
–
(6.4)
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The anisotropy measurements for the control, WLN5-6C51_CPM, and WLN56C6_CPM are shown in Figure 6.28. The anisotropy values for the CPM bound to the
protein were lower than the control. The anisotropy increased in all cases, but in the case
of the protein, the change was similar to the CD unfolding profile. In case of the control,
which is a CPM dye bound to a cysteine, the anisotropy is in direct relation with the
increasing of [GuHCl]. Therefore, at higher [GuHCl] the CPM is changing its orientation
quickly. Similar observations were noticed when the dye was bound to the proteins,
WLN5-6C51_CPM and WLN5-6C6_CPM, but the rate of the increase suddenly became
higher when the protein started to unfold. Unfolding of the protein will release the CPM
from being constrained to become free to orient itself and so the anisotropy increases.
The value of the anisotropy for WLN5-6C6_CPM is 0.30 which is higher by almost 10%
more than the value for WLN5-6C51_CPM, 0.27. This result shows that the CPM
orientation changes more when it is at position 51 rather than position 6. The cysteine at
position 51 is more exposed to the solvent since it is in the loop between β3 and α2;
however, position 6 is enveloped in the protein core.
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Figure 6.28: Change in Anisotropy with unfolding by GuHCl for the control, WLN56C51_CPM and WLN5-6C6_CPM

6.4

Summary
All the methods that have been used to monitor the unfolding showed a transition

at around 2.5 M GuHCl which was confirmed by the circular dichroism as a transition for
unfolding the protein. The maximum emission wavelength was shifted toward the longer
wavelength while increasing the denaturant concentration. During the unfolding, the local
environment around the CPM dye was changed and the dye became more exposed to the
solvent which stabilizes the excited state of the dye and lowers its energy. As a result, the
emission shifted toward longer wavelength while unfolding the protein. On the other
hand, the control fluorescence did not shift. The change of the anisotropy indicates a
change in the dipole moment orientation of the CPM dye while the protein unfolds. This
change is attributed to the change of the electric field around the dye. The change in the
anisotropy was quick compared to the changes based on other methods. The dye
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anisotropy changed from 0.27 in the folded protein to 0.34 for the unfolded state. The
control shows a slight increase in the anisotropy due to the increasing concentration of
denaturant. The two photon absorption cross-section (δ) is measured as the ratio between
the intensities of the two-photon fluorescence (I2P) and the intensities of one-photon
fluorescence (I1P) as in the equation (6.2). 2PA cross section also increases as the protein
unfolds. This change is due to the change of the dipole moment of the dye which was
produced because of the change in the electric field, equation (6.5).
( 6.5)

and

are the dipole moment at zero and non zero electric field.

polarizabilities of excited and ground state, respectively.

are the

is the angle between the

dipole moment and the electric field.
The increasing in 2PA means that the dye dipole moment is working against the electric
field of the protein and that they are antiparallel to each other as shown in Figure 6.29.
The 2PA cross section can be used to image the local electric field in the protein through
the dipole moment measurements of the fluorophore.
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Figure 6.29: The direction of the dipole moment in CPM in WLN5-6C51_CPM and WLN56C6_CPMwith respect to the electric field in WLN5-6 mutant
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The lifetime of the CPM dye is very dependent on its environment. So if it is in a
rigid environment as in the case of the folded protein, the excited state lifetime will be
longer than if it is more flexible. The lifetime of CPM in the folded state was 3.3 ns.
While in the unfolded state of the protein it decreased to be 2.7 ns. However, the CPM
dye lifetime in the control showed a continuous increase in the lifetime due to the
stability of the excited state as the denaturant concentration increases.
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CHAPTER VII
7

7.1

SUMMARY AND FUTURE OUTLOOK

Summary of dissertation work
The need of having six metal-binding domains in Wilson protein  and the

manner in which they are communicating with each other  is not well understood. To
better understand how the last four metal-binding domains function, a detailed
biophysical characterization of these domains was pursued. Molecular biology techniques
were used to produce domains 3 through 6 (WLN3-6), domains 4 through 6 (WLN4-6),
and mutants of domains 5 through 6 (WLN5-6). Unfolding of these constructs was
performed chemically using guanidine hydrochloride (GuHCl), and this process was
monitored by circular dichroism (CD). WLN5-6 unfolds with a two-state model, and half
of its α-helical structure is retained at 3.2 M GuHCl. However, denaturation of WLN3-6
and WLN4-6 produces a double sigmoidal curve. In which, the first sigmoidal transition
confers with the unfolding parameters of WLN5-6 while the second transition values
mirror the unfolding of WLN4 alone. These experiments agree with those reported in the
doctoral dissertation of Alia Hinz (Ph. D., Chemistry Department, Western Michigan
University, 2014) for WLN1-4 and WLN4 alone. The thermal-unfolding midpoints,
which were monitored by CD, are higher than most globular proteins by about 20
degrees, and these experiments show that both WLN3-6 and WLN4-6 are stable
constructs. These observations suggest that the WLN1-3 and WLN5-6 form a unit
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structure with a certain function, while WLN4 serve as a linker with and perhaps have
certain function that is different from the other two constructs (units).
On the other hand, a Wilson disease-causing mutant of WLN5-6, Y48H, which is
Y532H in the whole protein, was studied by both CD and femtosecond time-resolved
fluorescence spectroscopy. CD data show no significant differences in the thermal and
chemical unfolding relative to native WLN5-6. However, in fluorescence up-conversion
experiments, the mutant relaxed significantly faster than native WLN5-6 (~10 fold) in
picosecond time regime. This is attributed to the triad interaction of the three tyrosines
present in the interfacial region between WLN5 and WLN6. This study showed that
fluorescence up-conversion experiments probe the local protein environment near the
tyrosine residues, and monitor the interfacial region and communication between
domains 5 and 6 of WLN5-6.
To study the unfolding of the protein efficiently, two-photon absorption (2PA)
cross-sections was used as a novel fluorescence technique to monitor the unfolding of
proteins and imaging the change in its local electric field.

A derivative of Green

Fluorescent Protein (GFP) was used to test our hypothesis. GFP was successfully cloned
into pET32 Xa LIC vector, and expressed as a fusion protein, then purified using His Tag
affinity column and gel filtration technique. The unfolding of GFP by GuHCl was
monitored by CD. 50 % was unfolded at around 1.6 M GuHCl. The anionic form of GFP
chromophore absorbs light at 480 nm and emits light at around 508 nm. During the
unfolding, the neutral form of the chromophore percentage increased which was noticed
by its absorbance at 380 nm. As the protein unfolds, the chromophore fluorescence
quenched due to the solvent accessibility. The fluorescence lifetime and the fluorescence
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intensity both were decreasing while unfolding in a profile similar to the profile obtained
by CD, except that the CD signal was increasing. The 2PA cross-sections were increasing
to reach its maximum at around 1.6 M of GuHCl, and then it dropped to be lower than the
initial value. This is due to the change in the local electric field around the chromophore
and to the change in the chromophore form. Initially, the chromophore is in its anionic
form, its dipole moment seems to align with the local electric field, and the cross-section
was higher. At the initial stages of unfolding, the anionic form of chromophore
experiences additional electrostatic interactions that amplify the electric field around it.
However, when the protein is unfolded completely, the chromophore becomes neutral,
the protein loses its beta-barrel structure, and no influence of electric fields is seen on the
2PA cross-sections. Present results have conclusively shown that the 2PA cross-sections
of chromophores can be used as good markers to study the unfolding of proteins. Also,
the ratio of two-photon to one-photon fluorescence can be used to image the folded,
unfolded or mis-folded forms of proteins. In addition, ultrafast fluorescence
measurements were able to monitor the unfolding of GFP quite effectively.
Lastly, we applied the 2PA cross-section method on two mutants of WLN5-6
after binding it to an extrinsic CPM dye. Two constructs were produced, with CPM at
positions 51 and 6, WLN5-6C51_CPM and WLN5-6C6_CPM. In both constructs the
anisotropy and the 2PA cross-sections increased with protein unfolding and matched the
CD results. The change in the anisotropy was sharp compared to the changes based on the
other methods. 2PA cross section also increases as the protein unfolds. This change is due
to the change of the dipole moment of the dye which produced because of the change in
the electric field. Its increasing means that the dye dipole moment is working against the
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electric field in an anti-parallel orientation in the folded from. When the protein unfolds,
the influence of electric field is lost and the 2PA cross-section has increased. This result
suggests the validity of these novel ultrafast fluorescence methods; fluorescence
lifetimes, anisotropy and 2PA cross-section can be used to monitor protein unfolding.

7.2

Significance
The major contribution of my research work is in revealing of the stability of

WLN4 in WLN3-6 and WLN4-6 constructs of the N-terminal metal binding domain in
Wilson protein where we observed that WLN4 remains its integrity in almost all
constructs containing it. With this study, we were able to gain further evidence that WLN
domains 1-3 and 5-6 work cooperatively as units and domain 4 connecting them. A
second contribution of our research is in successfully applying ultrafast fluorescence
spectroscopic techniques to probe the structural changes around tyrosines in the
interfacial region between WLN5 and WLN6 in WLN5-6 and its mutants. Our results, for
the first time have shown that femtosecond fluorescence spectroscopy in the UV region
can be used to probe the local environment around any protein which contains tyrosine
residues but not tryptophan. The results have shown the importance of having three
tyrosines arranged spatially close to one another, explaining the mechanic behind fast
fluorescence quenching in the disease-causing mutant Y532H.
Another important contribution of this research is developing a novel technique to
monitor local electric fields in the form of 2PA cross-sections of chromophores. The
influence of environment on the 2PA cross sections of chromophores was utilized to
monitor local electric fields in proteins and thereby protein folding/unfolding transitions.
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7.3

Future outlook
The knowledge that was gained regarding the lack of co-operativity in WLN5-6

and the fact that WLN4 maintains its integrity in all constructs are interesting results that
are important to fully understand the functionality of the N-terminal metal binding
domains. We believe, after this research, that the six metal binding domains interacting as
two units, WLN1-3 and WLN5-6, with WLN4 acting independently. These results give a
better understanding of the mechanism whereby copper acquired by the N-terminal
domains.
The most important contribution of my research is the use of 2PA to monitor the
unfolding of the protein. This method will have applications in monitoring changes in the
local environment at a specific position. This method can also be utilized to image
protein-ligand interactions, protein aggregation, and drug delivery.
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Appendix A

Amino acid sequences of WLN5-6, WLN4-6, and WLN3-6
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WLN5-6 Sequence
MAPQKCFLQI KGMTCASCVS NIERNLQKEA GVLSVLVALM AGKAEIKYDP EVIQPLEIAQ
FIQDLGFEAA VMEDYAGSDG NIELTITGMT CASCVHNIES KLTRTNGITY ASVALATSKA
LVKFDPEIIG PRDIIKIIEE IGFHASLAQ

WLN4-6 Sequence
GTCSTTLIAI AGMTCASCVH SIEGMISQLE GVQQISVSLA EGTATVLYNP AVISPEELRA
AIEDMGFEAS VVSESCSTNP LGNHSAGNSM VQTTDGTPTS LQEVAPHTGR LPANHAPDIL
AKSPQSTRAV APQKCFLQIK GMTCASCVSN IERNLQKEAG VLSVLVALMA GKAEIKYDPE
VIQPLEIAQF IQDLGFEAAV MEDYAGSDGN IELTITGMTC ASCVHNIESK LTRTNGITYA
SVALATSKAL VKFDPEIIGP RDIIKIIEEI GFHASLAQ

WLN3-6 Sequence
GVVTLQLRID GMHCKSCVLN IEENIGQLLG VQSIQVSLEN KTAQVKYDPS CTSPVALQRA
IEALPPGNFK VSLPDGAEGS GTDHRSSSSH SPGSPPRNQV QGTCSTTLIA IAGMTCASCV
HSIEGMISQL EGVQQISVSL AEGTATVLYN PAVISPEELR AAIEDMGFEA SVVSESCSTN
PLGNHSAGNS MVQTTDGTPT SLQEVAPHTG RLPANHAPDI LAKSPQSTRA VAPQKCFLQI
KGMTCASCVS NIERNLQKEA GVLSVLVALM AGKAEIKYDP EVIQPLEIAQ FIQDLGFEAA
VMEDYAGSDG NIELTITGMT CASCVHNIES KLTRTNGITY ASVALATSKA LVKFDPEIIG
PRDIIKIIEE IGFHASLAQ
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Appendix B

Fluorescence lifetime decay and residuals of GFP at various concentrations of GuHCl
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Appendix C

Lifetime components of GFP at various concentrations of GuHCl
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GuHCl
(M)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6

τ1

a1

τ2

a2

τ3

a3

3.4
3.4
3.4
3.3
3.3
3.2
3.1
2.9
2.8
2.8
2.8
2.8
2.3
2.0

1
1
1
1
1
0.94
0.85
0.28
0.05
0.04
0.03
0.01
0.01
0.01

0
0
0
0
0
0.02
0.02
0.276
7.5E-4
8E-4
8E-4
6E-4
6E-4
7.18E-4

0
0
0
0
0
0.06
0.15
0.518
0.704
0.716
0.726
0.745
0.713
0.735

0
0
0
0
0
0
0
0.0135
0.0118
0.0075
0.0065
0.0085
0.0058
0.0052

0
0
0
0
0
0
0
0.206
0.25
0.241
0.246
0.255
0.287
0.265

τ: is the lifetime
a: is the corresponding population
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Time
(ns)
3.3841
3.407
3.3563
3.34
3.2712
2.97915
2.62463
0.80914
0.13259
0.12171
0.07919
0.03013
0.02491
0.02181
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